0001072613-22-000370.txt : 20220330 0001072613-22-000370.hdr.sgml : 20220330 20220330170213 ACCESSION NUMBER: 0001072613-22-000370 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220330 DATE AS OF CHANGE: 20220330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NETWORK-1 TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001065078 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 113027591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15288 FILM NUMBER: 22787402 BUSINESS ADDRESS: STREET 1: 65 LOCUST AVENUE CITY: NEW CANAAN STATE: CT ZIP: 06840 BUSINESS PHONE: 2039201055 MAIL ADDRESS: STREET 1: 65 LOCUST AVENUE CITY: NEW CANAAN STATE: CT ZIP: 06840 FORMER COMPANY: FORMER CONFORMED NAME: NETWORK 1 TECHNOLOGIES INC DATE OF NAME CHANGE: 20131015 FORMER COMPANY: FORMER CONFORMED NAME: NETWORK 1 SECURITY SOLUTIONS INC DATE OF NAME CHANGE: 19980629 10-K 1 network1_10k-123121.htm FORM 10K FOR YEAR ENDED DECEMBER 31, 2021
0001065078 false 2021 FY 0001065078 2021-01-01 2021-12-31 0001065078 2021-06-30 0001065078 2022-03-28 0001065078 2021-12-31 0001065078 2020-12-31 0001065078 2020-01-01 2020-12-31 0001065078 us-gaap:CommonStockMember 2019-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001065078 us-gaap:RetainedEarningsMember 2019-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001065078 2019-12-31 0001065078 us-gaap:CommonStockMember 2020-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001065078 us-gaap:RetainedEarningsMember 2020-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001065078 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001065078 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001065078 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001065078 us-gaap:CommonStockMember 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001065078 nssi:CiscoMember nssi:SettlementAndLicenseAgreementMember 2018-01-01 2020-03-07 0001065078 nssi:FullyPaidLicensesMember 2021-01-01 2021-12-31 0001065078 nssi:FullyPaidLicensesMember 2020-01-01 2020-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2021-01-01 2021-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2020-01-01 2020-12-31 0001065078 srt:MinimumMember 2021-01-01 2021-12-31 0001065078 srt:MaximumMember 2021-01-01 2021-12-31 0001065078 us-gaap:PatentsMember 2021-12-31 0001065078 us-gaap:PatentsMember 2020-12-31 0001065078 nssi:StockIncentivePlanMember 2021-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001065078 us-gaap:StockOptionMember nssi:DirectorsThreeMember 2020-01-01 2020-12-31 0001065078 us-gaap:StockOptionMember 2020-12-31 0001065078 us-gaap:StockOptionMember 2019-12-31 0001065078 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001065078 us-gaap:StockOptionMember 2020-01-01 2020-12-31 0001065078 us-gaap:StockOptionMember 2021-12-31 0001065078 nssi:CostBasisMember 2021-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2021-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2021-12-31 0001065078 nssi:FairValueMember 2021-12-31 0001065078 nssi:CostBasisMember 2020-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2020-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2020-12-31 0001065078 nssi:FairValueMember 2020-12-31 0001065078 nssi:IliadMember 2021-12-31 0001065078 nssi:IliadMember nssi:ClassCUnitsMember 2021-12-31 0001065078 nssi:IliadMember nssi:ClassCUnitsMember 2021-01-01 2021-12-31 0001065078 nssi:ILiadBiotechnologiesLLCMember 2021-03-12 0001065078 nssi:ILiadBiotechnologiesLLCMember 2021-03-01 2021-03-12 0001065078 nssi:IliadMember 2021-01-01 2021-12-31 0001065078 nssi:IliadMember 2020-01-01 2020-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member 2021-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member 2020-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member 2021-01-01 2021-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationSettlementFiledInJuly2010Member 2021-01-01 2021-12-31 0001065078 2013-05-01 2021-12-31 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2021-01-01 2021-12-31 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2020-01-01 2020-12-31 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2020-01-01 2020-12-31 0001065078 srt:ChiefFinancialOfficerMember 2021-01-01 2021-12-31 0001065078 srt:ChiefFinancialOfficerMember 2020-01-01 2020-12-31 0001065078 srt:VicePresidentMember 2021-01-01 2021-12-31 0001065078 srt:VicePresidentMember 2020-01-01 2020-12-31 0001065078 nssi:HewlettPackardEnterpriseMember 2021-07-25 2021-07-26 0001065078 nssi:LicenseAgreementMember 2019-01-01 2021-03-30 0001065078 nssi:GoogleMember nssi:OnAprilFourTwoThousandFourteenAndDecemberThreeTwoThousandFourteenMember 2021-01-01 2021-12-31 0001065078 nssi:FacebookMember 2017-05-08 2017-05-09 0001065078 2021-10-01 2021-10-26 0001065078 nssi:RemotePowerPatentMember 2020-01-01 2020-12-31 0001065078 nssi:RemotePowerPatentMember 2021-01-01 2021-12-31 0001065078 nssi:LicenseesTwoMember 2021-01-01 2021-12-31 0001065078 nssi:LicenseesOneMember 2020-01-01 2020-12-31 0001065078 nssi:BoardOfDirectorsMember 2021-05-26 2021-05-27 0001065078 nssi:BoardOfDirectorsMember 2021-06-11 0001065078 2011-08-01 2021-12-31 0001065078 2020-01-01 2020-06-09 0001065078 nssi:BoardOfDirectorsMember 2021-02-01 2021-02-23 0001065078 nssi:BoardOfDirectorsMember 2021-09-01 2021-09-10 0001065078 us-gaap:SubsequentEventMember nssi:BoardOfDirectorsMember 2022-02-01 2022-02-23 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-02-01 2021-02-23 0001065078 us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember 2022-03-01 2022-03-11 0001065078 us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember 2022-03-01 2022-03-22 0001065078 us-gaap:SubsequentEventMember 2022-03-01 2022-03-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure nssi:Number

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 10-K

_________________

 
☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2021

 

  

or

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

   

For the transition period from __________ to __________.

  

Commission File Number:   1-15288

_____________________

 

NETWORK-1 TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

_____________________

 

Delaware   11-3027591

(State or Other Jurisdiction of

Incorporation or Organization)

  

(I.R.S. Employer

Identification Number)

     

65 Locust Avenue

New Canaan, Connecticut 06840

(Address of Principal Executive Offices)

 

Registrant's telephone number, including area code:   (203) 920-1055

 

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol Name of each exchange on which registered
Common Stock $.01 par value NTIP NYSE American
     

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $.01 par value

(Title of Class)

_________________

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐    No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934. Yes ☐   No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

 

 
 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ☐ Accelerated filer  ☐
Non-accelerated filer  ☐ Smaller Reporting Company  ☒
Emerging growth company  ☐  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐   No ☒

The aggregate market value of the voting and non-voting common stock held by non-affiliates computed by reference to the price at which the common stock was last sold as of June 30, 2021 was approximately $47,450,000 based on the closing price as reported on NYSE American Exchange.  Shares of voting stock held by each officer and director and by each person, who as of June 30, 2021, the last business day of the Registrant’s most recently completed second quarter, may be deemed to have beneficially owned more than 10% of the voting stock have been excluded. This determination of affiliate status is not necessarily a conclusive determination of affiliate status for any other purpose.

The number of shares outstanding of Registrant's common stock as of March 28, 2022 was 23,883,024.

   

 

 
 

NETWORK-1 TECHNOLOGIES, INC.

2021 FORM 10-K

TABLE OF CONTENTS

Page No.

PART I

Item 1.      Business 2
Item 1A.   Risk Factors 11
Item 1B.   Unresolved Staff Comments 20
Item 2.      Properties 20
Item 3.      Legal Proceedings 21
Item 4.      Mine Safety Disclosures 22
PART II  
Item 5.      Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 23
Item 6.      (Reserved) 25
Item 7.      Management's Discussion and Analysis of Financial Condition and Results of Operations 25
Item 7A.   Quantitative and Qualitative Disclosures About Market Risk 32
Item 8.      Financial Statements and Supplementary Data 32
Item 9.      Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 32
Item 9A.   Controls and Procedures 32
Item 9B.   Other Information 34
Item 9C.   Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 34
PART IIII  
Item 10.    Directors, Executive Officers and Corporate Governance 35
Item 11.    Executive Compensation 39
Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 44
Item 13.    Certain Relationships and Related Transactions and Director Independence 46
Item 14.    Principal Accountant Fees and Services 47
PART IV  
Item 15.    Exhibits and Financial Statement Schedules 48
Signatures 50

  

 

-1- 
 

PART I

Forward-looking statements:

THIS ANNUAL REPORT ON FORM 10-K CONTAINS STATEMENTS ABOUT FUTURE EVENTS AND EXPECTATIONS WHICH ARE “FORWARD-LOOKING STATEMENTS”. ANY STATEMENT IN THIS 10-K THAT IS NOT A STATEMENT OF HISTORICAL FACT MAY BE DEEMED TO BE A FORWARD-LOOKING STATEMENT WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES EXCHANGE ACT OF 1933, AS AMENDED, OR SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. FORWARD-LOOKING STATEMENTS PROVIDE CURRENT EXPECTATIONS OF FUTURE EVENTS BASED ON CERTAIN ASSUMPTIONS AND INCLUDE ANY STATEMENT THAT DOES NOT DIRECTLY RELATE TO ANY HISTORICAL OR CURRENT FACT. STATEMENTS CONTAINING SUCH WORDS AS “MAY,” “WILL,” “EXPECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “COULD,” “ESTIMATE,” “CONTINUE” OR “PLAN” AND SIMILAR EXPRESSIONS OR VARIATIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS.  THESE STATEMENTS ARE BASED ON THE BELIEFS AND ASSUMPTIONS OF OUR MANAGEMENT BASED ON INFORMATION CURRENTLY AVAILABLE TO MANAGEMENT. SUCH FORWARD-LOOKING STATEMENTS ARE SUBJECT TO CURRENT RISKS, UNCERTAINTIES AND ASSUMPTIONS RELATED TO VARIOUS FACTORS SET FORTH IN THIS REPORT AND IN OTHER FILINGS MADE BY US WITH THE SECURITIES AND EXCHANGE COMMISSION. BASED UPON CHANGING CONDITIONS, SHOULD ANY ONE OR MORE OF THESE RISKS OR UNCERTAINTIES MATERIALIZE, INCLUDING THOSE DISCUSSED AS “RISK FACTORS” IN ITEM 1A AND ELSEWHERE IN THIS REPORT, OR SHOULD ANY OF OUR UNDERLYING ASSUMPTIONS PROVE INCORRECT, ACTUAL RESULTS MAY VARY MATERIALLY FROM THOSE DESCRIBED IN THIS REPORT. WE UNDERTAKE NO OBLIGATION TO UPDATE, AND WE DO NOT HAVE A POLICY OF UPDATING OR REVISING THESE FORWARD-LOOKING STATEMENTS. READERS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE THE STATEMENT WAS MADE. UNLESS THE CONTEXT OTHERWISE REQUIRES, THE TERMS “NETWORK-1,” “COMPANY,” “WE,” “OUR,” “US” MEAN NETWORK-1 TECHNOLOGIES, INC. AND ITS WHOLLY-OWNED SUBSIDIARIES, MIRROR WORLDS TECHNOLOGIES, LLC AND HFT SOLUTIONS, LLC.

ITEM 1. BUSINESS

Overview

Our principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-five (95) patents including (i) our Cox patent portfolio (the “Cox Patent Portfolio”) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) our M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded sim cards in next generation IoT, Machine-to-Machine, and other

 

-2- 
 

mobile devices, including smartphones tablets and computers; (iii) our HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) our Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) our remote power patent (“Remote Power Patent”) covering the delivery of power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.  In addition, we continually review opportunities to acquire or license additional intellectual property.

To date, we have invested $6,000,000 in ILiAD Biotechnologies, LLC, a clinical stage biotechnology company with an exclusive license to fifty-eight (58) patents (see “Investment in ILiAD Biotechnologies” at page 10 of this Annual Report).

Until March 7, 2020, when our Remote Power Patent expired, we had been actively engaged in the licensing of our Remote Power Patent (U.S. Patent No. 6,218,930) which generated licensing revenue in excess of $187,000,000 since May 2007. We achieved twenty-eight (28) license agreements with respect to our Remote Power Patent which, among others, included license agreements with Cisco Systems, Inc. (“Cisco”), Dell Inc., Hewlett-Packard Enterprise Company and Hewlett Packard Company (collectively, “Hewlett-Packard”), Extreme Networks, Inc., NETGEAR, Inc. (“Netgear”), Microsemi Corporation, Motorola Solutions, Inc., NEC Corporation, Samsung Electronics Co., Ltd, Huawei Technologies Co., Ltd., ShoreTel, Inc., Juniper Networks, Inc., Polycom, Inc. and Avaya, Inc.

As a result of the expiration of our Remote Power Patent, we no longer receive licensing revenue for such patent for any period subsequent to the expiration date (March 7,2020). However, subsequent to the expiration date of our Remote Power Patent, we received licensing revenue from certain licensees for periods prior to March 7, 2020.  On March 30, 2021, we entered into an amendment to our Settlement and License Agreement, dated May 25, 2011, with Cisco (the “Agreement”) pursuant to which Cisco paid $18,692,000 to us to resolve a dispute relating to Cisco’s contractual obligation to pay royalties under the Agreement pertaining to the Remote Power Patent for the period beginning in the fourth quarter of 2017 through March 7, 2020 (see Note K[2] to our consolidated financial statements included in this Annual Report).  In addition, on July 26, 2021, we entered into a settlement agreement with Hewlett-Packard pursuant to which Hewlett-Packard paid us $17,000,000 in full settlement of a patent litigation involving our Remote Power Patent (see Note K[1] to our consolidated financial statements included in this Annual Report). We believe that NETGEAR, Inc. (“Netgear”), another licensee of our Remote Power Patent, is obligated to pay us royalties that accrued but were not paid since the fourth quarter of 2017 through March 7, 2020.  We have pending litigation against Netgear to recover such royalties (see Note K[5] to our consolidated financial statements included in this Annual Report).

 

 

 

-3- 
 

 

Since acquisition of our Mirror Worlds Patent Portfolio in May 2013, we have received licensing and other revenue from the Mirror Worlds Patent Portfolio of $47,150,000 through December 31, 2021 including license agreements with Apple and Microsoft.

Our current strategy includes continuing our efforts to monetize our intellectual property. In addition, we continue to seek to acquire additional intellectual property assets to develop, commercialize, license or otherwise monetize. Our strategy includes working with inventors and patent owners to assist in the development and monetization of their patented technologies. Our patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as we have achieved with respect to our Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, we may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.

We have pending litigation involving our assertion of infringement claims concerning certain patents within our Cox Patent Portfolio and intend to appeal to the U.S. Court of Appeals for the Federal Circuit the District Court judgment of non-infringement dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 21-22 of this Annual Report).

At December 31, 2021, we had cash and cash equivalents and marketable securities of $59,623,000 and working capital of $55,665,000. Based on our current cash position, we believe that we will have sufficient cash to fund our operations for the foreseeable future. Based on our cash position, we continually review opportunities to acquire additional intellectual property as well as evaluate other strategic alternatives.

Overview of Our Patents

Cox Patent Portfolio

Our Cox Patent Portfolio, acquired from Dr. Ingemar Cox in February 2013, currently consists of thirty-nine (39) patents, relating to enabling technology for identifying media content on the Internet, such as audio and video, and taking further actions to be performed based on such identification. All of the patents within our Cox patent portfolio expired in September 2021 except for two patents which expire in July 2023 and November 2023. We have pending litigation against Google Inc. and YouTube, LLC involving assertion of certain patents within our Cox Patent Portfolio (see “Legal Proceedings” at pages 21-22 hereof). The patents within our Cox Patent Portfolio are based on a patent application filed in 2000. Since the acquisition of the Cox Patent Portfolio in February 2013, we have been issued thirty-four (34) additional patents relating to this portfolio. The claims in these thirty-four (34) additional patents are generally directed towards systems of content identification and performing actions following therefrom.

-4- 
 

We are obligated to pay Dr. Cox 12.5% of the net proceeds generated by us from licensing, sale or enforcement of the Cox Patent Portfolio. Dr. Cox provides consulting services to us with respect to the Cox Patent Portfolio and assists our efforts to develop the patent portfolio.

Dr. Cox is currently a Professor at the University of Copenhagen and University College London where he is head of its Media Futures Group. Dr. Cox was formerly a member of the Technical Staff at AT&T Bell Labs and a Fellow at NEC Research Institute. He is a Fellow of the ACM, IEEE, the IET (formerly IEE), and the British Computer Society and is a member of the UK Computing Research Committee. In 2019, Dr. Cox was the recipient of the Tony Kent Strix Award in recognition of his contribution to the field of information retrieval. He was founding co-editor in chief of the IEE Proc. on Information Security and was an associate editor of the IEEE Trans. on Information Forensics and Security. He is co-author of a book entitled “Digital Watermarking” and its second edition “Digital Watermarking and Steganography”. He is an inventor or co-inventor of over seventy (70) U.S. Patents.

 

M2M/IoT Patent Portfolio

Our M2M/IoT Patent Portfolio acquired in December 2017 relates to, among other things, enabling technology for authenticating, provisioning and using embedded SIM cards in next generation IoT, Machine-to-Machine and other mobile devices including smartphones, tablets and computers as well as automobiles and drones. The M2M/IoT Patent Portfolio currently consists of thirty (30) issued U.S. patents, five pending U.S. patent applications and seven additional pending non-U.S. patent applications. Since we acquired the M2M/IoT Patent Portfolio in December 2017 we have been issued eighteen (18) additional U.S. patents. We anticipate further issuances of additional claims for this portfolio. The expiration dates of the thirty (30) issued U.S. patents currently within our M2M/IoT Patent Portfolio range from September 2033 to May 2034. During the year ended December 31, 2021, we were issued one new U.S. patent and three non-U.S. patents for the M2M/IoT Portfolio.

We have an obligation to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities (as defined) related to our M2M/IoT Patent Portfolio. In addition, M2M will be entitled to receive from us $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio.

John Nix, the Managing Member of M2M, provides consulting services to us with respect to our M2M/IoT Patent Portfolio. Mr. Nix is an entrepreneur and inventor, and founder and Chief Executive Officer of Vobal Technologies, LLC. In 2016, Mr. Nix was recognized as “Creator of the Year” by the Intellectual Property Law Association of Chicago for his intellectual property related to embedded SIM technology.

 

  

-5- 
 

HFT Patent Portfolio

On March 25, 2022, we acquired the HFT Patent Portfolio from Nima Badizadegan. The newly acquired portfolio covers certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The HFT Patent Portfolio currently includes six issued U.S. patents and two pending U.S. patents.

In addition to the purchase price of that we paid to the seller at closing, we have an obligation to pay the seller an additional cash payment of $500,000 and $375,000 of our common stock contingent upon achieving certain milestones with respect to the patent portfolio. We also have an obligation to pay the seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated from the patent portfolio and 17.5% of net proceeds greater than $50 million.

 

Mirror Worlds Patent Portfolio

Our Mirror Worlds Patent Portfolio acquired in May 2013 covers foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system. All of our patents within our Mirror Worlds Patent Portfolio expired. The Mirror Worlds Patent Portfolio includes U.S. Patent No. 6,006,227 (the “227 Patent”) and U.S. Patent No. 8,255,439 which are currently being asserted in our litigation against Facebook, Inc. (see “Legal Proceedings” at pages 21-22 hereof). Our 227 Patent was previously asserted in litigations against Apple Inc. and Microsoft Corporation which were settled resulting in aggregate payments to us of $29,650,000.

The inventions relating to document stream operating systems covered by our Mirror Worlds Patent Portfolio resulted from the work done by Yale University computer scientist, Professor David Gelernter, and his then graduate student, Dr. Eric Freeman, in the mid-1990s. Certain aspects of the technologies developed by David Gelernter were commercialized in their company's product offering called “Scopeware.” Technologies embodied in Scopeware are now common in various computer and web-based operating systems. Professor Gelernter and Dr. Freeman each entered into consulting agreements with us as part of our acquisition of the Mirror Worlds Patent Portfolio.

As part of our acquisition of the Mirror Worlds Patent Portfolio in 2013, we also entered into an agreement with Recognition Interface, LLC (“Recognition”), an entity that financed the commercialization of the Mirror Worlds patent portfolio prior to its sale to Mirror Worlds, LLC and also retained an interest in the licensing proceeds of the Mirror Worlds patent portfolio. Pursuant to the terms of the agreement with us, we are obligated to pay Recognition an interest in the net proceeds realized from our monetization of the Mirror Worlds Patent Portfolio as follows: (i) 10% of the first $125

 

 

-6- 
 

 

million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, we have paid Recognition an aggregate of $3,127,000 with respect to such net proceeds interest in our Mirror Worlds Patent Portfolio (no such payments were made during the years 2021 and 2020). In addition to the net proceeds interest, we also issued to Recognition (and its affiliate) warrants to purchase an aggregate of 1,250,000 shares of our common stock at exercise prices ranging from $1.40 to $2.10 per share, which warrants were exercised in full.

 

Remote Power Patent

Our Remote Power Patent (U.S. Patent No. 6,218,930) covers the delivery of power over Ethernet cables for the purpose of remotely powering network devices such as wireless access ports, IP phones and network based cameras. Our Remote Power Patent expired on March 7, 2020. Notwithstanding the expiration of the Remote Power Patent in March 2020, we received in 2021 aggregate licensing revenue of $36,029,000 relating to periods prior to expiration of the patent.

The Institute of Electrical and Electronic Engineers (IEEE) is a non-profit, technical professional association.  The Standards Association of the IEEE is responsible for the creation of global industry standards for a broad range of technology industries. In 2000, at the urging of several industry vendors, the IEEE formed a task force to facilitate the adoption of a standardized methodology for the delivery of remote power over Ethernet networks which would ensure interoperability among vendors of switches and terminal devices. On June 13, 2003, the IEEE Standards Association approved the 802.3af Power over Ethernet standard (the “Standard”), which covers technologies deployed in delivering power over Ethernet networks. The Standard provides for the Power Sourcing Equipment (PSE) to be deployed in switches or as standalone midspan hubs to provide power to remote devices such as wireless access points, IP phones and network-based cameras. The technology is commonly referred to as Power over Ethernet (“PoE”). In 2009, the IEEE Standards Association approved 802.3at, a new PoE standard which, among other things, increased the available power for delivery over Ethernet networks. We believe that our Remote Power Patent covers several of the key technologies covered by both the 802.3af and 802.3at standards.

Patent Acquisitions or Strategic Relationships

We seek to acquire additional intellectual property assets in order to develop, commercialize, license or otherwise monetize such intellectual property. We review opportunities to acquire or license additional intellectual property assets from individual inventors, technology companies and others for the purpose of pursuing licensing opportunities related to our existing intellectual property portfolio or otherwise. In addition, we may enter into strategic relationships with such parties to develop, commercialize, license or otherwise monetize their intellectual property. The form of such relationships may vary depending upon the opportunity and may include, among other things, a strategic investment in such third party, the provision of financing to such third party or the formation of a joint venture for the purpose of monetizing such third party's intellectual property assets.

 

-7- 
 

Network-1 Strategy

Our strategy is to capitalize on our intellectual property assets by entering into licensing arrangements with third parties including manufacturers and users that utilize our intellectual property's proprietary technologies as well as any additional proprietary technologies covered by patents which may be acquired by us in the future. Our current patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as has been the case with our Remote Power Patent and Mirror Worlds Patent Portfolio. Our Remote Power Patent has generated licensing revenue in excess of $187,000,000 from May 2007 through December 31, 2021. Since acquisition of our Mirror Worlds Patent Portfolio in May 2013, we have received licensing and other revenue of $47,150,000 through December 31, 2021. In addition, we may enter into third party strategic relationships with inventors and patent owners to assist in the development and monetization of their patent technologies. Based on our cash position, we continually review opportunities to acquire additional intellectual property as well as evaluate other strategic alternatives.

In connection with our activities relating to the protection of our intellectual property assets, or the intellectual property assets of third parties with whom we have strategic relationships in the future, it may be necessary to assert patent infringement claims against third parties whom we believe are infringing our patents or those of our strategic partners. We are currently involved in several litigations to protect our patents including certain patents within our Cox Patent Portfolio and Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 21-22 hereof). We have previously successfully asserted litigation with respect to our Remote Power Patent and our Mirror Worlds Patent Portfolio and have also been successful in defending proceedings at the USPTO challenging the validity of our Remote Power Patent and certain patents within our Cox Patent Portfolio.

Significant Licensees

Revenue from our Remote Power Patent constituted 100% of our revenue for the years ended December 31, 2021 and December 31, 2020. For the year ended December 31, 2021, two licensees constituted 99% of our revenue. For the year ended December 31, 2020, one licensee constituted an aggregate of 94% of our revenue. It is anticipated that one or a few of our licensees or other third parties will continue to constitute a significant portion of our revenue for the foreseeable future.

Competition

With respect to our ability to acquire additional intellectual property assets or enter into strategic relationships with third parties to monetize their intellectual property assets, we face considerable competition from other companies, many of

 

 

-8- 
 

 

which have significantly greater financial and other resources than we have. The patent licensing and enforcement industry has grown and there has been a material increase in the number of companies seeking to acquire intellectual property assets from third parties or to provide financing to third parties seeking to monetize their intellectual property. Entities including, among others, Acacia Research Corporation (NASDAQ:ACTG), Intellectual Ventures, WI-LAN Inc., a subsidiary of Quarterhill Inc. (NASDAQ:QTRH), VirnetX Holdings Corporation (NYSE MKT:VHC) and RPX Corporation, seek to acquire intellectual property or partner with third parties to license or enforce intellectual property rights.  In addition, we also compete with strategic corporate buyers with respect to the acquisition of intellectual property assets. It is expected that others will enter this market as well. Many of these competitors have significantly greater financial and human resources than us.

We may also compete with litigation funding firms such as Burford Capital Limited, Validity Finance, LLC, Fortress Investment Group, LLC, Parabellum Capital LLC and Bentham Capital LLC, venture capital firms and hedge funds for intellectual property acquisitions and licensing opportunities. Many of these competitors also have greater financial resources and human resources than us.

The industries and markets covered by our intellectual property are characterized by intense competition and rapidly changing business conditions, customer requirements and technologies. Other companies may develop competing technologies that offer better or less expensive alternatives to the technologies covered by our intellectual property assets. Such competing technologies may adversely impact our licensing revenue. Moreover, technological advances or entirely different approaches developed by one or more of our competitors or adopted by various standards groups could render our intellectual property assets obsolete, less marketable or unenforceable.

Regulatory Environment

If new legislation, regulations or rules are implemented either by Congress, the USPTO or the courts that impact the patent application process, the patent enforcement process or the rights of patent holders, these changes could negatively affect our business, financial condition and results of operations. Certain legislation, regulations, and rulings by the courts and actions by the USPTO have materially increased the risk and cost of enforcement of patents.  U.S. patent laws were amended by the Leahy-Smith America Invents Act, referred to as the “America Invents Act”, which became effective on March 16, 2013. The America Invents Act included a number of significant changes to U.S. patent law. In general, it addressed issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, establishing new procedures for patent litigation and new administrative post-grant review procedures to challenge the patentability of issued patents outside of litigation, including Inter Partes Review (IPR) and Covered Business Method Review (CBM) proceedings which provide third parties a timely, cost effective alternative to district court litigation to challenge the validity of an issued patent. The America Invents Act and its implementation has increased the uncertainties and costs surrounding the enforcement of patent rights which could have a material adverse effect on our business, financial condition and results of operations.

 

 

-9- 
 

 

In addition, future changes in patent law could adversely impact our business. Such changes may not be advantageous to us and may make it more difficult to obtain adequate patent protection to enforce our patents. Increased focus on the growing number of patent lawsuits, particularly by non-practicing entities (NPEs), may result in legislative changes which increase the risk and costs of asserting patent litigation.

Investment in ILiAD Biotechnologies

During the period December 2018 – March 2021, we made an aggregate investment of $6,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. The aggregate investment of $6,000,000 by the Company includes a $5,000,000 equity investment and $1,0000,000 investment in convertible notes (see below). On December 31, 2021, we owned approximately 9.5% of the outstanding units of ILiAD on a non-fully diluted basis and 7.2% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options, warrants and convertible notes). In connection with our investment, Corey Horowitz, our Chairman and Chief Executive Officer, became a member of ILiAD’s Board of Managers.  ILiAD is developing key technologies and working with leading scientists to investigate the impact of Bordetella pertussis in a range of human disease and is currently focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). Pertussis is a life-threatening disease caused by the highly contagious respiratory bacterium Bordetella pertussis. According to the U.S. Centers for Disease Control and Prevention, each year pertussis affects approximately 16 million people globally, accounting for nearly 200,000 deaths. ILiAD has the exclusive license to fifty-eight (58) issued patents and has thirty-three (33) pending patent applications.

BPZE1 was developed in the laboratory of Camille Locht, PhD, at the Institut Pasteur de Lille (IPL) and French National Institute of Health and Medical research. BPZE1 is a live-attenuated intranasal vaccine designed to overcome deficiencies of current pertussis vaccines, including poor durability of protection and failure to prevent nasopharyngeal Bordetella pertussis infections that lead to escape mutants and transmission to vulnerable infants. Four clinical trials studying BPZE1 in healthy adults have been completed by ILiAD to date, including positive topline results from a 300-participant adult Phase 2b trial demonstrating that BPZE1 induced durable mucosal immunity and reduced nasal colonization — two key factors necessary for the prevention of transmission and reduction of epidemic pertussis cycles.

On March 12, 2021, we invested $1,000,000 in ILiAD as part of its private offering of up to $23,500,000 of convertible notes (the “Notes”). The Notes have a maturity of three years with interest accruing at 6% per annum. The Notes are required to be converted into a Qualified Financing (minimum financing of $15 million) at the lesser of (i) 80% of the price paid per unit in such offering or (ii) a price based on an enterprise value of $176,000,000. In addition, the Notes shall convert in the event of a merger at the lower of an enterprise value of $176,000,000 or the stated valuation of ILiAD in the merger transaction. In the event of a change-in-control, noteholders will also have the option to have the Notes repaid except in a Qualified Financing or a stock-for-stock merger.

In December 2021, ILiAD announced the initiation and enrollment of the first participants in a BPZE1 study involving school age children. On January 3, 2022, ILiAD announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for BPZE1.

 

 

-10- 
 

Corporate Information

We were incorporated under the laws of the State of Delaware in July 1990. Our principal offices are located at 65 Locust Avenue, New Canaan, Connecticut 06840 and our telephone number is (203) 920-1055.

Available Information

We file or furnish various reports, such as registration statements, quarterly and current reports, proxy statements and other materials with the SEC. Our Internet website address is www.network-1.com. You may obtain, free of charge on our Internet website, copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and amendments to those reports or statements filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information we post on our website is intended for reference purposes only; none of the information posted on our website is part of this Annual Report or incorporated by reference herein.

In addition to the materials that are posted on our website, you may read and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and other information statements, and other information regarding issuers, including us, that file electronically with the SEC. The address of the SEC's Internet site is http://www.sec.gov.

Employees and Consultants

On March 28, 2022, we had three employees and two consultants providing monthly services to us.

ITEM 1A. RISK FACTORS

Our operations and financial results are subject to various material risks and uncertainties, including those described below, which could adversely affect our business, financial condition, results of operations, cash flow, and the trading price of our common stock. You should carefully consider the material risks and uncertainties described below in addition to the other information set forth in this Annual Report on Form 10-K, including, but not limited to, the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The material risks described below are not the only risks we face. Additional risks that we do not know of or that we currently believe are immaterial may also impair our business operations. If any of the following risks actually occur, our business, financial condition, results of operations and cash flow could be materially adversely affected, and the trading price of our common stock could decline significantly.

 

 

-11- 
 

Risks Related to Our Business

Our revenue is uncertain.

Since March 2020 (the expiration of our Remote Power Patent), we no longer receive ongoing licensing revenue on a quarterly basis from licensees. Accordingly, except for our pending litigation against Netgear involving our Remote Power Patent (see Note K[5] to our consolidated financial statements included in this Annual Report), our revenue will be dependent upon litigation outcomes involving our Cox Patent Portfolio and Mirror Worlds Patent Portfolio, our ability to monetize our other patent portfolios or new patents to be acquired in the future. We currently have pending litigation against Google and YouTube involving certain patents within our Cox Patent Portfolio and we intend to appeal the District Court judgment granting Facebook summary judgment of non-infringement and dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 21-22 hereof). Patent litigation is inherently risky and the outcome is uncertain. Accordingly, our future revenue is uncertain.

We have been dependent upon our Remote Power Patent for a significant portion of our revenue and the patent has expired.

Our Remote Power Patent has generated licensing revenue for us in excess of $187,000,000 from May 2007 through December 31, 2021.  Revenue for the years ended December 31, 2021 ($36,029,000), 2020 ($4,403,000) and 2019 ($3,037,000) from license agreements for our Remote Power Patent constituted 100% of our revenue. As a result of the expiration of our Remote Power Patent on March 7, 2020, we no longer receive licensing revenue for our Remote Power Patent for any period subsequent to the expiration date. However, in April 2021, Cisco paid us $18,691,890 in licensing royalties for the period beginning in the fourth quarter of 2017 through March 7, 2020 (see Note K[2] to our consolidated financial statements included in this Annual Report). In addition, in July 2021, we entered into a settlement agreement with Hewlett-Packard pursuant to which we were paid $17,000,000 in settlement of patent infringement litigation. Furthermore, we have pending litigation against Netgear, another licensee of our Remote Power Patent, for unpaid royalties for a period prior to March 2020 (see Note K[5] to our consolidated financial statements included in this Annual Report).  Except for our pending litigation against Netgear involving our Remote Power Patent, our future revenue will be entirely dependent on our ability to monetize our patent portfolios or patents we acquire in the future.

 

 

 

-12- 
 

Our success is substantially dependent upon our ability to protect our patents.

Our success is substantially dependent upon our proprietary technologies and our ability to protect our intellectual property rights. We currently own ninety-five (95) patents that relate to various technologies including our Remote Power Patent, Cox Patent Portfolio, Mirror Worlds Patent Portfolio, M2M/IoT Patent Portfolio and HFT Patent Portfolio. Certain patents within our Mirror Worlds Patent Portfolio and Cox Patent Portfolio are currently being challenged in patent infringement litigation pending in the courts (see “Legal Proceedings” at pages 21-22 of this Annual Report). The uncertainty of the outcome of litigation creates risks that our efforts to protect our intellectual property assets may not be successful. If we are not successful in protecting our patents, our business would be negatively impacted.

We may not be able to capitalize in the future on our strategy to acquire high quality patents with significant licensing opportunities or enter into strategic relationships with third parties to license or otherwise monetize their intellectual property.

Based upon the success we achieved from licensing our Remote Power Patent (twenty-eight (28) license agreements which generated in excess of $187,000,000 of revenue), the revenue we generated from our Mirror Worlds Patent Portfolio ($47,150,000) and establishing a patent portfolio currently consisting of ninety-five (95) patents as well as our cash position, we believe we have the expertise and sufficient capital to compete in the intellectual property monetization market and to enter strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.  However, we may not be able to acquire additional intellectual property or, if acquired, we may not achieve material revenue or profit from such intellectual property.  Acquisitions of patent assets are competitive, time consuming, complex and costly to consummate. Our strategy is to focus on acquiring high quality patent assets which management believes have the potential for significant licensing opportunities.  These high quality patent opportunities are difficult to find and are often very competitive to acquire.  In addition, such acquisitions present material risks. Even if we acquire additional patent assets, we may not be able to achieve significant licensing revenue or even generate sufficient revenue related to such patent assets to offset the acquisition costs and the legal fees and expenses which may be incurred to enforce, license or otherwise monetize such patents. In addition, we may not be able to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property and, even if we consummate such strategic relationships, we may not achieve material revenue or profit from such relationships.

 

 

 

-13- 
 

 

We may not be successful in enforcing or defending our Cox Patent Portfolio, generating additional revenue from our Mirror Worlds Patent Portfolio or generating revenue from our M2M/IoT Patent Portfolio and HFT Patent Portfolio.

We acquired our Cox Patent Portfolio in 2013, which currently consists of thirty-nine (39) patents.  We have not yet achieved any revenue from our Cox Patent Portfolio. We are currently enforcing certain patents within our Cox Patent Portfolio against Google and YouTube, who are challenging these patents (see “Legal Proceedings” at page 22 hereof). We also intend to appeal the District Court decision granting Facebook summary judgment of non-infringement and dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings at pages 21-22 hereof). In addition, our M2M/IoT Patent Portfolio, currently consisting of thirty (30) patents, is not currently being asserted and thus it is not anticipated that this portfolio will generate revenue for at least the next twelve months. We also recently acquired our HFT Patent Portfolio, consisting of six patents and two pending patents. We may not have future success in enforcing or defending our Cox Patent Portfolio, Mirror Worlds Patent Portfolio, M2M/IoT Patent Portfolio and HFT Patent Portfolio, which would have a negative impact on our business.

Our quarterly and annual operating and financial results and our revenue are difficult to predict and are likely to fluctuate significantly in future periods.

Our quarterly and annual operating and financial results are difficult to predict and may fluctuate significantly from period to period. We had revenue of $36,029,000 and net income of $14,281,000 for the year ended December 31, 2021.  We had revenue of $4,403,000 and incurred a net loss of $1,709,000 for the year ended December 31, 2020 as compared to revenue of $3,037,000 and a net loss of $1,792,000 for the year ended December 31, 2019.  Our revenue and net income was $22,106,000 and $7,706,000, respectively, for the year ended December 31, 2018 and $16,451,000 and $4,133,000 for the year ended December 31, 2017. Accordingly, our revenue, net income and results of operations may widely fluctuate as a result of a variety of factors that are outside our control including our ability and timing in consummating future license agreements for our intellectual property assets, the timing and extent of payments received by us from licensees, the timing and our ability to achieve successful outcomes from current and future patent litigation, whether we will achieve a return on our investment in ILiAD Biotechnologies and the timing of any such gains, and the timing and our ability to achieve revenue from future strategic relationships.

 

 

 

-14- 
 

 

The patent monetization cycle is long, costly and unpredictable.

There is generally a significant time lag between acquiring a patent portfolio and recognizing revenue from those patent assets. During this time lag, significant costs are likely to be incurred which may have a negative impact on our results of operations, cash flow and financial position. Furthermore, the outcome of our efforts to monetize our patents is uncertain and we may not be successful.

In the future we could be classified as a Personal Holding Company resulting in a 20% tax on our PHC Income that we do not distribute to our shareholders.

The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments and reduced by certain distributions to shareholders. For a corporation to be classified as a PHC, it must satisfy two tests: (1) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (2) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities and rents (the “Income Test”). During the second half of 2021, based on available information concerning our shareholder ownership, we did not satisfy the Ownership Test and thus we were not a PHC for 2021. However, we may be determined to be a PHC in the future.  If we were determined to be a PHC in any future year, we would be subject to an additional 20% tax on our UPHCI. In such event, we may issue a special cash dividend to our shareholders in an amount equal to the UPHCI rather than incur the 20% tax.

We are dependent upon our CEO and Chairman.

Our success is largely dependent upon the personal efforts of Corey M. Horowitz, our Chairman, Chief Executive Officer and Chairman of our Board of Directors. On March 22, 2022, we entered into a new four year employment agreement with M. Horowitz pursuant to which he continues to serve as our Chairman and Chief Executive Officer. The loss of the services of Mr. Horowitz would have a material adverse effect on our business and prospects. We do not maintain key-man life insurance on the life of Mr. Horowitz.

Our investment in ILiAD Biotechnologies involves a high degree of risk and we may lose our entire investment.

We have invested $6,000,000 in ILiAD Biotechnologies, LLC, a privately held clinical stage biotechnology company, dedicated to the prevention and treatment of human disease caused by Bordetella pertussis with a current focus on its proprietary intranasal vaccine, BPZE1, for the prevention of pertussis (whooping cough). As a clinical stage biotechnology investment, our investment involves a high degree of risk including the potential loss of our entire investment.

 

 

-15- 
 

Cash dividends may not be continued to be paid.

Our dividend policy consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which are anticipated to be paid in March and September of each year. We have paid such semi-annual dividends since our dividend policy was enacted in December 2016.  Our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our earnings, financial requirements and other factors existing at the time.  We may not be in a position to continue to pay dividends in the future.

The global COVID-19 pandemic could have an adverse impact on our business.

The COVID-19 pandemic has and continues to impact economic activities and the financial markets around the world. As to the impact on our Company, COVID-19 has and continues to cause some delays in the courts including the scheduling of trial dates, which could adversely affect the timing of outcomes of our litigations. COVID-19 has not presented other direct material risks to our business.  Our cash is held at major financial institutions in money-market funds, certificates of deposit, or in short-term fixed income securities.  With only three employees, our employees are able to work remotely. However, the ongoing pandemic may present risks that we have not currently considered material or risks that may evolve quickly that could have a material adverse effect on our business, financial condition, operating results and prospects.

Legislation, regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcement of patents and may continue to do so in the future.

Legislation, regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcing patents. U.S. patent laws were amended by the Leahy-Smith America Invents Act, referred to as the America Invents Act, which became effective on March 16, 2013. The America Invents Act included a number of significant changes to U.S. patent law. In general, it addressed issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, established new procedures for patent litigation and new administrative post-grant review procedures to challenge the patentability of issued patents outside of litigation, including Inter Partes Review (IPR) and Covered Business Method Review (CBM) proceedings which provide third parties a timely, cost effective alternative to district court litigation to challenge the validity of an issued patent. In addition, the America Invents Act changed the way that parties may be joined in patent infringement actions, increased the likelihood that such actions will need to be brought against individual parties allegedly infringing by their respective individual actions or activities.   The America Invents Act and its implementation also increased the uncertainties and costs surrounding the enforcement of patent rights, which could have a material adverse effect on our business, financial condition and results of operations.

 

 

 

-16- 
 

Changes in patent law could adversely impact our business.

Patent laws may continue to change and may alter the protections afforded to owners of patent rights. Such changes may not be advantageous to us and may make it more difficult to obtain adequate patent protection to enforce our patents. Increased focus on the growing number of patent lawsuits, particularly by non-practicing entities (NPEs), may result in further legislative changes which increase the risk and costs of asserting patent litigation.

Our pending patent infringement litigations are time consuming and costly.

We have pending litigation against Google and YouTube involving certain patents within our Cox Patent Portfolio and intend to appeal the decision of District Court granting Facebook’s motion for summary judgment of non-infringement and dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 21-22 of this Annual Report). While we have contingent legal fee arrangements, or a contingency plus a fixed cash amount arrangement, with our patent litigation counsel in each litigation, we are responsible for all or a portion of the expenses which are anticipated to be material. In addition, the time and effort required of our management to effectively pursue these litigations is likely to be significant and it may adversely affect other business opportunities.

We face intense competition to acquire intellectual property and enter into strategic relationships.

With respect to our ability to acquire additional intellectual property or enter into strategic relationships with third parties to monetize their intellectual property, we face considerable competition from other companies, many of which have significantly greater financial and other resources than we have. The patent licensing and enforcement business has grown significantly over the past years and there has been an increase in the number of companies seeking to acquire intellectual property rights from third parties.  It is expected that others will enter this market as well. Many of these competitors have significantly more financial and human resources than us.

We may also compete with strategic corporate buyers, litigation funding firms, venture capital firms and hedge funds for intellectual property acquisitions and licensing opportunities. Many of these competitors have greater financial resources and human resources than us.

 

 

-17- 
 

Our markets are subject to rapid technological change and our technologies face potential technology obsolescence.

The markets covered by our intellectual property are characterized by rapid technological changes, changing customer requirements, frequent new product introductions and enhancements, and evolving industry standards. The introduction of products embodying new technologies and the emergence of new industry standards may render our technologies obsolete or less marketable.

In addition, other companies may develop competing technologies that offer better or less expensive alternatives to the technologies covered by our intellectual property. Moreover, technological advances or entirely different approaches developed by other companies or adopted by various standards groups could render our patents obsolete, less marketable or unenforceable.

The burdens of being a public company may adversely affect us including our ability to pursue litigation.

As a public company, our management must devote substantial time, attention and financial resources to comply with U.S. securities laws. This may have a material adverse effect on management's ability to effectively and efficiently pursue its business. In addition, our disclosure obligations under U.S. securities laws require us to disclose information publicly that will be available to litigation opponents. We may, from time to time, be required to disclose information that may have a material adverse effect on our litigation strategies. This information may enable our litigation opponents to develop effective litigation strategies that are contrary to our interests.

Risks Related to Our Common Stock

Investors may have limited influence on stockholder decisions because ownership of our common stock is concentrated.

As of March 15, 2022, our executive officers and directors beneficially owned 31.6% of our outstanding common stock. As a result, these stockholders may be able to exercise substantial control over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, such as a merger or other sale of our company or its assets. This concentration of ownership will limit other stockholders' ability to influence corporate matters and may have the effect of delaying or preventing a third party from acquiring control over us.

 

 

-18- 
 

 

Our common stock may be delisted from the NYSE American Exchange if we fail to comply with continued listing standards.

Our common stock is currently traded on the NYSE American Exchange under the symbol “NTIP”. If we fail to meet any of the continued listing standards of the NYSE American Exchange, our common stock could be delisted. Such delisting could adversely affect the price and trading (including liquidity) of our common stock.

Provisions in our corporate charter, by-laws and in Delaware law could make it more difficult for a third party to acquire us, discourage a takeover and adversely affect existing stockholders.

Our certificate of incorporation authorizes the board of directors to issue up to 10,000,000 shares of preferred stock. The preferred stock may be issued in one or more series, the terms of which may be determined at the time of issuance by our board of directors, without further action by stockholders, and may include, among other things, voting rights (including the right to vote as a series on particular matters), preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions, any of which could adversely affect holders of our common stock. Although there are currently no shares of preferred stock outstanding, future holders of preferred stock may have rights superior to our common stock and such rights could also be used to restrict our ability to merge with, or sell our assets to third parties.

We are also subject to the “anti takeover” provisions of Section 203 of the Delaware General Corporation Law, which could prevent us from engaging in a “business combination” with a 15% or greater stockholder for a period of three years from the date such person acquired that status unless appropriate board or stockholder approvals are obtained.

In addition, our By-laws contain advance notice requirements for director nominations and for new business to be brought up at stockholder meetings. Stockholders wishing to submit director nominations or raise matters to a vote of stockholders must provide notice to us within specified date windows and in very specific forms in order to have that matter voted on at a stockholders meeting.

The aforementioned provisions could deter unsolicited takeovers or delay or prevent changes in our control or management, including transactions in which stockholders might otherwise receive a premium for their shares over the then current market price. These provisions may also limit the ability of stockholders to delay, deter or prevent a change of control, or approve transactions that they may deem to be in their best interests.

 

 

 

-19- 
 

 

Our stock price may be volatile.

The market price of our common stock may be highly volatile and could fluctuate widely in price in response to various factors, many of which are beyond our control, including the following:

•  the outcome of our litigation against Google and YouTube involving certain patents within our Cox Patent Portfolio;
•  our ability to further develop, license and monetize our M2M/IoT Patent Portfolio;
•  our ability to further develop, license and monetize our recently acquired HFT Patent Portfolio;
•  the outcome of our intended appeal to the Federal Circuit of the District Court ruling granting Facebook summary judgment of non-infringement and dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio;
•  our ability to acquire additional intellectual property;
•  our ability to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property;
•  our ability to achieve a return on our investment in ILiAD Biotechnologies, LLC;
•  variations in our quarterly and annual operating results;
•  our ability to continue to pay cash dividends;
•  our ability to raise capital if needed;
•  sales of our common stock;
•  technology changes;
•  legislative, regulatory and competitive developments; and
•  economic and other external factors.

In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also have a material and adverse effect on the market price of our common stock.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our principal executive offices are located in New Canaan, Connecticut, where we lease approximately 2,000 square feet of office space on a monthly basis at a base rent of $7,300 per month. We believe that our office facility is suitable and appropriate to support our current needs.

 

-20- 
 

 

ITEM 3. LEGAL PROCEEDINGS

Remote Power Patent Litigation

Hewlett-Packard Litigation

On July 26, 2021, we agreed to settle our patent litigation against Hewlett-Packard Company and Hewlett-Packard Enterprise Company (collectively, “Hewlett-Packard”) pending in the U.S. District Court for the Eastern District of Texas, Tyler Division, for infringement of our Remote Power Patent. Under the terms of the settlement agreement, Hewlett-Packard Enterprise Company paid us $17,000,000 in full settlement of the litigation and Hewlett-Packard received a fully paid license and release to the Remote Power Patent for its full term, which applies to sales of Power over Ethernet (“PoE”) products by Hewlett-Packard and its wholly-owned subsidiary Aruba Networks, LLC.

Netgear Litigation

On December 15, 2020, we filed a lawsuit against Netgear in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with us for Netgear’s failure to make royalty payments, and provide corresponding royalty reports to us based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration with the American Arbitration Association (“AAA”) seeking to arbitrate certain issues raised in the litigation in the Supreme Court, State of New York, County of New York. We have objected to jurisdiction at the AAA and the dispute is pending.

Plantronics Litigation

On January 7, 2021, we filed a lawsuit against Plantronics, Inc., the successor to Polycom, Inc., in the Superior Court of the State of California, County of Santa Clara, for breach of a Settlement and License Agreement, dated September 2016, with us for the failure of Plantronics and Polycom to make royalty payments, and provide corresponding royalty reports, to us based on sales of PoE products. On October 26, 2021, Plantronics agreed to settle the litigation in consideration of a payment to us of $337,000.

Mirror Worlds Patent Portfolio Litigation

Facebook Litigation

On May 9, 2017, Mirror Worlds Technologies, LLC, our wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“Facebook”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within our Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Facebook’s core technologies that enable Facebook’s Newsfeed and Timeline features. The lawsuit further alleged that Facebook’s unauthorized use of the stream-based solutions of our asserted patents has helped Facebook become the most popular social networking site in the world.  We seek, among other things, monetary damages based upon reasonable royalties.

 

 

-21- 
 

On May 7, 2018, Facebook filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Facebook’s motion for summary judgment of non-infringement and dismissed the case. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in our favor and reversed the summary judgment finding on non-infringement of the District Court and remanded the litigation to the Southern District of New York for further proceedings.

On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Facebook. In its ruling the Court (i) denied Facebook’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. We strongly disagree with the decision on non-infringement and intend to file an appeal to the U.S. Court of Appeals for the Federal Circuit.

Cox Patent Portfolio Litigation

On April 4, 2014 and December 3, 2014, we initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of our patents within our Cox Patent Portfolio which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of our patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system.

The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings then pending at the Patent Trial and Appeal Board (PTAB) and the appeals to the U.S. District Court of Appeals for the Federal Circuit. Pursuant to a joint stipulation and order, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery is complete and a trial date has not yet been set.

ITEM 4. MINE SAFETY DISCLOSURES

None.

 

 

 

 

 

 

-22- 
 

PART II

 

ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information. Our common stock is listed for trading on the NYSE American Exchange under the symbol “NTIP”. On March 28, 2022, the closing price for our common stock as reported on the NYSE American Exchange was $2.45 per share. The number of record holders of our common stock was 38 as of March 28, 2022. In addition, we believe there were in excess of approximately 1,300 holders of our common stock in “street name” as of March 28, 2022.

Dividend Policy.  Our dividend policy consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which are anticipated to be paid in March and September of each year.  On February 23, 2021, our Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 31, 2021 to all common shareholders of record as of March 16, 2021. On September 10, 2021, our Board of Directors declared a semi-annual dividend of $0.05 per share with a payment date of September 30, 2021 to all common shareholders of record as of September 21, 2021.  Our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our earnings, financial requirements and other factors existing at the time.

As of December 31, 2021, we accrued dividends of $72,000 for unvested restricted stock units with dividend equivalent rights.

Recent Issuances of Unregistered Securities. There were no unregistered sales of equity securities during the quarter ended December 31, 2021.

Stock Repurchases.  On June 11, 2021, our Board of Directors authorized an extension and increase of the share repurchase program (“Share Repurchase Program”) to repurchase up to $5,000,000 of shares of our common stock over the subsequent 24 month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in our discretion. The timing and amount of the shares repurchased is determined by management based on its evaluation of market conditions and other factors. The Share Repurchase Program may be increased, suspended or discontinued at any time.

 

 

 

 

 

 

-23- 
 

 

During the months of October, November and December 2021, we repurchased common stock pursuant to our Share Repurchase Program as indicated below:

 

Period

 Total Number of Shares Purchased

Average Price

Paid Per Share

 Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Maximum Number (or Approximate Dollar Value) of Shares) that May Yet Be Purchased Under the Plans or Programs
October 1, 2021 to
October 31, 2021		 — — — $4,869,200
November 1, 2021 to
November 30, 2021		 57,600 $2.78 57,600 $4,709,163
December 1, 2021 to
December 31, 2021		 280,875 $2.77 280,875 $3,930,729
Total 338,475 $2.77 338,475  

 

During the year ended December 31, 2021, we repurchased an aggregate of 378,475 shares of our common stock pursuant to our Share Repurchase Program at a cost of $1,069,271 (exclusive of commissions) or an average price per share of $2.83.

Since inception of our Share Repurchase Program (August 2011) to December 31, 2021, we repurchased an aggregate of 8,984,134 shares of our common stock at a cost of $17,225,276 (exclusive of commissions) or an average per share price of $1.92.

Equity Compensation Plan Information

The following table summarizes share and exercise price information for our equity compensation plans as of December 31, 2021.

   

Number of

securities to be

issued upon

exercise of

outstanding

options and rights

  

Weighted-average

exercise price of

outstanding

options and

rights

  

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column(a))

    (a)   (b)   (c)
             
Equity compensation plans approved by security holders  

12,500(1)

   $ —(3)  

1,837,500

             
Equity compensation plans not approved by security holders  

500,000(2)

  

$1.19    

   —
             
Total   512,500       $1.19(3)   1,837,500

________________________________ 

(1) Consists of shares issuable upon vesting of outstanding restricted stock units.      

 

(2) Represents an individual option grant to our Chairman and Chief Executive Officer outside of, and prior to the establishment of, the 2013 Stock Incentive Plan in October 2013 referred to in the above table. The option agreement pertaining to such option grant contains customary anti-dilution provisions.      

 

(3) Does not take into account outstanding restricted stock units as these awards have no exercise price.          

 

 

-24- 
 

 

Our 2013 Stock Incentive Plan (“2013 Plan”) provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units.  Awards under the 2013 Plan may be granted singly, in combination, or in tandem.  Subject to standard anti-dilution adjustments as provided in the 2013 Plan, the 2013 Plan provides for an aggregate of 2,600,000 shares of our common stock to be available for distribution pursuant to the 2013 Plan.  The Compensation Committee (or the Board of Directors) will generally have the authority to administer the 2013 Plan, determine participants who will be granted awards under the 2013 Plan, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards.  Awards under the 2013 Plan may be granted to our employees, directors and consultants. As of December 31, 2021, there were options to purchase an aggregate of 500,000 shares of common stock outstanding and 12,500 shares issuable upon settlement of outstanding restricted stock units granted under the 2013 Plan, and a balance of 1,837,500 shares of common stock are reserved for issuance under the 2013 Plan.

ITEM 6. (RESERVED)

Not applicable.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes contained elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10-K, particularly in the “Risk Factors” Section on pages 11-20 hereof.

OVERVIEW

Our principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-five (95) patents including: (i) our Cox Patent Portfolio relating to enabling technology for identifying media content on the Internet and taking further action to be performed after such identification; (ii) our M2M/IoT Patent Portfolio relating to, among other things, enabling technology for authenticating, provisioning and using embedded sim cards in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) our HFT Patent Portfolio covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) our Mirror Worlds Patent Portfolio relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) our Remote Power Patent covering the delivery of power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.  In addition, we continually review opportunities to acquire or license additional intellectual property as well as other strategic alternatives.

 

-25- 
 

During the period December 2018 through March 2021, we made an aggregate investment of $6,000,000 in ILiAD, a clinical stage biotechnology company with an exclusive license to fifty-eight (58) patents (see Note H to our consolidated financial statements included herein). Our investment in ILiAD involves significant risk (see “Risk Factors” at page 15 hereof).

Until March 7, 2020, when our Remote Power Patent expired, we had been actively engaged in the licensing of our Remote Power Patent (U.S. Patent No. 6,218,930) which generated licensing revenue in excess of $187,000,000 from May 2007 through December 31, 2021. As a result of the expiration of our Remote Power Patent, we no longer receive licensing revenue for our Remote Power Patent for any period subsequent to the expiration date (March 7, 2020).  However, subsequent to the expiration date of our Remote Power Patent, we received licensing revenue from certain licensees for periods prior to March 7, 2020 as referenced below.

On March 30, 2021, we entered into an amendment (the “Amendment”) to the Settlement and License Agreement, dated May 25, 2011, between us and Cisco (the “Agreement”). Pursuant to the Amendment, Cisco agreed to pay $18,692,000 to us to resolve a dispute relating to Cisco’s contractual obligation to pay us royalties under the Agreement for the period beginning in the fourth quarter of 2017 through March 7, 2020 (when the Remote Power Patent expired) with respect to licensing the Remote Power Patent (see Note K[2] to our consolidated financial statements included in this Annual Report).

On July 26, 2021, we entered into a settlement agreement with Hewlett-Packard pursuant to which Hewlett-Packard paid us $17,000,000 in full settlement of a patent litigation involving our Remote Power Patent (see Note K[1] to our consolidated financial statements included in this Annual Report).  We believe that Netgear, another licensee of our Remote Power Patent, is obligated to pay us royalties that accrued but were not paid since the fourth quarter of 2017 through March 7, 2020. In December 2020, we commenced litigation against Netgear for such unpaid royalties (see Note K[5] to our consolidated financial statements included herein).

Our current strategy includes continuing our licensing efforts with respect to our intellectual property assets and the monetization of our patent portfolios.  In addition, we continue to seek to acquire additional intellectual property assets to develop, commercialize, license or otherwise monetize. Our strategy includes working with inventors and patent owners to assist in the development and monetization of their patented technologies. We may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property. Our patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as we have achieved with respect to our Remote Power Patent and Mirror Worlds Patent Portfolio.

On March 25, 2022, we completed the acquisition of a new patent portfolio (the HFT Patent Portfolio) consisting of six U.S. patents and two pending U.S. patents (see Note P[5] to our consolidated financial statements included in this Annual Report).

 

 

 

-26- 
 

Our future operating results may be materially impacted by our ability to acquire high quality patents which management believes have the potential to generate significant licensing opportunities. In the future, we may not be able to identify or consummate such patent acquisitions or achieve significant licensing revenue with respect to such patent acquisitions.

We have been dependent upon our Remote Power Patent for a significant portion of our revenue. Our Remote Power Patent has generated licensing revenue in excess of $187,000,000 from May 2007 through December 31, 2021. Revenue for the years ended December 31, 2021 of $36,029,000, 2020 of $4,403,000 and 2019 of $3,037,000 from license agreements for our Remote Power Patent constituted 100% of our revenue. As a result of the expiration of our Remote Power Patent on March 7, 2020, we no longer receive licensing revenue for our Remote Power Patent for any period subsequent to the expiration date. Except for our pending litigation against Netgear involving our Remote Power Patent, our future revenue will be entirely dependent on our ability to monetize our Cox, M2M/IoT, HFT and Mirror Worlds patent portfolios as well as any new patents we may acquire.

Our operating results for 2021 included revenue of $36,029,000 and net income of $14,281,000 which was primarily the result of the resolution of our contractual dispute with Cisco in which we received $18,692,000 and our litigation settlement of $17,000,000 with Hewlett-Packard. While we have pending litigation involving certain patents within our Cox Patent Portfolio against Google and YouTube and intend to appeal the judgment of the District Court dismissing our litigation against Facebook on the grounds of non-infringement involving certain patents within our Mirror Worlds Portfolio, we may not achieve successful outcomes of the litigation or the appeal. Accordingly, our operating results for 2021 may not be indicative of operating results in 2022 or future years.

The significant components of expenses impacting our net income include contingent legal fees and expenses related to our patent litigation (see Note B[8] to our consolidated financial statements included herein) and incentive compensation payable to our Chairman and Chief Executive Officer pursuant to his employment agreement (see Note J[1] to our consolidated financial statements included herein), both such components of expenses are based on a percentage of the licensing revenue received by us as a result of litigation or otherwise.

Our annual and quarterly operating and financial results may fluctuate significantly from period to period as a result of a variety of factors that are outside our control, including the timing and our ability to achieve successful outcomes of patent litigation, our ability and timing of consummating future license agreements for our intellectual property, and whether we will achieve a return on our investment in ILiAD Biotechnologies, LLC (“ILiAD”) and the timing of any such distributions.

At December 31, 2021, our principal sources of liquidity consisted of cash and cash equivalents and marketable securities of $59,623,000 and working capital of $55,665,000. Based on our current cash position, we believe that we will have sufficient cash to fund our operations for the next twelve months and for the foreseeable future. Based on our cash position, we continually review opportunities to acquire additional intellectual property as well as evaluate other strategic opportunities.

 

 

-27- 
 

 

In future years we could be classified as a Personal Holding Company. If this is the case, we would be subject to a 20% tax on the amount of any PHC Income (as defined) for such year that we do not distribute to our shareholders (see Note E to our consolidated financial statements included in this Annual Report).

As to the impact of the global COVID-19 pandemic on us, COVID-19 has and continues to cause some delays in the courts including the scheduling of trial dates, which could adversely affect the timing of our consummation of future license agreements (see “Risk Factors – The global COVID-19 pandemic could have an adverse impact on our Business”) at page 16 hereof.

On June 9, 2021, our Board of Directors approved the continuation of our dividend policy consisting of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which are anticipated to be paid in March and September of each year. In 2021, we paid semi-annual cash dividends in accordance with our dividend policy. Our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our financial requirements, earnings and other factors existing at the time (see Note O to our consolidated financial statements included herein).

RESULTS OF OPERATIONS

Year Ended December 31, 2021 Compared to Year Ended December 31, 2020

Revenue. We had revenue of $36,029,000 for the year ended December 31, 2021 (“2021”) as compared to revenue of $4,403,000 for the year ended December 31, 2020 (“2020”). The increase in revenue of $31,626,000 for 2021 was primarily due to revenue of $18,692,000 from our resolution of a contractual dispute with Cisco concerning licensing of our Remote Power Patent and revenue of $17,000,000 from our litigation settlement with Hewlett-Packard (see Notes K[1] and K[2] to our consolidated financial statements included herein).

Operating Expenses.  Operating expenses for 2021 were $16,443,000 as compared to $6,816,000 for 2020. The increase in operating expenses for 2021 was primarily due to an increase in costs of revenue of $10,494,000 as a result of revenue of $18,692,000 from resolution of our contractual dispute with Cisco concerning licensing of our Remote Power Patent and revenue of $17,000,000 from our litigation settlement with Hewlett-Packard (see Notes K[1] and K[2] to our consolidated financial statements included herein). We had costs of revenue of $12,147,000 and $1,653,000 for 2021 and 2020, respectively. Included in the costs of revenue for 2021 were contingent legal fees

 

-28- 
 

 

of $10,346,000 and $1,801,000 of incentive bonus compensation payable to our Chairman and Chief Executive Officer pursuant to his employment agreement (see Note J[1] to our consolidated financial statements included herein). Included in the costs of revenue for 2020 were contingent legal fees of $1,433,000 and $220,000 of incentive bonus compensation payable to our Chairman and Chief Executive Officer pursuant to his employment agreement.

Professional fees and related costs decreased by $907,000 for 2021 compared to 2020 primarily as a result of decreased expenses related to patent litigation.

Operating Income (Loss). We had operating income of $19,586,000 for 2021 compared with an operating loss of $2,413,000 for 2020. The increase in operating income of $21,999,000 for 2021 was primarily due to our increase in revenue of $31,626,000 for 2021 from the resolution of our contractual dispute with Cisco and our litigation settlement with Hewlett-Packard.

Interest and Dividend Income. Interest and dividend income for 2021 was $327,000 as compared to interest and dividend income of $522,000 for 2020 which decrease was primarily as a result of a change in the mix of our short-term fixed income investments and cash equivalents.

Income Taxes. In 2021, we had a current tax expense for federal, state and local income taxes of $2,952,000 and a deferred tax expense of $1,508,000. In 2020, we had a deferred tax benefit for federal, state and local income taxes of $490,000 related to the relief of our valuation allowance and a current tax benefit of $464,000 in connection with prior year losses. The difference between 2021 and 2020 was primarily as a result of an increase in operating income for 2021 of $21,999,000.

Share of Net Losses of Equity Method Investee. We incurred a net loss of $999,000 for 2021 related to our equity share in ILiAD Biotechnologies, a clinical stage biotechnology company, as compared to a net loss of $787,000 for 2020 as ILiAD Biotechnologies has no revenue from operations and continues to sustain losses (see Note H to our consolidated financial statements included herein).

Net Income (Loss).  As a result of the foregoing, we realized a net income of $14,281,000 or $0.59 per share basic and $0.58 diluted for 2021 compared with a net loss of $1,709,000 or $(0.07) per share basic and diluted for 2020. The increase in net income of $15,990,000 during 2021 was primarily due to income associated with our increased revenue of $36,029,000 from the resolution of our contractual dispute with Cisco and our litigation settlement with Hewlett-Packard (see Notes K[1] and K[2] to our consolidated financial statements included herein).

 

 

-29- 
 

 

LIQUIDITY AND CAPITAL RESOURCES

We have financed our operations primarily from revenue from licensing our patents. At December 31, 2021, our principal sources of liquidity consisted of cash and cash equivalents and marketable securities of $59,623,000 and working capital of $55,665,000. Based on our current cash position, we believe that we will have sufficient cash to fund our operations for the next twelve months and for the foreseeable future. Material increases in our liquidity and capital resources are primarily dependent upon litigation outcomes and licensing of our intellectual property as well as whether we will be able to achieve returns on our investment in ILiAD Biotechnologies.

Working capital increased by $12,706,000 at December 31, 2021 to $55,665,000 as compared to working capital of $42,959,000 at December 31, 2020. The increase in working capital of $12,706,000 for 2021 was primarily due to net income of $14,281,000 during 2021.

Net cash provided by (used in) operating activities for 2021 increased by $20,002,000 from $(503,000) for 2020 to $19,499,000 for 2021 primarily due to revenue of $36,029,000 from resolution of our contractual dispute with Cisco and our litigation settlement with Hewlett-Packard during 2021.

Net cash provided by investing activities during 2021 was $2,994,000 as compared to $6,306,000 for 2020 primarily as a result of the differential of purchases and sales of marketable securities and partially offset by our $1,000,000 convertible note investment in ILiAD Biotechnologies (see Note H to our consolidated financial statements included in this Annual Report).

Net cash used in financing activities for 2021 and 2020 was $3,501,000 and $2,885,000, respectively. The change of $616,000 primarily resulted from an increase of $824,000 in repurchases of our common stock offset by a decrease of $147,000 in the value of shares delivered to fund withholding taxes and a decrease of $61,000 in cash dividends paid.

We maintain our cash in money market funds and short-term fixed income securities. Accordingly, we do not believe that our investments have significant exposure to interest rate risk.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements.

CONTRACTUAL OBLIGATIONS

We do not have any long-term debt, capital lease obligations, purchase obligations, operating lease obligations, or other long-term liabilities.

 

 

-30- 
 

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our discussion and analysis of our financial condition, results of operations and cash flows are based on our audited consolidated financial statements which have been prepared in accordance with GAAP. The preparation of our financial statements included in this Annual Report on Form 10-K requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of our consolidated financial statements include revenue recognition, contingent legal fees and related expenses, income taxes, valuation of patents and equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based. See also Note B to our consolidated financial statements included in this Annual Report for full disclosure of our accounting policies.

We believe our most critical accounting policies to be the following:

Revenue Recognition

Under ASC 606, revenue is recognized when we complete the licensing of our intellectual property to our licensees, in an amount that reflects the consideration we expect to be entitled to in exchange for licensing our intellectual property. Revenue from our patent licensing business is generated from negotiated license agreements.  The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties.  These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to our assertion of patent infringement involving our intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license (a “Fully-Paid License”), or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to us for the life of the licensed patent (a “Royalty Bearing License”).

We recognize revenue from our Royalty Bearing Licenses in a manner consistent with the legal form of the arrangement, and in accordance with the royalty recognition constraint that applies to licenses of IP for which some or all of the consideration is in the form of sales or usage based royalty. Consequently, we recognize revenue at the later of when (1) the subsequent sale occurs or (2) the performance obligation to which some or all of the sales based royalty has been satisfied.

Fully-Paid Licenses provide for a non-refundable up-front payment, for which we have no future obligations or performance requirements, revenue is generally recognized when we have obtained the signed license agreement, all performance obligations have been substantially performed, amounts are fixed and determinable, and collectability is reasonably assured.  Revenue from Fully-Paid Licenses may consist of one or more installments. The timing and amount of revenue recognized from each licensee depends upon a number of factors including the specific terms of each agreement and the nature of the deliverables and obligations.

-31- 
 

 

Costs of Revenue and Related Costs

We include in costs of revenue for the year ended December 31, 2021 and 2020 contingent legal fees payable to patent litigation counsel, any other contractual payments related to net proceeds from settlements (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer.

ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The consolidated financial statements required hereby are located on pages F-1 through F-22 which follow Part III.

ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.CONTROLS AND PROCEDURES

(a)       Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this Annual Report on Form 10-K. Based upon this review, our executive officers concluded that, as of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in applicable rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

-32- 
 

 

(b)Internal Control Over Financial Reporting
(i)Management’s Annual Report on Internal Control over Financial Reporting

Our management is also responsible for establishing and maintaining adequate “internal control over financial reporting” of the Company, as defined in Rule 13a-15(f) of the Exchange Act.  Internal control over financial reporting is defined as a process designed by, or under the supervision of, the issuer’s principal executive and principal financial officer and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management, our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2021 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013).  Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our internal controls over financial reporting were effective as of the end of the period covered by this report.

(ii)Attestation Report of Registered Public Accounting Firm

We are a “smaller reporting company” as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended, and as such, are not required to provide the information contained in this sub-section pursuant to Item 308(b) of Regulation S-K. Accordingly, this Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.

(iii)Changes in Internal Control over Financial Reporting
-33- 
 

 

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended December 31, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B.OTHER INFORMATION

None.

ITEM 9C.DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not Applicable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-34- 
 

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The following information includes information each director and executive officer has given us about his or her age, all positions he or she holds, his or her principal occupation and business experience for at least the past five years, and the names of other publicly-held companies of which he or she currently serves as a director or has served as a director during the past five years. In addition to the information presented regarding each director’s specific experience, qualifications, attributes and skills that led our Board to the conclusion that he or she should serve as a director, we also believe that all of our directors have a reputation for integrity, honesty and adherence to high ethical standards. They each have demonstrated business acumen, exercise sound judgment, and a commitment of service to Network-1 and our Board.

Information about the number of shares of our common stock beneficially owned by each executive officer and director appears in this Annual Report under the heading “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” beginning on page 44 hereof. There are no family relationships among any of our directors and executive officers.

      NAME AGE POSITION
      Corey M. Horowitz 67 Chairman, Chief Executive Officer and Chairman of the Board of Directors
      David C. Kahn 70 Chief Financial Officer, Secretary and a Director
      Jonathan Greene 60 Executive Vice President
      Emanuel Pearlman 62 Director
      Niv Harizman 57 Director
      Allison Hoffman 51 Director

 

Corey M. Horowitz has been our Chairman and Chief Executive Officer since December 2003. Mr. Horowitz has also served as Chairman of our Board of Directors since January 1996 and has been a member of our Board of Directors since April 1994. In December 2018, Mr. Horowitz became a member of the Board of Managers of ILiAD Biotechnologies, LLC, a privately held biotechnology company, in connection with our investment in the company (see “Business-Investment in ILiAD Biotechnologies” at page 10 of this Annual Report). Mr. Horowitz is also a member of the Life Sciences Institute Leadership Council at the University of Michigan. We believe Mr. Horowitz’s qualifications to serve on our Board of Directors include his significant experience and expertise as an executive in the intellectual property field, his understanding of our intellectual property and the patent acquisition, licensing and enforcement business combined with his private equity and corporate transactional experience.

-35- 
 

 

David C. Kahn, CPA, has been our Chief Financial Officer since January 2004 and our Secretary since August 2012. Mr. Kahn was elected to our Board in April 2012. Since December 1989, Mr. Kahn has provided accounting and tax services on a consulting basis to private and public companies. From August 2000 until August 2012, Mr. Kahn served as a full-time faculty member of Yeshiva University in New York. We believe Mr. Kahn’s qualifications to serve on our Board include his background and expertise in accounting and tax matters.

Jonathan Greene became our Executive Vice President in October 2013. He served as a consultant to the Company from December 2004 until March 2013, providing technical and marketing analysis for our intellectual property portfolio. Mr. Greene became an employee of Network-1 in March 2013. From April 2006 to February 2009, Mr. Greene served as a marketing consultant for Avatier Corporation, a developer of identity management software. From August 2003 until December 2004, he served as a consultant to Neartek, Inc., a storage management software company (August 2003 until October 2003) and Kavado Inc., a security software company (November 2003 until December 2004). From January 2003 until July 2003, Mr. Greene served as Director of Product Management for FalconStor Software, Inc. (OTC:FALC), a storage management software company. From December 2001 through December 2002, Mr. Greene served as Senior Vice President of Marketing and Business Development of Network-1, at a time when Network-1 was engaged in the development, marketing and licensing of security software. From December 1999 until September 2001, he served as Senior Vice President of Marketing for Panacya Inc., a vendor of service management software.

Emanuel R. Pearlman has been a member of our Board of Directors since January 2012, where he serves as Chairman of our Audit Committee and a member of our Nominating and Corporate Governance Committee. Mr. Pearlman currently serves as the Chairman and Chief Executive Officer of Liberation Investment Group, a New York based investment management and financial consulting firm, which he founded in January 2003. In March 2022, Mr. Pearlman became a member of the Board of Directors and Chair of the Strategic Review Committee of Red Box Entertainment, Inc. (NASDAQ: RDBX), an entertainment company that provides consumers access to a large variety of content across digital and physical media.  In October 2020 and February 2021, Mr. Pearlman became a member of the Board of Directors of Atlas Crest Investment Corp. (NYSE:ACIC) and Atlas Crest Investment Corp. II (NYSE: ACII), each a special purpose acquisition company (SPAC). Mr. Pearlman also serves as Chairman of the Audit Committee and a member of the Compensation Committee and Nomination & Governance Committee of both Atlas Crest Investment Corp. and Atlas Crest Investment Corp. II. Mr. Pearlman served as Executive Chairman of Empire Resorts, Inc. (NASDAQ: NYNY) from June 2016 until November 2019, served as Non-Executive Chairman of the Board from September 2010 through May 2016, and served on the Board of Directors from May 2010 to November 2019. Mr. Pearlman was a member of the Board of Directors of CEVA Logistics, AG (SIX:CEVA) from May 2018 until October 2019 and served on its Audit Committee from May 2018 through October 2019 and its Nomination and Governance Committee from May 2018 through May 2019. From June 2013 through May 2018, he served on the Board of Directors of CEVA Holdings, LLC. From May 2017 through September 2017, Mr. Pearlman served on the Board of Directors of ClubCorp Holdings, Inc. (NYSE:MYCC), where he served on the Strategic Review Committee. We believe Mr. Pearlman’s qualifications to serve on our Board include his significant investment and financial experience and expertise combined with his Board experience.

 

 

-36- 
 

Niv Harizman has been a director of our company since December 2012. Mr. Harizman is a Managing Member of Tyto Capital Partners LLC, a private investment firm specializing in debt and equity investments in middle market companies and special situations, a position he has held since August 2010. Since March 2010, Mr. Harizman has also been the Managing Member of NHK Partners LLC, an entity that makes private investments and provides consulting services. Since November 2013, Mr. Harizman has been affiliated with Riverside Management Group, a merchant banking firm, and BCW Securities LLC, its affiliated broker-dealer. From May 2005 to March 2010, Mr. Harizman was a Founding Partner and Head of Corporate Finance at Plainfield Asset Management LLC, which was a privately held registered investment adviser focused on alternative investments. From May 2000 until May 2005, Mr. Harizman was a member of the Mergers & Acquisitions Group of Credit Suisse First Boston LLC, where he was a Managing Director from 2001-2005 and a Director from 2000 to 2001. From 1995 until 2000, Mr. Harizman was employed by Bankers Trust and its successors including BT Alex. Brown Incorporated and Deutsche Bank in various investment banking positions in the Mergers & Acquisitions Group and Leveraged Finance Group.  We believe Mr. Harizman’s qualifications to serve on our Board include his significant investment and financial transactional experience and expertise.

Allison Hoffman has been a director of our company since December 2012. Since August 2020, Ms. Hoffman has served as General Counsel of Phreesia, Inc. (NYSE:PHR), a leading provider of software solutions that healthcare organizations use to manage the patient intake process. From January 2016 until August 2020, Ms. Hoffman served as Chief Legal Officer and Chief Administrative Officer at Intersection Parent, Inc., an urban experience company that utilizes technology to make cities better, including bringing free Wi-Fi throughout New York City.  From September 2013 to December 2015, Ms. Hoffman served as Executive Vice President, General Counsel and Corporate Secretary of Martha Stewart Living Omnimedia, Inc. (NYSE:MSO), a media and merchandising company providing consumers with high quality life style content and products. From December 2012 until September 2013, she provided legal services to Martha Stewart Living Omnimedia, Inc. From January 2007 until September 2012, Ms. Hoffman served as Senior Vice President, Chief Legal Officer and Secretary of ALM Media, LLC, a leading provider of specialized news and information for the legal and commercial real estate sectors. We believe that Ms. Hoffman’s qualifications to serve on our Board include her extensive legal background and transactional experience.

 

 

 

 

-37- 
 

 

Committees of the Board of Directors

Our Board of Directors currently has four standing committees: an Audit Committee; a Compensation Committee; a Nominating and Corporate Governance Committee and a Strategic Development Committee.  Each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee has a charter.  These charters are available on our website at: http://ir.Network-1.com/governance-docs. Each member of each committee is an “independent” director under the standards of the NYSE American LLC Company Guide. Three of our current five directors, Emanuel Pearlman, Allison Hoffman and Niv Harizman, are considered independent directors under Rule 803A(2) of the NYSE American LLC Company Guide.

Audit Committee

Our Board of Directors has a separately standing audit committee in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended, and Section 803B of the NYSE American Company LLC Guide consisting of Emanuel Pearlman (Chairman) and Allison Hoffman.  Emanuel Pearlman and Allison Hoffman each qualify as an audit committee financial expert under applicable SEC rules. Mr. Pearlman and Ms. Hoffman also qualify as “independent” as independence for audit committee members is defined under Rule 10A-3 under the Securities Exchange Act of 1934, as amended, and Section 803B(2) of the NYSE American LLC Company Guide.

The Audit Committee is appointed by our Board of Directors to provide assistance to the Board in fulfilling its oversight responsibility with respect to, among other things, (i) the integrity of our financial statements, (ii) our compliance with legal and regulatory requirements, (iii) selecting and evaluating the qualifications and independence of our independent registered public accounting firm, (iv) evaluating the performance of our internal audit function and independent registered public accounting firm, and (v) our internal controls and procedures.

Compensation Committee

The Compensation Committee consists of Allison Hoffman (Chairperson) and Niv Harizman. The Compensation Committee is appointed by our Board of Directors to assist the Board in carrying out its responsibilities relating to compensation of our executive officers and directors.  The Committee has overall responsibility for evaluating and approving the officer and director compensation plans, policies and our programs.

Nominating and Corporate Governance Committee

Our Board has a Nominating and Corporate Governance Committee consisting of Niv Harizman (Chairman) and Emanuel Pearlman.  The Nominating and Corporate Governance Committee is responsible for, among other things, developing and recommending to the Board a set of corporate governance policies for the Company, establishing criteria for selecting new directors, and identifying, screening and recruiting new directors. The Committee also recommends to the Board nominees for directors and recommends directors for committee membership to the Board.

 

 

-38- 
 

 

Strategic Development Committee

We also have a Strategic Development Committee to assist our Chairman and Chief Executive Officer in strategic development and planning of our business relating to identifying potential strategic partners, the acquisition of new IP and other acquisition opportunities.  The Committee also assists in capital markets related activities. Niv Harizman is the sole member of the Strategic Development Committee.

Code of Ethics

We have adopted a Code of Ethics that applies to our executive officers, directors and employees. Copies of the Code of Ethics may be obtained, without charge, upon written request addressed to: Network-1 Technologies, Inc., 65 Locust Avenue, New Canaan, Connecticut 06840, Attn: Chief Executive Officer. 

ITEM 11.  EXECUTIVE COMPENSATION

The following table summarizes compensation for the years ended December 31, 2021 and December 31, 2020, awarded to, earned by or paid to our Chief Executive Officer (“CEO”) and to each of our executive officers who received total compensation in excess of $100,000 for the year ended December 31, 2021 for services rendered in all capacities to us (collectively, the “Named Executive Officers”).

Summary Compensation Table

 

Name and
Principal Position		  Year   Salary ($)   Bonus ($)   Stock
Awards($)(3)		   All Other
Compensation($)(1)		     Total($) 
                              
Corey M. Horowitz  2021   $535,000   $1,976,000(2)  $—   $38,500(4)  $2,549,500 

Chairman and Chief

Executive Officer

  2020   $527,000   $345,000(2)  $—   $81,250(4)  $953,250 
                              
David C. Kahn  2021   $175,000   $22,500   $—(3)  $29,291(5)  $226,791 
Chief Financial Officer  2020   $175,000   $15,000   $25,200(3)  $34,828(5)  $250,028 
                              
Jonathan Greene  2021   $200,000   $40,000   $—(3)  $36,120(6)  $276,120 
Executive Vice President  2020   $200,000   $25,000   $33,600(3)  $43,000(6)  $301,600 

__________________________

(1)We have concluded that the aggregate amount of perquisites and other personal benefits paid in 2021 and 2020 to either Mr. Horowitz, Mr. Kahn or Mr. Greene did not exceed $10,000.
(2)Mr. Horowitz received the following cash incentive bonus payments for 2021: (i) an annual discretionary bonus of $175,000 and (ii) incentive bonus compensation of $1,801,000 pursuant to his employment agreement (see “Employment Agreements-Termination of Employment and Change In-Control Arrangements” below). Mr. Horowitz received the following cash incentive bonus payments for 2020: (i) an annual discretionary bonus of $125,000 and (ii) incentive bonus compensation of $220,000 pursuant to his employment agreement.

 

 

 

 

-39- 
 

 

(3)The amounts in this column represent the aggregate grant date fair value of restricted stock units awards granted to the Named Executive Officers computed in accordance with FASB ASC Topic 718. In accordance with SEC rules, the grant date fair value of an award that is subject to a performance condition is based on the probable outcome of the performance condition. See Note B[10] to our consolidated financial statements included in this Annual Report for a discussion of the assumptions made by the Company in determining the grant date fair value.
(4)Includes 401 (k) matching funds contributions by the Company and profit sharing under the Company's 401 (k) Plan for the benefit of Mr. Horowitz of $38,500 for 2021 and $37,500 for 2020, respectively. Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr. Horowitz for 2021 of $-0- and 2020 of $43,750.
(5)Includes 401 (k) matching funds contributions by the Company and profit sharing under the Company's 401 (k) Plan for the benefit of Mr. Kahn of $28,728 for 2021 and $30,453 for 2020. Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr. Kahn for 2021 and 2020 of $563 and $4,375, respectively.
(6)Represents 401 (k) matching funds contributions by the Company and profit sharing under the Company's 401 (k) Plan for the benefit of Mr. Greene of $35,201 for 2021 and $37,500 for 2020. Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr. Greene for 2021 and 2020 of $919 and $5,500, respectively.

Narrative Disclosure to Summary Compensation Table

 

Employment Agreements, Termination of Employment and Change-In-Control Arrangements

On March 22, 2022, we entered into a new employment agreement (“Agreement”) with Corey M. Horowitz, our Chairman and Chief Executive Officer, pursuant to which he continues to serve as our Chairman and Chief Executive Officer for a four year term (“Term”), at an annual base salary of $535,000 which shall be increased by 3% per annum during the Term.  The Agreement established an annual target bonus of $175,000 for our Chairman and Chief Executive Officer based upon performance.  During the year ended December 31, 2021 and December 31, 2020, our Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000 and $125,000, respectively.

In addition, pursuant to the Agreement, we granted to our Chairman and Chief Executive Officer, under our 2013 Plan, 600,000 restricted stock units (the “RSUs”, each RSU awarded by us to our officers, directors and consultants represents a contingent right to receive one share of our common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to Mr. Horowitz’s continued employment by us through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the Term our common stock (the “Common Stock”) achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the Term of the Agreement our Common Stock achieves a Closing Price (as defined above) of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the term of the Agreement, our Common Stock achieves a Closing Price of a

 

-40- 
 

 

minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”).  In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by you for Good Reason (as defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by us to our officers, directors or consultants have dividend equivalent rights.

Under the terms of the Agreement, so long as Mr. Horowitz continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, Mr. Horowitz shall also receive incentive compensation in an amount equal to 5% of our gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to our Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of our royalties and other payments relating to Licensing Activities with respect to patents other than our Remote Power Patent (including all of our existing patent portfolios and our investment in ILiAD Biotechnologies) (collectively, the “Incentive Compensation”). During the year ended December 31, 2021 and December 31, 2020, Mr. Horowitz earned Incentive Compensation of $1,801,000 and $220,000, respectively.

The Incentive Compensation shall continue to be paid to Mr. Horowitz for the life of each of our patents with respect to licenses entered into with third parties during the Term or at any time thereafter, whether he is employed by us or not; provided, that, the employment of Mr. Horowitz has not been terminated by us “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of our assets, we have the option to extinguish the right of Mr. Horowitz to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that Mr. Horowitz’s employment is terminated by us “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), Mr. Horowitz shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.

In connection with the Agreement, Mr. Horowitz has also agreed not to compete with us as follows: (i) during the Term and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 month base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by us or “Without Good Reason” by Mr. Horowitz.

 

 

-41- 
 

 

David Kahn serves as our Chief Financial Officer on an at-will basis at a current annual base salary of $175,000. Mr. Kahn received a discretionary annual bonus of $22,500 for 2021 and $15,000 for 2020. On December 29, 2020, Mr. Kahn was granted 7,500 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022) subject to his continued employment. In addition, in the event Mr. Kahn’s employment is terminated without “Good Cause” (as defined), he shall receive (i) (a) 6 months base salary or (b) 12 months base salary in the event of a termination without “Good Cause” within 6 months following a “Change of Control” of the Company (as defined) and (ii) accelerated vesting of all remaining unvested shares underlying his options, RSUs or any other awards he may receive in the future.

Jonathan Greene serves as our Executive Vice President on an at-will basis at an annual base salary of $200,000. Mr. Greene received a discretionary annual bonus of $40,000 for 2021 and $25,000 in 2020. On December 29, 2020, Mr. Greene was granted 10,000 RSUs under the 2013 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022) subject to his continued employment. On January 18, 2022, Mr. Greene was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024).

Profit Sharing 401(k) Plan

We offer all employees who have completed a year of service (as defined) participation in a 401(k) retirement savings plan, 401(k) plans provide a tax-advantaged method of saving for retirement. We expensed matching contributions and profit sharing of $102,500 and $105,500 under the 401(k) plan for the years ended December 31, 2021 and 2020, respectively.

Director Compensation

In 2021, we compensated each non-management director of our Company by granting to each such outside director 15,000 RSUs. The RSUs vested in equal amounts of 3,750 RSUs on each of March 15, 2021, June 15, 2021, September 15, 2021 and December 15, 2021. In addition, we pay our non-management directors cash director fees of $40,000 per annum ($10,000 per quarter). Non-management directors also receive additional cash compensation on an annual basis for serving on the following Board committees: The Audit Committee Chairperson receives $7,500 and members receive $5,000; the Chairperson and members of each of the Compensation Committee and Nominating and Corporate Governance Committee receive annual fees of $3,750 and $2,500, respectively.

In consideration for serving as the sole member of our Strategic Development Committee, in June 2013 we issued to Niv Harizman a five-year stock option to purchase 300,000 shares of our common stock, at an exercise price of $1.88 per share and such option was exercised in full in June 2018.

 

 

-42- 
 

 

The following table sets forth the compensation awarded to, earned by or paid to all persons who served as members of our board of directors (other than our Named Executive Officers) during the year ended December 31, 2021. No director who is also a Named Executive Officer received any compensation for services as a director in 2021.

Name

  

Fees earned or
paid in cash ($)(1)

  

Stock Awards

  ($)(2) (3)

  

All other
compensation ($)(4)

  

Total

($)

Emanuel Pearlman   $ 50,000   $ 46,988   $ 1,125   $ 98,113
Niv Harizman   $ 46,250   $ 46,988   $ 1,125   $ 94,363
Allison Hoffman   $ 48,830   $ 46,988   $ 1,125   $ 96,943

___________________________

(1)Represents directors’ fees payable in cash to each non-management director of $10,000 per quarter ($40,000 per annum) for 2021 plus additional cash fees for serving on Board committees as disclosed above.
(2)The amounts included in this column represent the grant date fair value of restricted stock unit awards (RSUs) granted to directors, computed in accordance with FASB ASC Topic 718. For a discussion of valuation assumptions see Note B[10] to our consolidated financial statements included in this Annual Report. The 15,000 RSUs granted to each non-management director vested on a quarterly basis beginning March 15, 2021. Each restricted stock unit represents the contingent right to receive one share of common stock.
(3)As of December 31, 2021, no stock options were owned by any of the above listed directors.
(4)Includes payment of dividends (dividend equivalent rights) on RSUs for 2021.

Outstanding Equity Awards at December 31, 2021

The following table sets forth information relating to unexercised options and unvested restricted stock units for each Named Executive Officer as of December 31, 2021:

 

Option Awards

Stock Awards

Name

 
Number of Securities
Underlying Unexercised
Options

Option Exercise
Price ($)

Option Expiration
Date

Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested

Equity incentive plan awards: Market value of unearned shares, units or other rights that have not vested(1) ($)



Exercisable

Unexercisable

Corey M. Horowitz

Chairman and CEO

 

500,000

 

—

 

$1.19

 

11/01/22

 

 — $   —

David Kahn

Chief Financial Officer

 

—     

 

 —

—

 

 —

 

 

 3,750(2) $10,575

Jonathan Greene

Executive Vice President

—     

 

 —

—

 

—

 

 5,000(3) $14,100

_________________________________

(1)In accordance with SEC rules, market value is based on $2.82 per share representing the closing price of our common stock on the last trading day of the year.
(2)Represents 3,750 restricted stock units, which vest on December 29, 2022, subject to Mr. Kahn’s continued employment by us.
(3)Represents 5,000 restricted stock units, which vest on December 29, 2022, subject to Mr. Greene’s continued employment by us.
-43- 
 

 

ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth information regarding the beneficial ownership of our common stock as of March 15, 2022 for (i) each of our directors, (ii) each of our executive officers, (iii) each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock, and (iv) all of our executive officers and directors as a group.

NAME AND ADDRESS

OF BENEFICIAL OWNER

  

AMOUNT AND NATURE

OF BENEFICIAL

OWNERSHIP (1)(2)

   PERCENTAGE
OF COMMON STOCK BENEFICIALLY OWNED(2)

Executive Officers and Directors:

Corey M. Horowitz(3)

    

 

7,016,751 

      

 

28.8%

  
CMH Capital Management Corp(4)     2,291,372        9.6%  
Niv Harizman(5)     275,985        1.2%  
David C. Kahn(6)     116,053       *  
Allison Hoffman(7)     105,811       *  
Emanuel Pearlman (8)     102,059       *  
Jonathan E. Greene(9)     85,717       *  
All officers and directors as a group
(6 Persons)		     7,702,376       31.6%  
5% Stockholders:                
Steven D. Heinemann(10)     1,961,201       8.2%  
Goose Hill Capital LLC(11)     1,376,068       5.8%  

_____________________________________

 *        Less than 1%.

(1)Unless otherwise indicated, we believe that all persons named in the above table have sole voting and investment power with respect to all shares of our common stock beneficially owned by them. Unless otherwise indicated the address for each listed beneficial owner is c/o Network-1 Technologies, Inc., 65 Locust Avenue, New Canaan, Connecticut 06840.
(2)A person is deemed to be the beneficial owner of shares of common stock that can be acquired by such person within 60 days from March 15, 2022 upon the exercise of stock options or restricted stock units that vest within such 60 day period. Each beneficial owner's percentage ownership is determined by assuming that all stock options and restricted stock units held by such person (but not those held by any other person) and which are exercisable or vest within 60 days from March 15, 2022 have been exercised or vested.  Assumes a base of 23,883,024 shares of our common stock outstanding as of March 15, 2022.

 

-44- 
 

(3)Includes (i) 3,703,368 shares of common stock held by Mr. Horowitz, (ii) 500,000 shares of common stock subject to currently exercisable stock options held by Mr. Horowitz, (iii) 2,157,097 shares of common stock held by CMH Capital Management Corp., an entity solely owned by Mr. Horowitz, (iv) 134,275 shares of common stock owned by the CMH Capital Management Corp. Profit Sharing Plan, of which Mr. Horowitz is the trustee, (v) 67,470 shares of common stock owned by Donna Slavitt, the wife of Mr. Horowitz, (vi) an aggregate of 452,250 shares of common stock held by two trusts and a custodian account for the benefit of Mr. Horowitz’s three children, and (vii) 2,291 shares of common stock held by Horowitz Partners, a general partnership of which Mr. Horowitz is a partner.
(4)Includes 2,157,097 shares of common stock owned by CMH Capital Management Corp. and 134,275 shares of common stock owned by CMH Capital Management Corp. Profit Sharing Plan.  Corey M. Horowitz, by virtue of being the sole officer, director and shareholder of CMH Capital Management Corp. and the trustee of the CMH Capital Management Corp. Profit Sharing Plan, has the sole power to vote and dispose of the shares of common stock owned by CMH Capital Management Corp. and the CMH Capital Management Corp. Profit Sharing Plan.
(5)Includes (i) 275,985 shares of common stock. Does not include 11,250 shares of common stock subject to restricted stock units owned by Mr. Harizman that do not vest within 60 days from March 15, 2022.
(6)Includes 116,053 shares of common stock. Does not include 3,750 shares of common stock subject to restricted stock units owned by Mr. Kahn that do not vest within 60 days from March 15, 2022.
(7)Includes (i) 105,811 shares of common stock. Does not include 11,250 shares of common stock subject to restricted stock units owned by Ms. Hoffman that do not vest within 60 days from March 15, 2022.
(8)Includes (i) 102,059 shares of common stock. Does not include 11,250 shares of common stock subject to restricted stock units owned by Mr. Pearlman that do not vest within 60 days from March 15, 2022.
(9)Includes 85,717 shares of common stock.  Does not include 20,000 shares of common stock subjected to restricted stock units owned by Mr. Greene that do not vest within 60 days from March 15, 2022.
(10)Includes 585,133 shares of common stock owned by Mr. Heinemann and 1,376,068 shares of common stock owned by Goose Hill Capital LLC. Goose Hill Capital LLC is a limited liability company of which Mr. Heinemann is the sole member. Mr. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon Amendment No. 9 to Schedule 13G filed by Mr. Heinemann with the SEC on February 4, 2022.  The address for Mr. Heinemann is c/o Goose Hill Capital, LLC, 12378 Indian Road, North Palm Beach, Florida 33408.
(11)Includes 1,376,068 shares of common stock. Steven D. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon Amendment No. 9 to Schedule 13G filed by Mr. Heinemann with the SEC on February 4, 2022. The address for Goose Hill Capital LLC is 12378 Indian Road, North Palm Beach, Florida 33408.

 

 

-45- 
 

ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

On May 27, 2021, we repurchased from Emanuel Pearlman, a director of the Company, 40,000 shares of its common stock at a purchase price of $3.27 per share for an aggregate purchase price of $130,800.

Review, Approval or Ratification of Transactions with Related Persons

The Audit Committee has responsibility for reviewing and approving related-persons transactions in accordance with its charter. A related person is any executive officer, director, nominee for director or more than 5% stockholder of the Company, including immediate family members, and any entity owned or controlled by such persons. In addition, pursuant to our Codes of Ethics, all of our officers, directors and employees are to avoid conflicts of interest and to refrain from taking part or exercising influence in any transaction in which such party’s personal interest may conflict with the best interest of the Company.  Except for provisions of the Audit Committee Charter, there are no written procedures governing review of related-persons transactions.

Director Independence

Three of our five directors, Emanuel Pearlman, Niv Harizman and Allison Hoffman, are considered independent directors in compliance with the standard of independence in Section 803A(2) of the NYSE American LLC Company Guide.

 

 

 

 

 

 

 

-46- 
 

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Audit Fees

Friedman LLP, our independent registered public accounting firm, billed us aggregate fees of $135,535 and $125,211 for the years ended December 31, 2021 and December 31, 2020, respectively, for the audit of our annual financial statements, review of our financial statements included in our Form 10-Qs and for other services in connection with statutory or regulatory filings.

Audit Related Fees, Tax Fees and All Other Fees

Friedman LLP provided various tax compliance services for which it billed us $22,890 and $33,577, respectively, for the years ended December 31, 2021 and December 31, 2020. Friedman LLP did not render any other professional services other than those discussed above for 2021 and 2020.

Audit Committee Pre-Approval Policies and Procedures

Our audit committee charter provides that our audit committee must comply with SEC rules to maintain auditor independence as set forth in Rule 2-01(c)(7)(i) of Regulation S-X. The Audit Committee has a policy to pre-approve all audit and permissible non-audit services to be provided by our independent registered public accounting firm. All the services above were approved in advance by our Board of Directors.

 

 

 

 

 

 

 

 

 

-47- 
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

 

 

 

   
 

Index to Consolidated Financial Statements

 PAGE
   
Report of Independent Registered Public Accounting Firm (PCAOB Firm ID #711) F-1
   
Consolidated Balance Sheets as of December 31, 2021 and 2020 F-2
   
Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2021 and 2020 F-3
   
Consolidated Statements of Changes in Stockholders' Equity for the years ended December 31, 2021 and 2020 F-4
   
Consolidated Statements of Cash Flows for the years ended December 31, 2021 and 2020 F-5
   
Notes to Consolidated Financial Statements F-6
   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-48- 
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Board of Directors and Stockholders

Network-1 Technologies, Inc.

 

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Network-1 Technologies, Inc. and Subsidiary (“the Company”) as of December 31, 2021 and 2020, and the related consolidated statements of operations and comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the years ended December 31, 2021 and 2020, and the related notes and schedules (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years ended December 31, 2021 and 2020, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are not critical audit matters.

 

 

/s/ Friedman LLP

 

We have served as the Company’s auditor since 2014.

 

New York, New York

March 30, 2022

 

 

F-1
 

NETWORK-1 TECHNOLOGIES, INC.

 

CONSOLIDATED BALANCE SHEETS

 

 

           
  

December 31,

 
  

2021

  

2020

 
ASSETS:        
           
CURRENT ASSETS:          
Cash and cash equivalents  $44,497,000   $25,505,000 
Marketable securities, at fair value   15,126,000    19,366,000 
Other current assets   150,000    120,000 
           
Total Current Assets   59,773,000    44,991,000 
           
OTHER ASSETS:          
Deferred tax assets, net   —    954,000 
Patents, net of accumulated amortization   1,384,000    1,578,000 
Equity investment   2,651,000    3,650,000 
Convertible note investment   1,000,000    — 
Security deposits   13,000    21,000 
           
Total Other Assets   5,048,000    6,203,000 
           
TOTAL ASSETS  $64,821,000   $51,194,000 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY:          
           
CURRENT LIABILITIES:          
Income taxes payable  $2,952,000   $— 
Accounts payable   459,000    597,000 
Accrued contingency fees and related costs   137,000    932,000 
Accrued payroll   380,000    277,000 
Other accrued expenses   180,000    226,000 
           
Total Current Liabilities  $4,108,000   $2,032,000 
           
LONG TERM LIABILITIES:          
Deferred tax liability   554,000    — 
           
TOTAL LIABILITIES  $4,662,000   $2,032,000 
           
COMMITMENTS AND CONTINGENCIES          
           
STOCKHOLDERS' EQUITY          
           

Preferred stock, $0.01 par value; authorized 10,000,000 shares;

none issued and outstanding at December 31, 2021 and December 31, 2020

   —    — 
           

Common stock, $0.01 par value; authorized 50,000,000 shares;

23,792,212 and 24,105,879 shares issued and outstanding at December 31, 2021

and December 31, 2020, respectively

   238,000    241,000 
           
Additional paid-in capital   66,361,000    66,124,000 
Accumulated deficit   (6,428,000)   (17,193,000)
Accumulated other comprehensive loss   (12,000)   (10,000)
           
TOTAL STOCKHOLDERS’ EQUITY   60,159,000    49,162,000 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

  $64,821,000   $51,194,000 

 

 

 

The accompanying notes are an integral part of the consolidated financial statements

 

F-2 
 

NETWORK-1 TECHNOLOGIES, INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

 

 

           
  

Years Ended
December 31,

 
  

2021

  

2020

 
REVENUE  $36,029,000   $4,403,000 
           
OPERATING EXPENSES:          
Costs of revenue   12,147,000    1,653,000 
Professional fees and related costs   1,500,000    2,407,000 
General and administrative   2,263,000    2,162,000 
Amortization of patents   295,000    292,000 
Stock-based compensation   238,000    302,000 
           
TOTAL OPERATING EXPENSES   16,443,000    6,816,000 
           
OPERATING INCOME (LOSS)   19,586,000    (2,413,000)

 

OTHER INCOME

          
Interest and dividend income, net   327,000    522,000 
Net realized and unrealized gain (loss) on marketable securities   (173,000)   15,000 
Total other income, net   154,000    537,000 
           
INCOME (LOSS) BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE   19,740,000    (1,876,000)
           
INCOME TAXES PROVISION (BENEFIT):          
Current   2,952,000    (464,000)
Deferred taxes, net   1,508,000    (490,000)
Total income taxes (benefit)   4,460,000    (954,000)

 

INCOME (LOSS) BEFORE SHARE OF NET LOSSES OF

EQUITY METHOD INVESTEE:

   15,280,000    (922,000)

 

SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE

  $

 

(999,000

)  $

(787,000

)
           
NET INCOME (LOSS)  $14,281,000   $(1,709,000)
           
Net Income (Loss) Per Share:          
Basic  $0.59   $(0.07)
Diluted  $0.58   $(0.07)
           
Weighted average common shares outstanding:          
Basic   24,136,821    24,011,354 
Diluted   24,530,568    24,011,354 
           
Cash dividends declared per share  $0.10   $0.10 
           
NET INCOME (LOSS)  $14,281,000   $(1,709,000)
           
OTHER COMPREHENSIVE LOSS          
Net unrealized holding loss on corporate bonds and notes
arising during the year, net of tax		   (2,000)   (89,000)
           
COMPREHENSIVE INCOME (LOSS)  $14,279,000   $(1,798,000)

 

 

 

 

The accompanying notes are an integral part of the consolidated financial statements

 

F-3 
 

NETWORK-1 TECHNOLOGIES, INC.

 

 CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

 

 

                               
   Common Stock                 
   Shares   Amount   Additional
Paid-in
Capital		   Accumulated Deficit   Accumulated Other Comprehensive Income
(Loss)		  

Total

Stockholders’ Equity

 
                               
Balance – January 1, 2020   24,036,071   $240,000   $65,824,000   $(12,636,000)  $79,000   $53,507,000 
Dividends and dividend equivalents declared   —    —    —    (2,435,000)   —    (2,435,000)
Stock-based compensation   —    —    302,000    —    —    302,000 
Vesting of restricted stock units   247,500    3,000    (3,000)   —    —    — 
Value of shares delivered to pay withholding taxes   (66,510)   (1,000)   1,000    (161,000)   —    (161,000)
Cashless exercise of options   105,000    1,000    —    —    —    1,000 
Value of shares delivered to pay withholding taxes   (100,293)   (1,000)   —    —    —    (1,000)
Treasury stock purchased and retired   (115,889)   (1,000)   —    (252,000)   —    (253,000)
Net unrealized loss on corporate bonds and notes   —    —    —    —    (89,000)   (89,000)
Net loss   —    —    —    (1,709,000)   —    (1,709,000)
Balance – December 31, 2020   24,105,879   $241,000   $66,124,000   $(17,193,000)  $(10,000)  $49,162,000 
Dividends and dividend equivalents declared   —    —    —    (2,429,000)   —    (2,429,000)
Stock-based compensation   —    —    238,000    —    —    238,000 
Vesting of restricted stock units   70,000    1,000    (1,000)   —    —    — 
Value of shares delivered to pay withholding taxes   (5,192)   —    —    (14,000)   —    (14,000)
Treasury shares purchased and retired   (378,475)   (4,000)   —    (1,073,000)   —    (1,077,000)
Net unrealized loss on corporate bonds and notes   —    —    —    —    (2,000)   (2,000)
Net income   —    —    —    14,281,000    —    14,281,000 
Balance – December 31, 2021   23,792,212   $238,000   $66,361,000   $(6,428,000)  $(12,000)  $60,159,000 
                               

 

 

 

 

 

 

The accompanying notes are an integral part of the consolidated financial statements

 

F-4
 

NETWORK-1 TECHNOLOGIES, INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

           
   Years Ended
 December 31,		 
   2021   2020 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $14,281,000   $(1,709,000)

Adjustments to reconcile net income (loss) to net cash

used in operating activities:

          
Amortization of patents   295,000    292,000 
Stock-based compensation   238,000    302,000 
Loss from equity investment   999,000    787,000 
Deferred tax expense (benefit)   1,508,000    (954,000)
Amortization of right of use asset   —    41,000 
Unrealized (gain) loss on marketable securities   148,000    (88,000)
           
Changes in operating assets and liabilities:          
Royalty receivables   —    343,000 
Other current assets   (30,000)   (22,000)
Accounts payable   (142,000)   180,000 
Income taxes payable   2,952,000    — 
Security deposit   8,000    — 
Operating lease obligations   —    (41,000)
Accrued expenses   (758,000)   366,000 
           
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES   19,499,000    (503,000)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Sales of marketable securities   17,154,000    24,216,000 
Purchases of marketable securities   (13,059,000)   (17,859,000)
Development of patents   (101,000)   (51,000)
Convertible note investment   (1,000,000)   — 
           

 

NET CASH PROVIDED BY INVESTING ACTIVITIES

   2,994,000    6,306,000 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Cash dividends paid   (2,410,000)   (2,471,000)
Value of shares delivered to fund withholding taxes   (14,000)   (161,000)
Repurchases of common stock, inclusive of commissions   (1,077,000)   (253,000)
           
NET CASH USED IN FINANCING ACTIVITIES   (3,501,000)   (2,885,000)
           
NET INCREASE IN CASH AND CASH EQUIVALENTS   18,992,000    2,918,000 
           
CASH AND CASH EQUIVALENTS, beginning of year   25,505,000    22,587,000 
           
CASH AND CASH EQUIVALENTS, end of year  $44,497,000   $25,505,000 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid during the years for:          
Interest  $—   $— 
Income taxes  $—   $— 
           
NON-CASH FINANCING ACTIVITY          
Accrued dividend rights on restricted stock units  $20,000   $31,000 
           

 

 

 

The accompanying notes are an integral part of the consolidated financial statements

 

F-5
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note A – Business

 

Network-1 Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns ninety-five (95) patents including (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded sim cards in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds (see Note P[5]); (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.

Until March 7, 2020, when the Remote Power Patent expired, the Company had been actively engaged in licensing its Remote Power Patent (U.S. Patent No. 6,218,930). As of March 7, 2020, the Company had twenty-seven (27) license agreements with respect to its Remote Power Patent. As a result of the expiration of the Remote Power Patent, the Company no longer receives licensing revenue for its Remote Power Patent for any period subsequent to the expiration date (March 7, 2020). However, subsequent to the expiration date of the Remote Power Patent, the Company received licensing revenue from certain licensees for periods prior to March 7, 2020. On March 30, 2021, the Company entered into an amendment (the “Amendment”) to the Settlement and License Agreement, dated May 25, 2011, between the Company and Cisco (the “Agreement”). Pursuant to the Amendment, Cisco paid $18,691,890 to the Company to resolve a dispute relating to Cisco’s contractual obligation to pay royalties under the Agreement to the Company for the period beginning in the fourth quarter of 2017 through March 7, 2020 (when the Remote Power Patent expired) with respect to licensing the Remote Power Patent (see Note K[2] hereof). In addition, on July 26, 2021, the Company entered into a settlement agreement with Hewlett-Packard pursuant to which Hewlett-Packard paid the Company $17,000,000 in full settlement of a patent litigation involving the Remote Power Patent (see Note K[1] hereof). The Company believes that NETGEAR, Inc. (“Netgear”), another licensee of the Remote Power Patent, is obligated to pay the Company royalties that accrued but were not paid since the fourth quarter of 2017 through March 7, 2020. The Company has pending litigation against Netgear to recover such royalties (see Note K[5] hereof).

The Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition, the Company continually reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.

 

 
F-6
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note B – Summary of Significant Accounting Policies

 

[1]Principles of Consolidation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiary, Mirror Worlds Technologies, LLC. All intercompany transactions and balances are eliminated in consolidation.

 

[2]Use of Estimates and Assumptions

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements include revenue recognition, contingent legal fees and related costs, income taxes, valuation of patents and equity method investments, including evaluation of the Company’s basis difference. Actual results could be materially different from those estimates, upon which the carrying values were based.

[3]Cash and Cash Equivalents

The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $250,000. At December 31, 2021 and 2020, the Company had $8,109,000 and $5,477,000, respectively, in excess of the FDIC insured limit.

 

The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.

 

[4]Marketable Securities

 

The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, fixed income mutual funds, and corporate bonds and notes (see Note G). At December 31, 2021 and December 31, 2020, included in marketable securities, the Company had aggregate certificates of deposit of $— and $3,500,000, respectively, at financial institutions that were within the FDIC limit. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.

 

[5]Revenue Recognition

 

Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.

 

The Company determines revenue recognition through the follow steps:

 

•identification of the license agreement;
•identification of the performance obligations in the license agreement;
•determination of the consideration for the license;
•allocation of the transaction price to the performance obligations in the contract; and
•recognition of revenue when the Company satisfies its performance obligations.

 

 

 
F-7
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note B – Summary of Significant Accounting Policies (continued)

 

Revenue disaggregated by source is as follows:

Schedule of disaggregation of revenue          
   Years Ended December 31, 
   2021   2020 
Fully-Paid Licenses  $17,000,000(1)  $— 
Royalty Bearing Licenses   19,029,000(2)   4,403,000(3)
Total Revenue  $36,029,000   $4,403,000 

__________________________

(1)Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
(2)Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).
(3)Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.

The Company relied on royalty reports received from third party licensees to record its revenue. From time to time, the Company may audit or otherwise dispute royalties reported from licensees. Any adjusted royalty revenue as a result of such audits or dispute is recorded by the Company in the period in which such adjustment is agreed to by the Company and the licensee or otherwise determined.

 

Revenue from the Company’s patent licensing business is generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license (a “Fully-Paid License”), or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent (a “Royalty Bearing License”).

 

The Company’s license agreements, both Fully-Paid Licenses and Royalty Bearing Licenses, typically include some combination of the following: (i) the grant of a non-exclusive license to manufacture and/or sell products covered by its patented technologies; (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted pursuant to these licenses typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company typically has no further performance obligations with respect to the grant of the non-exclusive licenses. Generally, the license agreements provide for the grant of the licenses, releases, and other obligations following execution of the agreement and the receipt of the up-front lump sum payment for a Fully-Paid License or a license initiation fee for a Royalty Bearing License.

 

The Company recognizes revenue from their Royalty Bearing Licenses in a manner consistent with the legal form of the arrangement, and in accordance with the royalty recognition constraint that applies to licenses of IP for which some or all of the consideration is in the form of sales or usage based royalty. Consequently, the Company recognizes revenue at the later of when (1) the subsequent sale occurs or (2) the performance obligation to which some or all of the sales based royalty has been satisfied.

 

Non-Refundable Up-Front Fees: Fully-Paid Licenses provide for a non-refundable up-front payment, for which the Company has no future obligations or performance requirements, revenue is generally recognized when the Company has obtained the signed license agreement, all performance obligations have been substantially performed, amounts are fixed and determinable, and collectability is reasonably assured. Revenue from Fully-Paid Licenses may consist of one or more installments. The timing and amount of revenue recognized from each licensee depends upon a number of factors including the specific terms of each agreement and the nature of the deliverables and obligations.

 

 
F-8
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note B – Summary of Significant Accounting Policies (continued)

 

[6]Equity Method Investments

 

Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized. Upon sale of equity method investments, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss.

 

[7]Patents

The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.

 

[8]Costs of Revenue and Related Costs

The Company includes in costs of revenue for the year ended December 31, 2021 and 2020 contingent legal fees payable to patent litigation counsel, any other contractual payments related to net proceeds from settlements (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer.

During the year ended December 31, 2020, the Company had a change in estimate related to accrued contingency fees and related costs. The change was the result of the Company receiving new information reflecting additional legal costs in connection with certain contingent litigation. The effect of this change in estimate for the year ended December 31, 2020 was an increase in professional fees and related costs of $886,000 and a corresponding increase in our operating loss and net loss of $886,000, and a decrease in basic and diluted earnings per share of $0.04 per share.

 

[9]Income Taxes

The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.

ASC 740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2021 and 2020.

F-9 
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note B – Summary of Significant Accounting Policies (continued)

 

U.S. federal, state and local income tax returns prior to 2018 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.

 

[10]Stock-Based Compensation

 

The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income based on their grant date fair values.

Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.

 

[11]Earnings Per Share

The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.

 

[12]Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.

There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents, royalty receivable, other assets, accounts payable, and accrued expenses approximates fair value because of the short-term nature of these financial instruments.

F-10
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note B – Summary of Significant Accounting Policies (continued)

The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.

The Company’s equity investment in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held development stage biotechnology company, is measured on a non-recurring basis and is classified within Level 3 as it is valued using significant unobservable inputs or data in an inactive market, and the valuation requires management judgment due to the absence of market price and inherent lack of liquidity.

 

[13]Carrying Value, Recoverability and Impairment of Long-Lived Assets

An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2021 and 2020, there was no impairment to the Company’s patents and equity investment.

The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.

 

[14]Dividend Policy

Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).

 

[15]New Accounting Standards

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes. The ASU removes certain exceptions for performing intra-period allocation and calculating income taxes in interim periods. It also simplifies the accounting for income taxes by requiring recognition of franchise tax partially based on income as an income-based tax, requiring reflection of enacted changes in tax laws in the interim period and making improvements for income taxes related to employee stock ownership plans. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The adoption of this standard did not have a material effect on its consolidated financial statements.

 

Equity Securities

 

In January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The ASU amends and clarifies certain interactions between the guidance under Topic 321, Topic 323 and Topic 815, by reducing diversity in practice and increasing comparability of the accounting for these interactions. The amendments in the ASU should be applied on a prospective basis. The ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of this standard did not have a material effect on the Company’s consolidated financial statements.

 

 

 
F-11 
 

NETWORK-1 TECHNOLOGIES, INC.

 

Note C – Patents

The Company’s intangible assets at December 31, 2021 include patents with estimated remaining economic useful lives ranging from 1.50 to 12.33 years. For all periods presented, all the Company’s patents were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of December 31, 2021 and 2020 were as follows:

        
 

2021

  

2020

 
Gross carrying amount  $7,949,000   $7,848,000 
Accumulated amortization   (6,565,000)   (6,270,000)
Patents, net  $1,384,000   $1,578,000 

 

Amortization expense for the years ended December 31, 2021 and 2020 was $295,000 and $292,000, respectively. Future amortization of current intangible assets, net is as follows:

Schedule of future amortization of current intangible     
For the years ended December 31,     
2022   $301,000 
2023    236,000 
2024    90,000 
2025    90,000 
2026 and thereafter    667,000 
Total   $1,384,000 

 

The Company’s Remote Power Patent expired on March 7, 2020. All patents within our Mirror Worlds Patent Portfolio and QoS Patents have also expired. All patents within the Cox Patent Portfolio expired in September 2021 except for two patents which expire in July 2023 and November 2023. The expiration dates of patents within the Company’s M2M/IoT Patent Portfolio range from September 2033 to May 2034.

 

Note D – Income (Loss) Per Share

Basic Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during the period. Diluted per share data included the dilutive effects of stock options and restricted stock units. Potential shares of 12,500 and 662,500 at December 31, 2021 and 2020, respectively, consist of options and restricted stock units. Computations of basic and diluted weighted average common shares outstanding are as follows:

  2021   2020 
         
Weighted-average common shares
outstanding – basic		   24,136,821    24,011,354 
           

Dilutive effect of stock options and

restricted stock units

   393,747    

 

—

 
           
Weighted-average common shares
outstanding – diluted		   24,530,568    24,011,354 
           
Stock option and restricted stock units
excluded from the computation of diluted
income per share because the effect of
inclusion would have been anti-dilutive		   12,500    662,500 

 

 

 

 

F-12
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note E – Income Taxes

Significant components of the income taxes were as follows for the years ended December 31, 2021 and 2020.

   2021   2020 
Current          
   State and local  $144,000   $(34,000)
   Federal   2,808,000    (430,000)
Total Current Tax Expense (Benefit)  $2,952,000   $(464,000)
           
Deferred          
   State and local   83,000    (32,000)
   Federal   1,425,000    (458,000)
Total Deferred Tax Expense (Benefit)   1,508,000    (490,000)
           
Total Income Taxes  $4,460,000   $(954,000)

 

Significant components of deferred tax assets as of December 31, 2021 and 2020 consisted of the following:

Schedule of components of deferred tax assets   2021   2020 

Deferred tax assets (liability):
Net operating loss carry forwards

  $
—		   $1,665,000 
           
Deferred Tax Liability(1)   (554,000)   (711,000)
           
Total deferred tax assets (liability)  $(554,000)  $954,000 

_________________________

(1)   Deferred tax liability as a result of a temporary difference related to the Company’s equity method investment.

 

There was no valuation allowance as of December 31, 2021. As of December 31, 2020, the Company relieved a valuation allowance of $490,000.

The reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to the net income before income taxes is as follows:

  Years Ended 
  

December 31,

 
  

2021

  

2020

 
         
Income tax - statutory rate   21.00%   21.0%
Permanent difference   1.69%   (5.05)%
State and other   1.11%   1.48%
Valuation allowance on deferred tax assets   —%   18.4%
  Total   23.80%   35.83%

 

While only the tax returns for the three years ended prior to December 31, 2021 are open for examination for taxes payable for those years, tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent that they generated loss carry-forwards that are available for those future years.

The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation to be classified as a PHC, it must satisfy two tests: (i) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (ii) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities

F-13
 

NETWORK-1 TECHNOLOGIES, INC.

 

Note E – Income Taxes (continued)

and rents (the “Income Test”). During the second half of 2021, based on available information concerning the Company’s shareholder ownership, the Company did not satisfy the Ownership Test and thus the Company was not a PHC for 2021. If the Company were to become a PHC in any future year, we would be subject to an additional 20% tax on our UPHCI. In such event, the Company may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.

Note F – Stockholders’ Equity

The 2013 Stock Incentive Plan (“2013 Plan”) provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units. Awards under the 2013 Plan may be granted singly, in combination, or in tandem. Subject to standard anti-dilution adjustments as provided, the 2013 Plan provides for an aggregate of 2,600,000 shares of the Company’s common stock to be available for distribution. The Company’s Compensation Committee generally has the authority to administer the 2013 Plan, determine participants who will be granted awards, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2013 Plan may be granted to employees, directors and consultants of the Company and its subsidiaries. As of December 31, 2021, there were 1,837,500 shares of common stock available for issuance under the 2013 Plan.

[1]Restricted Stock Units

A summary of restricted stock units granted during the years ended December 31, 2021 and December 31, 2020 is as follows (each restricted stock unit represents the contingent right to receive one share of the Company’s common stock):

  2021   2020 
  

Number

of Shares

   Weighted-Average Grant
Date Fair Value		  

Number

of Shares

   Weighted-Average Grant
Date Fair Value		 
Balance of restricted stock units outstanding at beginning of year   162,500   $2.25    340,000   $2.15 
Grants of restricted stock units   45,000    3.51    70,000    2.68 
Vested restricted stock units(1)   (195,000)   (2.47)   (247,500)   (2.23)
Balance of restricted stock units outstanding at end of year   12,500   $3.36    162,500   $2.25 

__________________________

(1)       Includes 125,000 shares of common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer which vested on July 14, 2021 and settled on March 11, 2022.

 

Restricted stock unit compensation expense was $238,000 for the year ended December 31, 2021 and $302,000 for the year ended December 31, 2020.

The Company has an aggregate of $42,000 of unrecognized restricted stock unit compensation expense as of December 31, 2021 to be expensed over a weighted average period of 0.99 years.

The fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards.

All of the Company’s issued restricted stock units have dividend equivalent rights. As of December 31, 2021 and 2020, there was $72,000 and $53,000 accrued for dividend equivalent rights which were included in other accrued expenses.

 

 
F-14
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note F – Stockholders’ Equity (continued)
[2]Stock Options

At December 31, 2021, one stock option to purchase 500,000 shares of common stock was outstanding representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan). The one stock option has a weighted average exercise price of $1.19 and a weighted average remaining life of 0.84 years. There were no grants of stock options during the years ended December 31, 2021 and 2020.

The following table summarizes stock option activity for the years ended December 31:

 

 

2021

  

2020

 
       Weighted       Weighted 
       Average       Average 
   Options   Exercise   Options   Exercise 
  

Outstanding

  

Price

  

Outstanding

  

Price

 
Options outstanding
at beginning of year		   500,000   $1.19    605,000   $1.39 
Granted   —    —    —    — 
Expired   —    —    —    — 
Exercised   —    —    (105,000)  $2.34 
Options outstanding at end of year   500,000   $1.19    500,000   $1.19 
Options exercisable at end of year   500,000   $1.19    500,000   $1.19 

 

During the year ended December 31, 2021 and 2020, the Company did not recognize any stock-based compensation related to the vesting of prior issued stock options to employees and directors. The Company at December 31, 2021 and 2020 had no remaining unrecognized expenses related to unvested stock options to employees and directors. The aggregate intrinsic value of all stock options exercisable at December 31, 2021 and 2020 was $815,000 and $1,250,000, respectively.

During the year ended December 31, 2020, stock options to purchase an aggregate of 105,000 shares of the Company’s Common Stock at an exercise price of $2.34 per share were exercised on net exercise (cashless basis) by each of the Company’s three outside directors. With respect to the net exercise (cashless) of these stock options, 4,707 aggregate net shares were delivered to the outside directors.

F-15
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note G – Marketable Securities

Marketable securities as of December 31, 2021 and 2020 were composed of: 

                
   December 31, 2021 
  

Cost
Basis

  

Gross Unrealized Gains

  

Gross Unrealized Losses

  

Fair Value

 
                 
Fixed income mutual funds  $14,462,000   $—   $(137,000)  $14,325,000 
Corporate bonds and notes   813,000    —    (12,000)   801,000 
Total marketable securities  $15,275,000   $—   $(149,000)  $15,126,000 

 

   December 31, 2020 
  

Cost
Basis

  

Gross Unrealized Gains

  

Gross Unrealized Losses

  

Fair Value

 
                 
Certificates of deposit  $3,534,000   $7,000   $—   $3,541,000 
Fixed income mutual funds   11,255,000    80,000    —    11,335,000 
Corporate bonds and notes   4,500,000    18,000    (28,000)   4,490,000 
Total marketable securities  $19,289,000   $105,000   $(28,000)  $19,366,000 

 

Note H – Equity Investment

During the period December 2018 – March 2021, the Company made an aggregate investment of $6,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is developing key technologies and working with leading scientists to investigate the impact of Bordetella pertussis in a range of human disease and is currently focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). The aggregate investment of $6,000,000 by the Company includes a $5,000,000 equity investment and a $1,000,000 investment in a convertible note (see below). At December 31, 2021, the Company owned approximately 9.5% of the outstanding units of ILiAD on a non-fully diluted basis and 7.2% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options, warrants and convertible notes). In connection with its investment, the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same compensation for service on the Board of Managers as other non-management Board members.

On March 12, 2021, the Company invested $1,000,000 in ILiAD as part of its private offering of up to $23,500,000 of convertible notes (the “Notes”). The Notes have a maturity of three years with interest accruing at 6% per annum. The Notes are required to be converted into a Qualified Financing (minimum financing of $15 million) at the lesser of (i) 80% of the price paid per unit in such offering or (ii) a price based on an enterprise value of $176,000,000. In addition, the Notes shall convert in the event of a merger at the lower of an enterprise value of $176,000,000 or the stated valuation of ILiAD in the merger transaction. In the event of a change-in-control, noteholders will also have the option to have the Notes repaid except in a Qualified Financing or a stock-for-stock merger.

For the years ended December 31, 2021 and 2020, the Company recorded a net loss from its equity method investment in ILiAD of $999,000 and $787,000, respectively.

The difference between the Company’s share of equity in ILiAD’s net assets and the equity investment carrying value reported on the Company’s consolidated balance sheet at December 31, 2021 is due to an excess amount paid over the book value of the investment totaling approximately $5,000,000 which are accounted for as equity method goodwill.

 
F-16
 

NETWORK-1 TECHNOLOGIES, INC.

 

Note I – Commitments and Contingencies

[1]Legal fees:

Russ, August & Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook, Inc. in the U.S. District Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds Patent Portfolio (see Note K[4] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for cash payments on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

Russ, August & Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and December 2014 against Google Inc. and YouTube, LLC in the U.S. District Court for the Southern District of New York relating to certain patents within the Cox Patent Portfolio acquired by the Company from Dr. Cox (see Note K[3] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for legal fees on a full contingency basis ranging from 15% to 30% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

Dovel & Luner, LLP provided legal services to the Company with respect to the Company’s patent litigation filed in September 2011 against sixteen (16) data networking equipment manufacturers in the U.S. District Court for the Eastern District of Texas, (Tyler Division) (see Note K[1]). The terms of the Company’s agreement with Dovel & Luner LLP essentially provided for legal fees on a full contingency basis ranging from 12.5% to 35% (with certain exceptions) of the net recovery (after deduction for expenses) depending on the stage of the preceding in which a result (settlement or judgment) is achieved. The Company was responsible for a portion of the expenses incurred with respect to this litigation. For the year ended December 31, 2021 and 2020, the Company incurred contingent legal fees and expenses to Dovel & Luner of $4,586,000 and $1,428,000, respectively, with respect to the litigation. As of December 31, 2021, the Company accrued contingency fees expenses of $137,000 to Dovel & Luner with respect to the litigation (see Note B[8] hereof).

Dovel & Luner, LLP also provided legal services to the Company with respect to the Company’s patent litigation settled in July 2010 against several major data networking equipment manufacturers including Cisco (see Note K[3]). The terms of the Company’s agreement with Dovel & Luner, LLP provided for legal fees of a maximum aggregate cash payment of $1.5 million plus a contingency fee of up to 24% (based on the settlement being achieved at the trial stage) including legal fees of local counsel in Texas. With respect to any royalty payments payable by Cisco relating to royalties for the period prior to the expiration of the Remote Power Patent (March 7, 2020), the Company had an obligation to pay Dovel & Luner contingency fees of 24% (see Note K[2] hereof). During the year ended December 31, 2021, the Company paid Dovel and Luner contingency fees and expenses of $5,760,000. There were no contingency fees paid to Dovel and Luner for the year ended December 31, 2020. In addition, as of December 31, 2021 and 2020, there were no outstanding contingency fees due Dovel & Luner with respect to this litigation.

[2]Patent Acquisitions:

In connection with the Company’s acquisition of its Cox Patent Portfolio, the Company is obligated to pay Dr. Cox 12.5% of the net proceeds (after deduction of expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the years ended December 31, 2021, and 2020, no expense was incurred with respect to the Cox Patent Portfolio. As of December 31, 2021 and 2020, no amounts were accrued with respect to the Cox Patent Portfolio.

As part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition Interface, LLC (“Recognition”) pursuant to which Recognition received from the Company an interest in the net proceeds realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: (i) 10% of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, the Company has paid Recognition an aggregate of $3,127,000 with respect to such net proceeds interest related to the Mirror Worlds Patent Portfolio. No such payments were made by the Company to Recognition during the year ended December 31, 2021 and 2020.

 

F-17
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note I – Commitments and Contingencies (continued)

In connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is obligated to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities (as defined) related to the patent portfolio. In addition, M2M will be entitled to receive from the Company $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio. As of the years ended December 31, 2021, and 2020, no expense was incurred with respect to the M2M/IoT Patent Portfolio. As of December 31, 2021 and 2020, no amounts were accrued with respect to the M2M/IoT Patent Portfolio.

[3]Savings and investment plan:

 

The Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts determined by the Board of Directors, subject to statutory limits. The 401(k) Plan expense for the years ended December 31, 2021 and 2020 was $102,000 and $105,000, respectively, all of which was accrued as of December 31, 2021 and 2020 and is recorded within accrued expenses on the Company’s consolidated balance sheets.

Note J - Employment Arrangements and Other Agreements

[1] On March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive Officer, pursuant to which he continues to serve as our Chairman and Chief Executive Officer for a four year term (“Term”), at an annual base salary of $535,000 which shall be increased by 3% per annum during the term of the Agreement. The Agreement established an annual target bonus of $175,000 for the Chairman and Chief Executive Officer based upon performance. During the year ended December 31, 2021 and December 31, 2020, the Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000 and $125,000, respectively.

In addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, 600,000 restricted stock units (the “RSUs”, each RSU awarded by the Company to its officers, directors and consultants represents a contingent right to receive one share of the Company’s common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to the Chairman and Chief Executive Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the term of the Agreement that the Company’s common stock (the “Common Stock”) achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the term of the Agreement that the Common Stock achieves a Closing Price (as defined above) of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the term of the Agreement, that the Common Stock achieves a Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by you for Good Reason (as defined) in each case prior to the last day of the term of the Agreement, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors or consultants have dividend equivalent rights.

Under the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in an amount equal to 5% of the Company’s gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to our Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities with respect to patents other than the Remote

F-18 
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note J - Employment Arrangements and Other Agreements (continued)

Power Patent (including all of the Company’s patent portfolios and its investment in ILiAD Biotechnologies) (collectively, the “Incentive Compensation”). During the year ended December 31, 2021 and December 31, 2020, the Chairman and Chief Executive Officer earned Incentive Compensation of $1,801,000 and $220,000, respectively.

The Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s patents with respect to licenses entered into with third parties during the term of his employment or at anytime thereafter, whether he is employed by us or not; provided, that, the employment of the Chairman and Chief Executive Officer has not been terminated by the Company “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that the Chairman and Chief Executive Officer’s employment is terminated by us “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief Executive Officer shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.

In connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i) during the term of the Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 month base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by us or “Without Good Reason” by the Chairman and Chief Executive Officer.

[2] The Company’s Chief Financial Officer serves on an at-will basis at an annual base salary of $175,000. The Company’s Chief Financial Officer received a discretionary annual bonus of $22,500 for the year ended December 31, 2021 and $15,000 for the year ended December 31, 2020. On December 29, 2020, the Chief Financial Officer was granted 7,500 RSUs under the 2013 Plan. 50% of such RSUs vested on the one year anniversary of the grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022), subject to the Chief Financial Officer’s continued service to the Company. In addition, in the event the Chief Financial Officer’s employment is terminated without “Good Cause” (as defined), he shall receive (i) (a) 6 months base salary or (b) 12 months base salary in the event of a termination without “Good Cause” within 6 months following a “Change of Control” of the Company (as defined) and (ii) accelerated vesting of all remaining unvested shares underlying his options, RSUs or any other awards he may receive in the future.

[3] The Company’s Executive Vice President serves on an at-will basis at an annual base salary of $200,000. The Executive Vice President received a discretionary annual bonus of $40,000 and $25,000 for the year ended December 31, 2021 and 2020, respectively. On December 29, 2020, the Company’s Executive Vice President was granted 10,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022), subject to the Executive Vice President’s continued service to the Company. On January 18, 2022, the Company’s Executive Vice President was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024).

Note K – Legal Proceedings

[1] On July 26, 2021, the Company agreed to settle its patent litigation against Hewlett-Packard Company and Hewlett-Packard Enterprise Company (collectively, “Hewlett-Packard”) pending in the U.S. District Court for the Eastern District of Texas, Tyler Division, for infringement of the Company’s Remote Power Patent. Under the terms of the settlement agreement, Hewlett-Packard Enterprise Company paid the Company $17,000,000 in full settlement of the litigation and Hewlett-Packard received a fully paid license and release to the Remote Power Patent for its full term, which applies to sales of Power over Ethernet (“PoE”) products by Hewlett-Packard and its wholly-owned subsidiary Aruba Networks, LLC.

 
F-19 
 

NETWORK-1 TECHNOLOGIES, INC.

 

Note K – Legal Proceedings (continued)

[2] On March 30, 2021, the Company entered into an amendment (the “Amendment”) to the Settlement and License Agreement, dated May 25, 2011, between the Company and Cisco (the “Agreement”). Pursuant to the Amendment, Cisco paid $18,692,000 to the Company to resolve a dispute relating to Cisco’s contractual obligation to pay royalties under the Agreement to the Company for the period beginning in the fourth quarter of 2017 through March 7, 2020 (when the Remote Power Patent expired) with respect to licensing the Remote Power Patent.

[3] On April 4, 2014 and December 3, 2014, the Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery has been substantially completed and a trial date has not yet been set.

[4] On May 9, 2017, Mirror Worlds Technologies, LLC, the Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“Facebook”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Facebook’s core technologies that enable Facebook’s Newsfeed and Timeline features. The lawsuit further alleged that Facebook’s unauthorized use of the stream-based solutions of the Company’s asserted patents has helped Facebook become the most popular social networking site in the world. On May 7, 2018, Facebook filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Facebook’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018, the Company filed a Notice of Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit reversed the summary judgment finding of the District Court and remanded the litigation to the Southern District of New York for further proceedings.

On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Facebook. In its ruling the Court (i) denied Facebook’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and intends to file an appeal to the U.S. Court of Appeals for the Federal Circuit.

[5] On December 15, 2020, the Company filed a lawsuit against Netgear in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company has objected to jurisdiction at the AAA and the dispute is pending.

[6] On January 7, 2021, the Company filed a lawsuit against Plantronics, Inc., the successor entity to Polycom, Inc., in the Supreme Court of the State of California, County of Santa Clara, for breach of a Settlement and License Agreement, dated September 29, 2016, with the Company for the failure of Plantronics and Polycom to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of PoE products. On October 26, 2021, the Company settled its litigation with Plantronics, Inc. in consideration for payment of $337,000.

 

 
F-20 
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note L - Concentrations

Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2021 and 2020. Revenue from two licensees constituted an aggregate of 99% of the Company’s revenue for the year ended December 31, 2021. Revenue from one licensee constituted an aggregate of 94% of the Company’s revenue for the year ended December 31, 2020. At December 31, 2021 and December 31, 2020, there were no royalty receivables from licensees.

Note M – Related Party Transaction

On May 27, 2021, the Company repurchased from a director of the Company 40,000 shares of its common stock at a purchase price of $3.27 per share or aggregate consideration of $130,800.

Note N – Stock Repurchase Program

On June 11, 2021, the Company’s Board of Directors authorized an extension and increase of the Share Repurchase Program to repurchase up to $5,000,000 of the Company’s common stock over the subsequent 24-month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in the Company’s discretion. The timing and amount of the shares repurchased are determined by management based on its evaluation of market conditions and other factors. The repurchase program may be increased, suspended or discontinued at any time.

During the year ended December 31, 2021, the Company repurchased an aggregate of 378,475 shares of its common stock pursuant to the Share Repurchase Program at a cost of approximately $1,077,000 or an average price per share of $2.85 per share.

Since inception of the Share Repurchase Program (August 2011) through December 31, 2021, the Company has repurchased an aggregate of 8,984,134 shares of its common stock at a cost of approximately $17,225,276 (exclusive of commissions) or an average per share price of $1.92 per share.

Note O – Dividend Policy

On June 9, 2020, the Company’s Board of Directors approved the continuation of the Company’s dividend policy which consists of a semi-annual cash dividend of $0.05 per common share ($0.10 per common share annually) which are anticipated to be paid in March and September of each year. On February 23, 2021, the Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 31, 2021 to all common shareholders of record as of March 16, 2021. On September 10, 2021, the Board of Directors declared a semi-annual dividend of $0.05 per share with a payment date of September 30, 2021 to all common shareholders of record as of September 21, 2021. The Company’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.

Note P – Subsequent Events

[1] On February 23, 2022, the Company’s Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 24, 2022 to all common shareholders of record as of March 9, 2022.

[2] On February 23, 2022, the Company’s Board of Directors approved the grant of 15,000 RSUs to each of the Company’s three non-management directors. The RSUs vest over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15, 2022, June 15, 2022, September 15, 2022 and December 15, 2022.

[3] On March 11, 2022, 125,000 shares of the Company’s common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer were settled. With respect to the restricted stock unit settlement, the Chairman and Chief Executive Officer delivered 45,438 shares to satisfy withholding taxes and received 79,562 net shares of common stock. 

[4] On March 22, 2022, the Company entered into a new four year employment agreement with its Chairman and Chief Executive Officer. In connection with the agreement the Company granted to its Chairman and Chief Executive Officer 600,000 restricted stock units which vest in four tranches subject to certain conditions (see Note J[1] hereof). 

 
F-21 
 

NETWORK-1 TECHNOLOGIES, INC.

 

 

Note P – Subsequent Events (continued)

[5] On March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) consisting of six U.S. patents and two pending U.S. patents covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The Company paid the seller $500,000 at the closing and has an obligation to pay the seller an additional $500,000 and $375,000 of the Company's common stock upon achieving certain milestones with respect to the patent portfolio. The Company also has an obligation to pay the seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and 17.5% of net proceeds greater than $50 million.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

F-22 
 

PART IV

ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)(1) Financial Statements:

The following are included under Item 8 “Financial Statements and Supplementary Data”:

Report of Independent Registered Public Accounting Firm

Consolidated balance sheets as of December 31, 2021 and 2020

Consolidated statements of operations and comprehensive (loss) income for the years ended December 31, 2021 and 2020

Consolidated statements of changes in stockholders' equity for the years ended December 31, 2021 and 2020

Consolidated statements of cash flows for the years ended December 31, 2021 and 2020

Notes to consolidated financial statements

(a)(2) Financial Statements Schedules:

Financial statement schedules are omitted because the information is not applicable.

 

(a)(3) Exhibits:

3(i)(a)Certificate of Incorporation, as amended. Previously filed as Exhibit 3.1 to the Company’s Registration Statement on Form SB-2 (Registration No. 333-59617), declared effective by the SEC on November 12, 1998 (the “1998 Registration Statement”), and incorporated herein by reference.
3(i)(b)Certificate of Amendment to the Certificate of Incorporation dated November 27, 2001. Previously filed as Exhibit 3.1.1 to the Company’s Registration Statement on Form S-3 (Registration No. 333-81344) declared effective by the SEC on February 12, 2002, and incorporated herein by reference (the “February 2002 Form S-3”)
3(i)(c)Certificate of Amendment to the Certificate of Incorporation dated October 9, 2013. Previously filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 10, 2013, and incorporated herein by reference.
3(ii)Second Amended and Restated By-laws. Previously filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2016 filed on November 14, 2016 and incorporated herein by reference.
4.1Form of Common Stock certificate. Previously filed as Exhibit 4.1 to the 1998 Registration Statement and incorporated herein by reference.
10.1+2013 Stock Incentive Plan. Previously filed as Appendix B to the Company’s Schedule 14A (Proxy Statement) filed on August 20, 2013 and incorporated herein by reference.
10.2Form of stock option agreement, previously filed as Exhibit 4.1 to the Company’s Registration Statement on Form S-8, filed on October 14, 2009 and incorporated herein by reference.
10.3+Employment Agreement, dated July 14, 2016, between the Company and Corey M. Horowitz, Chairman and Chief Executive Officer. Previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 19, 2016 and incorporated herein by reference.
10.4+Employment Agreement, dated March 22, 2022, between the Company and Corey M. Horowitz, Chairman and Chief Executive Officer. Previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 28, 2022 and incorporated herein by reference.
10.5Form of Indemnification Agreement for directors and officers. Previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 13, 2019 and incorporated herein by reference.

 

-48- 
 

 

 

 

14Code of Ethics. Previously filed as Exhibit 14 to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2004 filed on April 14, 2004 and incorporated herein by reference.
21.1*List of Subsidiaries of Registrant.
23.1*Consent of Friedman, LLP, Independent Registered Public Accounting Firm.
31.1*Section 302 Certification of Chief Executive Officer.
31.2*Section 302 Certification of Chief Financial Officer.
32.1*Section 906 Certification of Chief Executive Officer.
32.2*Section 906 Certification of Chief Financial Officer.

101*         Interactive data files: *

101.INS         XBRL Instance Document.

101.SCH       XBRL Scheme Document.

101.CAL       XBRL Calculation Linkbase Document.

101.DEF        XBRL Definition Linkbase Document.

101.LAB       XBRL Label Linkbase Document.

101.PRE        XBRL Presentation Linkbase Document.

_________________________________________________________________ 

 

*  Filed herewith

+  Management contract or compensatory plan or arrangement

 

 

 

 

 

 

 

 

 

 

 

 

 

-49-
 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

NETWORK-1 TECHNOLOGIES, INC.

 

By  /s/ Corey M. Horowitz                               

Corey M. Horowitz

Chairman and Chief Executive Officer

March 30, 2022

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

 

NAME   TITLE   DATE

 

/s/ Corey M. Horowitz

Corey M. Horowitz

  

 

Chairman and Chief Executive Officer, Chairman of the Board of Directors (principal executive officer)

  

 

March 30, 2022

 

/s/ David Kahn

David Kahn

  

 

Chief Financial Officer, Secretary and a Director (principal financial officer and principal accounting officer)

  

 

March 30, 2022

 

/s/ Emanuel Pearlman

Emanuel Pearlman

  

 

 

Director

  

 

 

March 30, 2022

 

/s/ Niv Harizman

Niv Harizman

  

 

 

Director

  

 

 

March 30, 2022

 

/s/ Allison Hoffman

Allison Hoffman

  

 

 

Director

  

 

 

March 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-50-

 

 

 EX-21.1 2 exh21-1_18604.htm LIST OF SUBSIDIARIES OF NETWORK-1 TECHNOLOGIES, INC.

 

EXHIBIT 21.1

 

 

 

List of Subsidiaries of Network-1 Technologies, Inc.

 

 

Name   Jurisdiction
     
Mirror Worlds Technologies, LLC   Delaware

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 EX-23.1 3 exh23-1_18604.htm CONSENT OF FRIEDMAN, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

EXHIBIT 23.1

 

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

 

 

The Board of Directors

Network-1 Technologies, Inc.

 

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 Nos. 333-192811 and 333-186612 with respect to the consolidated financial statements of Network-1 Technologies, Inc. and subsidiary included in this Annual Report (Form 10-K) of Network-1 Technologies, Inc. and subsidiary for the year ended December 31, 2021.

 

 

 

 

/s/ FRIEDMAN LLP

New York, New York

March 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 EX-31.1 4 exh31-1_18604.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TOSECTION 302 OF THE SARBANES

EXHIBIT 31.1

 

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.ss.1350)

 

I, Corey M. Horowitz, Chairman and Chief Executive Officer of Network-1 Technologies, Inc. (the "Registrant"), certify that:

 

1. I have reviewed this report on Form 10-K of the Registrant;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

 

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

 

   
Date:   March 30, 2022 /s/ Corey M. Horowitz
    Corey M. Horowitz
Chairman and Chief Executive Officer

 

 

 

 EX-31.2 5 exh31-2_18604.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TOSECTION 302 OF THE SARBANES

EXHIBIT 31.2

 

 

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.ss.1350)

 

I, David C. Kahn, Chief Financial Officer of Network-1 Technologies, Inc. (the "Registrant"), certify that:

 

1. I have reviewed this report on Form 10-K of the Registrant;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

 

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

 

   
Date:  March 30, 2022 /s/ David C. Kahn
    David C. Kahn
Chief Financial Officer

 

 

 

 EX-32.1 6 exh32-1_18604.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TOSECTION 906 OF THE SARBANES

EXHIBIT 32.1

 

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350)

 

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Corey M. Horowitz, Chairman and Chief Executive Officer of Network-1 Technologies, Inc., a Delaware corporation (the "Company"), does hereby certify that:

 

The Annual Report on Form 10-K for the year ended December 31, 2021 of the Company (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

/s/ Corey M. Horowitz                                     
Chief Executive Officer and Chairman

March 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 EX-32.2 7 exh32-2_18604.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TOSECTION 906 OF THE SARBANES

EXHIBIT 32.2

 

 

 

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350)

 

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, David C. Kahn, Chief Financial Officer of Network-1 Technologies, Inc., a Delaware corporation (the "Company"), does hereby certify that:

 

The Annual Report on Form 10-K for the year ended December 31, 2021 of the Company (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

/s/ David C. Kahn                                    
Chief Financial Officer

March 30, 2022

 

 

 

 

 

 

 

 

 

 EX-101.CAL 8 nssi-20211231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 nssi-20211231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 nssi-20211231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Related Party Transaction [Axis] Cisco [Member] Plan Name [Axis] Settlement And License Agreement [Member] Product and Service [Axis] Fully Paid Licenses [Member] Royalty Bearing Licenses [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] 2013 Stock Incentive Plan [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Financial Instrument [Axis] Equity Option [Member] Title of Individual [Axis] Directors Three [Member] Other Investment Not Readily Marketable [Axis] Cost Basis [Member] Gross Unrealized Gains [Member] Gross Unrealized Losses [Member] Concentration Risk Benchmark [Axis] Fair Value [Member] Iliad [Member] Derivative Instrument [Axis] Class C Units [Member] I Liad Biotechnologies L L C [Member] Litigation Status [Axis] Legal Service Agreement With Dovel And Luner For Litigation Filed In September 2011 [Member] Legal Service Agreement With Dovel And Luner For Litigation Settlement In July 2010 [Member] Chief Executive Officer [Member] New Employment Agreement [Member] Chairman And Chief Executive Officer [Member] Chief Financial Officer [Member] Vice President [Member] Hewlett Packard Enterprise [Member] Consolidated Entities [Axis] License Agreement [Member] Google [Member] Award Date [Axis] On April 4, 2014 and December 3, 2014 [Member] Facebook [Member] Concentration Risk Type [Axis] Remote Power Patent [Member] Licensees Two [Member] Licensees One [Member] Board Of Directors [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Name Auditor Location Auditor Firm ID Statement of Financial Position [Abstract] ASSETS: CURRENT ASSETS: Cash and cash equivalents Marketable securities, at fair value Other current assets Total Current Assets OTHER ASSETS: Deferred tax assets, net Patents, net of accumulated amortization Equity investment Convertible note investment Security deposits Total Other Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY: CURRENT LIABILITIES: Income taxes payable Accounts payable Accrued contingency fees and related costs Accrued payroll Other accrued expenses Total Current Liabilities LONG TERM LIABILITIES: Deferred tax liability TOTAL LIABILITIES COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' EQUITY Preferred stock, $0.01 par value; authorized 10,000,000 shares; none issued and outstanding at December 31, 2021 and December 31, 2020 Common stock, $0.01 par value; authorized 50,000,000 shares; 23,792,212 and 24,105,879 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] REVENUE OPERATING EXPENSES: Costs of revenue Professional fees and related costs General and administrative Amortization of patents Stock-based compensation TOTAL OPERATING EXPENSES OPERATING INCOME (LOSS)   OTHER INCOME Interest and dividend income, net Net realized and unrealized gain (loss) on marketable securities Total other income, net INCOME (LOSS) BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE INCOME TAXES PROVISION (BENEFIT): Current Deferred taxes, net Total income taxes (benefit)   INCOME (LOSS) BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE:   SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE NET INCOME (LOSS) Net Income (Loss) Per Share: Basic Diluted Weighted average common shares outstanding: Basic Diluted Cash dividends declared per share OTHER COMPREHENSIVE LOSS Net unrealized holding loss on corporate bonds and notes arising during the year, net of tax COMPREHENSIVE INCOME (LOSS) Statement [Table] Statement [Line Items] Balance – December 31, 2020 Balance at beginning, Shares Dividends and dividend equivalents declared Vesting of restricted stock units Vesting of restricted stock units, Shares Value of shares delivered to pay withholding taxes Value of shares delivered to pay withholding taxes, Shares Cashless exercise of options Cashless exercise of options, Shares Value of shares delivered to pay withholding taxes Value of shares delivered to pay withholding taxes, Shares Treasury shares purchased and retired Treasury shares purchased and retired, Shares Net unrealized loss on corporate bonds and notes Net income Balance – December 31, 2021 Balance at ending, Shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) Adjustments to reconcile net income (loss) to net cash used in operating activities: Loss from equity investment Deferred tax expense (benefit) Amortization of right of use asset Unrealized (gain) loss on marketable securities Changes in operating assets and liabilities: Royalty receivables Other current assets Accounts payable Income taxes payable Security deposit Operating lease obligations Accrued expenses NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES: Sales of marketable securities Purchases of marketable securities Development of patents Convertible note investment   NET CASH PROVIDED BY INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES: Cash dividends paid Value of shares delivered to fund withholding taxes Repurchases of common stock, inclusive of commissions NET CASH USED IN FINANCING ACTIVITIES NET INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of year CASH AND CASH EQUIVALENTS, end of year SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid during the years for: Interest Income taxes NON-CASH FINANCING ACTIVITY Accrued dividend rights on restricted stock units Accounting Policies [Abstract] Business Summary of Significant Accounting Policies Patents Patents Earnings Per Share [Abstract] Loss Per Share Income Tax Disclosure [Abstract] Income Taxes Equity [Abstract] Stockholders’ Equity Marketable Securities Marketable Securities Equity Method Investments and Joint Ventures [Abstract] Equity Investment Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Employment Arrangements And Other Agreements Employment Arrangements and Other Agreements Legal Proceedings Risks and Uncertainties [Abstract] Concentrations Related Party Transactions [Abstract] Related Party Transaction Other Liabilities Disclosure [Abstract] Stock Repurchase Program Dividend Policy Subsequent Events [Abstract] Subsequent Events Principles of Consolidation Use of Estimates and Assumptions Cash and Cash Equivalents Marketable Securities Revenue Recognition Equity Method Investments Patents Income Taxes Stock-Based Compensation Earnings Per Share Fair Value Measurements Carrying Value, Recoverability and Impairment of Long-Lived Assets Dividend Policy New Accounting Standards Schedule of disaggregation of revenue Schedule of patent Schedule of future amortization of current intangible Schedule of Earnings per share Schedule of components of the income taxes Schedule of components of deferred tax assets Schedule of reconciliation of income tax Schedule of Restricted Stock Units Schedule of stock option activity Schedule of Marketable Securities Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Patents owned Contractual obligation to pay royalties Schedule of Product Information [Table] Product Information [Line Items] Total Revenue FDIC insured limit Cash in excess of FDIC insured limit Certificates of deposit Increase in professional fees and related costs Increase operating loss and net loss Decrease in basic and diluted earnings per share Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Gross carrying amount Accumulated amortization Patents, net 2022 2023 2024 2025 2026 and thereafter Total Estimated remaining economic useful of patents Amortization expense Expiration dates of the patents within the Cox patent portfolio Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio Weighted-average common shares outstanding – basic Dilutive effect of stock options and restricted stock units Weighted-average common shares outstanding – diluted Stock option and restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive Potentially Dilutive Shares Current    State and local    Federal Total Current Tax Expense (Benefit) Deferred    State and local    Federal Total Deferred Tax Expense (Benefit) Total Income Taxes Deferred tax assets (liability): Net operating loss carry forwards Net operating loss carry forwards Deferred Tax Liability Total deferred tax assets (liability) Income tax - statutory rate Permanent difference State and other, net Valuation allowance on deferred tax assets Total Valuation allowance Restricted stock, Outstanding Number of shares, Beginning Balance Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance Grants of restricted stock units Grants of restricted stock units, Weighted Average Grant Date Fair Value Vested restricted stock units Vested restricted stock units, Weighted Average Grant Date Fair Value Unvested Resricted stock, Outstanding Number of shares, Ending Balance Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Option outstanding, beginning balance Outstanding exercise price Granted Granted Expired Expired Exercised Exercised Option outstanding, ending balance Option outstanding exercise price, at end of year Option exercisable at end of year Option exercise price at end of year Common stock available for issuance Restricted stock unit compensation expense Unrecognized restricted stock unit compensation expense Weighted average amortized period Accrued dividend rights on restricted stock unit Aggregate intrinsic value of options exercisable Stock options exercised to purchase shares on cashless basis Exercise price Aggregate net shares issued Other Investment Not Readily Marketable [Table] Other Investment Not Readily Marketable [Line Items] Fixed income mutual funds Corporate bonds and notes Total marketable securities Certificates of deposit Aggregrate investment Equity investment Convertable note investment Ownership percentage not fully diluted Ownership percentage fully diluted Additional convertable note investment Maximum convertible debt offering Interest rate Notes conversion, description Equity investment net loss Loss Contingencies [Table] Loss Contingencies [Line Items] Accrued expenses Contingent legal fees Obligated to pay Cox, net proceeds percentage Obligated to pay Recognition First $125 Million Next $125 Million Over $250 Million Recognition net proceeds payment related to Mirror Worlds patents Obligated to pay M2M First $100 Million Next $100 Million Additional consideration payable upon occurrence of certain future events Plan expense Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] Annual base salary Target annual bonus paid Chairman and CEO Annual discretionary bonus Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold Plantronics Litigation Amount of royalties paid by Cisco Litigation pending, description Concentration Risk [Table] Concentration Risk [Line Items] Percentage revenue Royalty Receivables Number of shares, common stock repurchased Price per share, common stock repurchased Aggregate cost of common stock Stock Repurchase Program, dollar amount Number of shares, common stock repurchased since inception Aggregate cost of common stock repurchased since inception Average price per share, common stock repurchased since inception Common Stock, Dividends, Per Share, Declared Debt Instrument, Maturity Date Semi-annual cash dividend record date Subsequent Event [Table] Subsequent Event [Line Items] Semi-annual cash dividend per common share Dividend payment date Restricted stock units granted to directors RSU settled Shares delivered for withholding taxes Net shares received Restricted stock units granted Amount paid to seller Contigent Obligation to pay seller Common stock issued upon achieving certain milestones First $50 million Greater than $50 million Legal Fees payment ,Terms The member represent Legal Service Agreement With Russ, August Kabot For Litigation Filed In April 2014 and December 2014. The member represent legal service agreement with dovel and luner for litigation filed in september 2011. The member represent Legal Service Agreement With Dovel And Luner For Litigation Settlement In July 2010. The member represent Legal Service Agreement With Russ, August Kabot For Litigation Filed In May 2017. Obligated to pay Cox, net proceeds percentage. Represent percentage of first $125 million. Represent next $125 Million. Over $250 Million Represent percentage of first $100 million. Represent percentage of next $100 million. Additional consideration payable upon occurrence of certain future events The member represent new employment agreement. The amount of Target annual bonus paid Chairman and CEO. The amount of royalties agreed to be paid by Cisco. The member represent License Agreement. Litigation pending, description. The member represent google. The member represent On April 4, 2014 and December 3, 2014. The member represent facebook. The member represent board of directors. Weighted average price per share common stock subject to repurchase. Semi-annual cash dividend record date Assets, Current Other Assets Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income (Loss) from Equity Method Investments Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding ValueOfSharesDeliveredToPayWithholdingTax ValueOfSharesDeliveredToPayWithholdingTaxShares Gain (Loss) on Investments Marketable Securities, Unrealized Gain (Loss) Increase (Decrease) in Receivables Increase (Decrease) in Other Current Assets Increase (Decrease) in Other Accounts Payable Increase (Decrease) in Income Taxes Payable Net Cash Provided by (Used in) Operating Activities Marketable Securities, Gain (Loss) Payments to Acquire Marketable Securities Payments to Acquire Intangible Assets ConvertibleNoteInvestment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Common Stock ValueOfSharesDeliveredToFundWithholdingTaxes Payments for Repurchase of Common Stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect PatentsTextBlock MarketableSecuritiesDisclosureTextBlock Marketable Securities, Policy [Policy Text Block] PatentsPolicyTextBlock Cost of Goods and Service [Policy Text Block] Policyholders' Dividend [Policy Text Block] Deferred State and Local Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Certificates of deposit [Default Label] Goodwill Accrued Liabilities and Other Liabilities EX-101.PRE 11 nssi-20211231_pre.xml XBRL PRESENTATION FILE EX-101.SCH 12 nssi-20211231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Patents link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Equity Investment link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Employment Arrangements and Other Agreements link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Concentrations link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Related Party Transaction link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Stock Repurchase Program link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Dividend Policy link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Patents (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Patents (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Patents (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Patents (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Loss Per Share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Income Taxes (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Income Taxes (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Stockholders' Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Equity Investment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Employment Arrangements and Other Agreements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Legal Proceedings (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Concentrations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Related Party Transaction (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Stock Repurchase Program (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Dividend Policy (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2021
Mar. 28, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2021    
Current Fiscal Year End Date --12-31    
Entity File Number 1-15288    
Entity Registrant Name NETWORK-1 TECHNOLOGIES, INC.    
Entity Central Index Key 0001065078    
Entity Tax Identification Number 11-3027591    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 65 Locust Avenue    
Entity Address, City or Town New Canaan    
Entity Address, State or Province CT    
Entity Address, Postal Zip Code 06840    
City Area Code (203)    
Local Phone Number 920-1055    
Title of 12(b) Security Common Stock $.01 par value    
Trading Symbol NTIP    
Security Exchange Name NYSEAMER    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 47,450,000
Entity Common Stock, Shares Outstanding   23,883,024  
ICFR Auditor Attestation Flag false    
Auditor Name Friedman LLP    
Auditor Location New York, New York    
Auditor Firm ID 711    
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2021
Dec. 31, 2020
CURRENT ASSETS:    
Cash and cash equivalents $ 44,497,000 $ 25,505,000
Marketable securities, at fair value 15,126,000 19,366,000
Other current assets 150,000 120,000
Total Current Assets 59,773,000 44,991,000
OTHER ASSETS:    
Deferred tax assets, net 954,000
Patents, net of accumulated amortization 1,384,000 1,578,000
Equity investment 2,651,000 3,650,000
Convertible note investment 1,000,000
Security deposits 13,000 21,000
Total Other Assets 5,048,000 6,203,000
TOTAL ASSETS 64,821,000 51,194,000
CURRENT LIABILITIES:    
Income taxes payable 2,952,000
Accounts payable 459,000 597,000
Accrued contingency fees and related costs 137,000 932,000
Accrued payroll 380,000 277,000
Other accrued expenses 180,000 226,000
Total Current Liabilities 4,108,000 2,032,000
LONG TERM LIABILITIES:    
Deferred tax liability 554,000
TOTAL LIABILITIES 4,662,000 2,032,000
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 par value; authorized 10,000,000 shares; none issued and outstanding at December 31, 2021 and December 31, 2020
Common stock, $0.01 par value; authorized 50,000,000 shares; 23,792,212 and 24,105,879 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively 238,000 241,000
Additional paid-in capital 66,361,000 66,124,000
Accumulated deficit (6,428,000) (17,193,000)
Accumulated other comprehensive loss (12,000) (10,000)
TOTAL STOCKHOLDERS’ EQUITY 60,159,000 49,162,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 64,821,000 $ 51,194,000
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Preferred Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Common Stock, Shares Authorized 50,000,000 50,000,000
Common Stock, Shares, Issued 23,792,212 24,105,879
Common Stock, Shares, Outstanding 23,792,212 24,105,879
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
REVENUE $ 36,029,000 $ 4,403,000
OPERATING EXPENSES:    
Costs of revenue 12,147,000 1,653,000
Professional fees and related costs 1,500,000 2,407,000
General and administrative 2,263,000 2,162,000
Amortization of patents 295,000 292,000
Stock-based compensation 238,000 302,000
TOTAL OPERATING EXPENSES 16,443,000 6,816,000
OPERATING INCOME (LOSS) 19,586,000 (2,413,000)
  OTHER INCOME    
Interest and dividend income, net 327,000 522,000
Net realized and unrealized gain (loss) on marketable securities (173,000) 15,000
Total other income, net 154,000 537,000
INCOME (LOSS) BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE 19,740,000 (1,876,000)
INCOME TAXES PROVISION (BENEFIT):    
Current 2,952,000 (464,000)
Deferred taxes, net 1,508,000 (490,000)
Total income taxes (benefit) 4,460,000 (954,000)
  INCOME (LOSS) BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE: 15,280,000 (922,000)
  SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (999,000) (787,000)
NET INCOME (LOSS) $ 14,281,000 $ (1,709,000)
Net Income (Loss) Per Share:    
Basic $ 0.59 $ (0.07)
Diluted $ 0.58 $ (0.07)
Weighted average common shares outstanding:    
Basic 24,136,821 24,011,354
Diluted 24,530,568 24,011,354
Cash dividends declared per share $ 0.10 $ 0.10
OTHER COMPREHENSIVE LOSS    
Net unrealized holding loss on corporate bonds and notes arising during the year, net of tax $ (2,000) $ (89,000)
COMPREHENSIVE INCOME (LOSS) $ 14,279,000 $ (1,798,000)
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance – December 31, 2020 at Dec. 31, 2019 $ 240,000 $ 65,824,000 $ (12,636,000) $ 79,000 $ 53,507,000
Balance at beginning, Shares at Dec. 31, 2019 24,036,071        
Dividends and dividend equivalents declared (2,435,000) (2,435,000)
Stock-based compensation 302,000 302,000
Vesting of restricted stock units $ 3,000 (3,000)
Vesting of restricted stock units, Shares 247,500        
Value of shares delivered to pay withholding taxes $ (1,000) 1,000 (161,000) (161,000)
Value of shares delivered to pay withholding taxes, Shares (66,510)        
Cashless exercise of options $ 1,000 1,000
Cashless exercise of options, Shares 105,000        
Value of shares delivered to pay withholding taxes $ (1,000) (1,000)
Value of shares delivered to pay withholding taxes, Shares (100,293)        
Treasury shares purchased and retired $ (1,000) (252,000) (253,000)
Treasury shares purchased and retired, Shares (115,889)        
Net unrealized loss on corporate bonds and notes (89,000) (89,000)
Net income (1,709,000) (1,709,000)
Balance – December 31, 2021 at Dec. 31, 2020 $ 241,000 66,124,000 (17,193,000) (10,000) 49,162,000
Balance at ending, Shares at Dec. 31, 2020 24,105,879        
Dividends and dividend equivalents declared (2,429,000) (2,429,000)
Stock-based compensation 238,000 238,000
Vesting of restricted stock units $ 1,000 (1,000)
Vesting of restricted stock units, Shares 70,000        
Value of shares delivered to pay withholding taxes (14,000) (14,000)
Value of shares delivered to pay withholding taxes, Shares (5,192)        
Treasury shares purchased and retired $ (4,000) (1,073,000) (1,077,000)
Treasury shares purchased and retired, Shares (378,475)        
Net unrealized loss on corporate bonds and notes (2,000) (2,000)
Net income 14,281,000 14,281,000
Balance – December 31, 2021 at Dec. 31, 2021 $ 238,000 $ 66,361,000 $ (6,428,000) $ (12,000) $ 60,159,000
Balance at ending, Shares at Dec. 31, 2021 23,792,212        
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ 14,281,000 $ (1,709,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Amortization of patents 295,000 292,000
Stock-based compensation 238,000 302,000
Loss from equity investment 999,000 787,000
Deferred tax expense (benefit) 1,508,000 (954,000)
Amortization of right of use asset 41,000
Unrealized (gain) loss on marketable securities 148,000 (88,000)
Changes in operating assets and liabilities:    
Royalty receivables 343,000
Other current assets (30,000) (22,000)
Accounts payable (142,000) 180,000
Income taxes payable 2,952,000
Security deposit 8,000
Operating lease obligations (41,000)
Accrued expenses (758,000) 366,000
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 19,499,000 (503,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Sales of marketable securities 17,154,000 24,216,000
Purchases of marketable securities (13,059,000) (17,859,000)
Development of patents (101,000) (51,000)
Convertible note investment (1,000,000)
  NET CASH PROVIDED BY INVESTING ACTIVITIES 2,994,000 6,306,000
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends paid (2,410,000) (2,471,000)
Value of shares delivered to fund withholding taxes (14,000) (161,000)
Repurchases of common stock, inclusive of commissions (1,077,000) (253,000)
NET CASH USED IN FINANCING ACTIVITIES (3,501,000) (2,885,000)
NET INCREASE IN CASH AND CASH EQUIVALENTS 18,992,000 2,918,000
CASH AND CASH EQUIVALENTS, beginning of year 25,505,000 22,587,000
CASH AND CASH EQUIVALENTS, end of year 44,497,000 25,505,000
Cash paid during the years for:    
Interest
Income taxes
NON-CASH FINANCING ACTIVITY    
Accrued dividend rights on restricted stock units $ 20,000 $ 31,000
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Business
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Business

Note A – Business

 

Network-1 Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns ninety-five (95) patents including (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded sim cards in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds (see Note P[5]); (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.

Until March 7, 2020, when the Remote Power Patent expired, the Company had been actively engaged in licensing its Remote Power Patent (U.S. Patent No. 6,218,930). As of March 7, 2020, the Company had twenty-seven (27) license agreements with respect to its Remote Power Patent. As a result of the expiration of the Remote Power Patent, the Company no longer receives licensing revenue for its Remote Power Patent for any period subsequent to the expiration date (March 7, 2020). However, subsequent to the expiration date of the Remote Power Patent, the Company received licensing revenue from certain licensees for periods prior to March 7, 2020. On March 30, 2021, the Company entered into an amendment (the “Amendment”) to the Settlement and License Agreement, dated May 25, 2011, between the Company and Cisco (the “Agreement”). Pursuant to the Amendment, Cisco paid $18,691,890 to the Company to resolve a dispute relating to Cisco’s contractual obligation to pay royalties under the Agreement to the Company for the period beginning in the fourth quarter of 2017 through March 7, 2020 (when the Remote Power Patent expired) with respect to licensing the Remote Power Patent (see Note K[2] hereof). In addition, on July 26, 2021, the Company entered into a settlement agreement with Hewlett-Packard pursuant to which Hewlett-Packard paid the Company $17,000,000 in full settlement of a patent litigation involving the Remote Power Patent (see Note K[1] hereof). The Company believes that NETGEAR, Inc. (“Netgear”), another licensee of the Remote Power Patent, is obligated to pay the Company royalties that accrued but were not paid since the fourth quarter of 2017 through March 7, 2020. The Company has pending litigation against Netgear to recover such royalties (see Note K[5] hereof).

The Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition, the Company continually reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note B – Summary of Significant Accounting Policies

 

[1]Principles of Consolidation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiary, Mirror Worlds Technologies, LLC. All intercompany transactions and balances are eliminated in consolidation.

 

[2]Use of Estimates and Assumptions

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements include revenue recognition, contingent legal fees and related costs, income taxes, valuation of patents and equity method investments, including evaluation of the Company’s basis difference. Actual results could be materially different from those estimates, upon which the carrying values were based.

[3]Cash and Cash Equivalents

The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $250,000. At December 31, 2021 and 2020, the Company had $8,109,000 and $5,477,000, respectively, in excess of the FDIC insured limit.

 

The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.

 

[4]Marketable Securities

 

The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, fixed income mutual funds, and corporate bonds and notes (see Note G). At December 31, 2021 and December 31, 2020, included in marketable securities, the Company had aggregate certificates of deposit of $— and $3,500,000, respectively, at financial institutions that were within the FDIC limit. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.

 

[5]Revenue Recognition

 

Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.

 

The Company determines revenue recognition through the follow steps:

 

•identification of the license agreement;
•identification of the performance obligations in the license agreement;
•determination of the consideration for the license;
•allocation of the transaction price to the performance obligations in the contract; and
•recognition of revenue when the Company satisfies its performance obligations.

 

Revenue disaggregated by source is as follows:

Schedule of disaggregation of revenue          
   Years Ended December 31, 
   2021   2020 
Fully-Paid Licenses  $17,000,000(1)  $— 
Royalty Bearing Licenses   19,029,000(2)   4,403,000(3)
Total Revenue  $36,029,000   $4,403,000 

__________________________

(1)Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
(2)Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).
(3)Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.

The Company relied on royalty reports received from third party licensees to record its revenue. From time to time, the Company may audit or otherwise dispute royalties reported from licensees. Any adjusted royalty revenue as a result of such audits or dispute is recorded by the Company in the period in which such adjustment is agreed to by the Company and the licensee or otherwise determined.

 

Revenue from the Company’s patent licensing business is generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license (a “Fully-Paid License”), or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent (a “Royalty Bearing License”).

 

The Company’s license agreements, both Fully-Paid Licenses and Royalty Bearing Licenses, typically include some combination of the following: (i) the grant of a non-exclusive license to manufacture and/or sell products covered by its patented technologies; (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted pursuant to these licenses typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company typically has no further performance obligations with respect to the grant of the non-exclusive licenses. Generally, the license agreements provide for the grant of the licenses, releases, and other obligations following execution of the agreement and the receipt of the up-front lump sum payment for a Fully-Paid License or a license initiation fee for a Royalty Bearing License.

 

The Company recognizes revenue from their Royalty Bearing Licenses in a manner consistent with the legal form of the arrangement, and in accordance with the royalty recognition constraint that applies to licenses of IP for which some or all of the consideration is in the form of sales or usage based royalty. Consequently, the Company recognizes revenue at the later of when (1) the subsequent sale occurs or (2) the performance obligation to which some or all of the sales based royalty has been satisfied.

 

Non-Refundable Up-Front Fees: Fully-Paid Licenses provide for a non-refundable up-front payment, for which the Company has no future obligations or performance requirements, revenue is generally recognized when the Company has obtained the signed license agreement, all performance obligations have been substantially performed, amounts are fixed and determinable, and collectability is reasonably assured. Revenue from Fully-Paid Licenses may consist of one or more installments. The timing and amount of revenue recognized from each licensee depends upon a number of factors including the specific terms of each agreement and the nature of the deliverables and obligations.

 

 

[6]Equity Method Investments

 

Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized. Upon sale of equity method investments, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss.

 

[7]Patents

The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.

 

[8]Costs of Revenue and Related Costs

The Company includes in costs of revenue for the year ended December 31, 2021 and 2020 contingent legal fees payable to patent litigation counsel, any other contractual payments related to net proceeds from settlements (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer.

During the year ended December 31, 2020, the Company had a change in estimate related to accrued contingency fees and related costs. The change was the result of the Company receiving new information reflecting additional legal costs in connection with certain contingent litigation. The effect of this change in estimate for the year ended December 31, 2020 was an increase in professional fees and related costs of $886,000 and a corresponding increase in our operating loss and net loss of $886,000, and a decrease in basic and diluted earnings per share of $0.04 per share.

 

[9]Income Taxes

The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.

ASC 740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2021 and 2020.

U.S. federal, state and local income tax returns prior to 2018 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.

 

[10]Stock-Based Compensation

 

The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income based on their grant date fair values.

Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.

 

[11]Earnings Per Share

The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.

 

[12]Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.

There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents, royalty receivable, other assets, accounts payable, and accrued expenses approximates fair value because of the short-term nature of these financial instruments.

The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.

The Company’s equity investment in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held development stage biotechnology company, is measured on a non-recurring basis and is classified within Level 3 as it is valued using significant unobservable inputs or data in an inactive market, and the valuation requires management judgment due to the absence of market price and inherent lack of liquidity.

 

[13]Carrying Value, Recoverability and Impairment of Long-Lived Assets

An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2021 and 2020, there was no impairment to the Company’s patents and equity investment.

The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.

 

[14]Dividend Policy

Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).

 

[15]New Accounting Standards

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes. The ASU removes certain exceptions for performing intra-period allocation and calculating income taxes in interim periods. It also simplifies the accounting for income taxes by requiring recognition of franchise tax partially based on income as an income-based tax, requiring reflection of enacted changes in tax laws in the interim period and making improvements for income taxes related to employee stock ownership plans. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The adoption of this standard did not have a material effect on its consolidated financial statements.

 

Equity Securities

 

In January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The ASU amends and clarifies certain interactions between the guidance under Topic 321, Topic 323 and Topic 815, by reducing diversity in practice and increasing comparability of the accounting for these interactions. The amendments in the ASU should be applied on a prospective basis. The ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of this standard did not have a material effect on the Company’s consolidated financial statements.

 
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Patents
 12 Months Ended
Dec. 31, 2021
Patents  
Patents

Note C – Patents

The Company’s intangible assets at December 31, 2021 include patents with estimated remaining economic useful lives ranging from 1.50 to 12.33 years. For all periods presented, all the Company’s patents were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of December 31, 2021 and 2020 were as follows:

        
 

2021

  

2020

 
Gross carrying amount  $7,949,000   $7,848,000 
Accumulated amortization   (6,565,000)   (6,270,000)
Patents, net  $1,384,000   $1,578,000 

 

Amortization expense for the years ended December 31, 2021 and 2020 was $295,000 and $292,000, respectively. Future amortization of current intangible assets, net is as follows:

Schedule of future amortization of current intangible     
For the years ended December 31,     
2022   $301,000 
2023    236,000 
2024    90,000 
2025    90,000 
2026 and thereafter    667,000 
Total   $1,384,000 

 

The Company’s Remote Power Patent expired on March 7, 2020. All patents within our Mirror Worlds Patent Portfolio and QoS Patents have also expired. All patents within the Cox Patent Portfolio expired in September 2021 except for two patents which expire in July 2023 and November 2023. The expiration dates of patents within the Company’s M2M/IoT Patent Portfolio range from September 2033 to May 2034.

 
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Loss Per Share
 12 Months Ended
Dec. 31, 2021
Net Income (Loss) Per Share:  
Loss Per Share

Note D – Income (Loss) Per Share

Basic Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during the period. Diluted per share data included the dilutive effects of stock options and restricted stock units. Potential shares of 12,500 and 662,500 at December 31, 2021 and 2020, respectively, consist of options and restricted stock units. Computations of basic and diluted weighted average common shares outstanding are as follows:

  2021   2020 
         
Weighted-average common shares
outstanding – basic		   24,136,821    24,011,354 
           

Dilutive effect of stock options and

restricted stock units

   393,747    

 

—

 
           
Weighted-average common shares
outstanding – diluted		   24,530,568    24,011,354 
           
Stock option and restricted stock units
excluded from the computation of diluted
income per share because the effect of
inclusion would have been anti-dilutive		   12,500    662,500 

 

 

 
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes

Note E – Income Taxes

Significant components of the income taxes were as follows for the years ended December 31, 2021 and 2020.

   2021   2020 
Current          
   State and local  $144,000   $(34,000)
   Federal   2,808,000    (430,000)
Total Current Tax Expense (Benefit)  $2,952,000   $(464,000)
           
Deferred          
   State and local   83,000    (32,000)
   Federal   1,425,000    (458,000)
Total Deferred Tax Expense (Benefit)   1,508,000    (490,000)
           
Total Income Taxes  $4,460,000   $(954,000)

 

Significant components of deferred tax assets as of December 31, 2021 and 2020 consisted of the following:

Schedule of components of deferred tax assets   2021   2020 

Deferred tax assets (liability):
Net operating loss carry forwards

  $
—		   $1,665,000 
           
Deferred Tax Liability(1)   (554,000)   (711,000)
           
Total deferred tax assets (liability)  $(554,000)  $954,000 

_________________________

(1)   Deferred tax liability as a result of a temporary difference related to the Company’s equity method investment.

 

There was no valuation allowance as of December 31, 2021. As of December 31, 2020, the Company relieved a valuation allowance of $490,000.

The reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to the net income before income taxes is as follows:

  Years Ended 
  

December 31,

 
  

2021

  

2020

 
         
Income tax - statutory rate   21.00%   21.0%
Permanent difference   1.69%   (5.05)%
State and other   1.11%   1.48%
Valuation allowance on deferred tax assets   —%   18.4%
  Total   23.80%   35.83%

 

While only the tax returns for the three years ended prior to December 31, 2021 are open for examination for taxes payable for those years, tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent that they generated loss carry-forwards that are available for those future years.

The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation to be classified as a PHC, it must satisfy two tests: (i) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (ii) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities

and rents (the “Income Test”). During the second half of 2021, based on available information concerning the Company’s shareholder ownership, the Company did not satisfy the Ownership Test and thus the Company was not a PHC for 2021. If the Company were to become a PHC in any future year, we would be subject to an additional 20% tax on our UPHCI. In such event, the Company may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Stockholders’ Equity

Note F – Stockholders’ Equity

The 2013 Stock Incentive Plan (“2013 Plan”) provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units. Awards under the 2013 Plan may be granted singly, in combination, or in tandem. Subject to standard anti-dilution adjustments as provided, the 2013 Plan provides for an aggregate of 2,600,000 shares of the Company’s common stock to be available for distribution. The Company’s Compensation Committee generally has the authority to administer the 2013 Plan, determine participants who will be granted awards, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2013 Plan may be granted to employees, directors and consultants of the Company and its subsidiaries. As of December 31, 2021, there were 1,837,500 shares of common stock available for issuance under the 2013 Plan.

[1]Restricted Stock Units

A summary of restricted stock units granted during the years ended December 31, 2021 and December 31, 2020 is as follows (each restricted stock unit represents the contingent right to receive one share of the Company’s common stock):

  2021   2020 
  

Number

of Shares

   Weighted-Average Grant
Date Fair Value		  

Number

of Shares

   Weighted-Average Grant
Date Fair Value		 
Balance of restricted stock units outstanding at beginning of year   162,500   $2.25    340,000   $2.15 
Grants of restricted stock units   45,000    3.51    70,000    2.68 
Vested restricted stock units(1)   (195,000)   (2.47)   (247,500)   (2.23)
Balance of restricted stock units outstanding at end of year   12,500   $3.36    162,500   $2.25 

__________________________

(1)       Includes 125,000 shares of common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer which vested on July 14, 2021 and settled on March 11, 2022.

 

Restricted stock unit compensation expense was $238,000 for the year ended December 31, 2021 and $302,000 for the year ended December 31, 2020.

The Company has an aggregate of $42,000 of unrecognized restricted stock unit compensation expense as of December 31, 2021 to be expensed over a weighted average period of 0.99 years.

The fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards.

All of the Company’s issued restricted stock units have dividend equivalent rights. As of December 31, 2021 and 2020, there was $72,000 and $53,000 accrued for dividend equivalent rights which were included in other accrued expenses.

[2]Stock Options

At December 31, 2021, one stock option to purchase 500,000 shares of common stock was outstanding representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan). The one stock option has a weighted average exercise price of $1.19 and a weighted average remaining life of 0.84 years. There were no grants of stock options during the years ended December 31, 2021 and 2020.

The following table summarizes stock option activity for the years ended December 31:

 

 

2021

  

2020

 
       Weighted       Weighted 
       Average       Average 
   Options   Exercise   Options   Exercise 
  

Outstanding

  

Price

  

Outstanding

  

Price

 
Options outstanding
at beginning of year		   500,000   $1.19    605,000   $1.39 
Granted   —    —    —    — 
Expired   —    —    —    — 
Exercised   —    —    (105,000)  $2.34 
Options outstanding at end of year   500,000   $1.19    500,000   $1.19 
Options exercisable at end of year   500,000   $1.19    500,000   $1.19 

 

During the year ended December 31, 2021 and 2020, the Company did not recognize any stock-based compensation related to the vesting of prior issued stock options to employees and directors. The Company at December 31, 2021 and 2020 had no remaining unrecognized expenses related to unvested stock options to employees and directors. The aggregate intrinsic value of all stock options exercisable at December 31, 2021 and 2020 was $815,000 and $1,250,000, respectively.

During the year ended December 31, 2020, stock options to purchase an aggregate of 105,000 shares of the Company’s Common Stock at an exercise price of $2.34 per share were exercised on net exercise (cashless basis) by each of the Company’s three outside directors. With respect to the net exercise (cashless) of these stock options, 4,707 aggregate net shares were delivered to the outside directors.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Marketable Securities
 12 Months Ended
Dec. 31, 2021
Marketable Securities  
Marketable Securities

Note G – Marketable Securities

Marketable securities as of December 31, 2021 and 2020 were composed of: 

                
   December 31, 2021 
  

Cost
Basis

  

Gross Unrealized Gains

  

Gross Unrealized Losses

  

Fair Value

 
                 
Fixed income mutual funds  $14,462,000   $—   $(137,000)  $14,325,000 
Corporate bonds and notes   813,000    —    (12,000)   801,000 
Total marketable securities  $15,275,000   $—   $(149,000)  $15,126,000 

 

   December 31, 2020 
  

Cost
Basis

  

Gross Unrealized Gains

  

Gross Unrealized Losses

  

Fair Value

 
                 
Certificates of deposit  $3,534,000   $7,000   $—   $3,541,000 
Fixed income mutual funds   11,255,000    80,000    —    11,335,000 
Corporate bonds and notes   4,500,000    18,000    (28,000)   4,490,000 
Total marketable securities  $19,289,000   $105,000   $(28,000)  $19,366,000 

 
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Investment
 12 Months Ended
Dec. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Equity Investment

Note H – Equity Investment

During the period December 2018 – March 2021, the Company made an aggregate investment of $6,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is developing key technologies and working with leading scientists to investigate the impact of Bordetella pertussis in a range of human disease and is currently focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). The aggregate investment of $6,000,000 by the Company includes a $5,000,000 equity investment and a $1,000,000 investment in a convertible note (see below). At December 31, 2021, the Company owned approximately 9.5% of the outstanding units of ILiAD on a non-fully diluted basis and 7.2% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options, warrants and convertible notes). In connection with its investment, the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same compensation for service on the Board of Managers as other non-management Board members.

On March 12, 2021, the Company invested $1,000,000 in ILiAD as part of its private offering of up to $23,500,000 of convertible notes (the “Notes”). The Notes have a maturity of three years with interest accruing at 6% per annum. The Notes are required to be converted into a Qualified Financing (minimum financing of $15 million) at the lesser of (i) 80% of the price paid per unit in such offering or (ii) a price based on an enterprise value of $176,000,000. In addition, the Notes shall convert in the event of a merger at the lower of an enterprise value of $176,000,000 or the stated valuation of ILiAD in the merger transaction. In the event of a change-in-control, noteholders will also have the option to have the Notes repaid except in a Qualified Financing or a stock-for-stock merger.

For the years ended December 31, 2021 and 2020, the Company recorded a net loss from its equity method investment in ILiAD of $999,000 and $787,000, respectively.

The difference between the Company’s share of equity in ILiAD’s net assets and the equity investment carrying value reported on the Company’s consolidated balance sheet at December 31, 2021 is due to an excess amount paid over the book value of the investment totaling approximately $5,000,000 which are accounted for as equity method goodwill.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note I – Commitments and Contingencies

[1]Legal fees:

Russ, August & Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook, Inc. in the U.S. District Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds Patent Portfolio (see Note K[4] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for cash payments on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

Russ, August & Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and December 2014 against Google Inc. and YouTube, LLC in the U.S. District Court for the Southern District of New York relating to certain patents within the Cox Patent Portfolio acquired by the Company from Dr. Cox (see Note K[3] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for legal fees on a full contingency basis ranging from 15% to 30% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.

Dovel & Luner, LLP provided legal services to the Company with respect to the Company’s patent litigation filed in September 2011 against sixteen (16) data networking equipment manufacturers in the U.S. District Court for the Eastern District of Texas, (Tyler Division) (see Note K[1]). The terms of the Company’s agreement with Dovel & Luner LLP essentially provided for legal fees on a full contingency basis ranging from 12.5% to 35% (with certain exceptions) of the net recovery (after deduction for expenses) depending on the stage of the preceding in which a result (settlement or judgment) is achieved. The Company was responsible for a portion of the expenses incurred with respect to this litigation. For the year ended December 31, 2021 and 2020, the Company incurred contingent legal fees and expenses to Dovel & Luner of $4,586,000 and $1,428,000, respectively, with respect to the litigation. As of December 31, 2021, the Company accrued contingency fees expenses of $137,000 to Dovel & Luner with respect to the litigation (see Note B[8] hereof).

Dovel & Luner, LLP also provided legal services to the Company with respect to the Company’s patent litigation settled in July 2010 against several major data networking equipment manufacturers including Cisco (see Note K[3]). The terms of the Company’s agreement with Dovel & Luner, LLP provided for legal fees of a maximum aggregate cash payment of $1.5 million plus a contingency fee of up to 24% (based on the settlement being achieved at the trial stage) including legal fees of local counsel in Texas. With respect to any royalty payments payable by Cisco relating to royalties for the period prior to the expiration of the Remote Power Patent (March 7, 2020), the Company had an obligation to pay Dovel & Luner contingency fees of 24% (see Note K[2] hereof). During the year ended December 31, 2021, the Company paid Dovel and Luner contingency fees and expenses of $5,760,000. There were no contingency fees paid to Dovel and Luner for the year ended December 31, 2020. In addition, as of December 31, 2021 and 2020, there were no outstanding contingency fees due Dovel & Luner with respect to this litigation.

[2]Patent Acquisitions:

In connection with the Company’s acquisition of its Cox Patent Portfolio, the Company is obligated to pay Dr. Cox 12.5% of the net proceeds (after deduction of expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the years ended December 31, 2021, and 2020, no expense was incurred with respect to the Cox Patent Portfolio. As of December 31, 2021 and 2020, no amounts were accrued with respect to the Cox Patent Portfolio.

As part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition Interface, LLC (“Recognition”) pursuant to which Recognition received from the Company an interest in the net proceeds realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: (i) 10% of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, the Company has paid Recognition an aggregate of $3,127,000 with respect to such net proceeds interest related to the Mirror Worlds Patent Portfolio. No such payments were made by the Company to Recognition during the year ended December 31, 2021 and 2020.

 

In connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is obligated to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities (as defined) related to the patent portfolio. In addition, M2M will be entitled to receive from the Company $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio. As of the years ended December 31, 2021, and 2020, no expense was incurred with respect to the M2M/IoT Patent Portfolio. As of December 31, 2021 and 2020, no amounts were accrued with respect to the M2M/IoT Patent Portfolio.

[3]Savings and investment plan:

 

The Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts determined by the Board of Directors, subject to statutory limits. The 401(k) Plan expense for the years ended December 31, 2021 and 2020 was $102,000 and $105,000, respectively, all of which was accrued as of December 31, 2021 and 2020 and is recorded within accrued expenses on the Company’s consolidated balance sheets.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Employment Arrangements and Other Agreements
 12 Months Ended
Dec. 31, 2021
Employment Arrangements And Other Agreements  
Employment Arrangements and Other Agreements

Note J - Employment Arrangements and Other Agreements

[1] On March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive Officer, pursuant to which he continues to serve as our Chairman and Chief Executive Officer for a four year term (“Term”), at an annual base salary of $535,000 which shall be increased by 3% per annum during the term of the Agreement. The Agreement established an annual target bonus of $175,000 for the Chairman and Chief Executive Officer based upon performance. During the year ended December 31, 2021 and December 31, 2020, the Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000 and $125,000, respectively.

In addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, 600,000 restricted stock units (the “RSUs”, each RSU awarded by the Company to its officers, directors and consultants represents a contingent right to receive one share of the Company’s common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to the Chairman and Chief Executive Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the term of the Agreement that the Company’s common stock (the “Common Stock”) achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the term of the Agreement that the Common Stock achieves a Closing Price (as defined above) of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the term of the Agreement, that the Common Stock achieves a Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by you for Good Reason (as defined) in each case prior to the last day of the term of the Agreement, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors or consultants have dividend equivalent rights.

Under the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in an amount equal to 5% of the Company’s gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to our Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities with respect to patents other than the Remote

Power Patent (including all of the Company’s patent portfolios and its investment in ILiAD Biotechnologies) (collectively, the “Incentive Compensation”). During the year ended December 31, 2021 and December 31, 2020, the Chairman and Chief Executive Officer earned Incentive Compensation of $1,801,000 and $220,000, respectively.

The Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s patents with respect to licenses entered into with third parties during the term of his employment or at anytime thereafter, whether he is employed by us or not; provided, that, the employment of the Chairman and Chief Executive Officer has not been terminated by the Company “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that the Chairman and Chief Executive Officer’s employment is terminated by us “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief Executive Officer shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.

In connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i) during the term of the Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 month base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by us or “Without Good Reason” by the Chairman and Chief Executive Officer.

[2] The Company’s Chief Financial Officer serves on an at-will basis at an annual base salary of $175,000. The Company’s Chief Financial Officer received a discretionary annual bonus of $22,500 for the year ended December 31, 2021 and $15,000 for the year ended December 31, 2020. On December 29, 2020, the Chief Financial Officer was granted 7,500 RSUs under the 2013 Plan. 50% of such RSUs vested on the one year anniversary of the grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022), subject to the Chief Financial Officer’s continued service to the Company. In addition, in the event the Chief Financial Officer’s employment is terminated without “Good Cause” (as defined), he shall receive (i) (a) 6 months base salary or (b) 12 months base salary in the event of a termination without “Good Cause” within 6 months following a “Change of Control” of the Company (as defined) and (ii) accelerated vesting of all remaining unvested shares underlying his options, RSUs or any other awards he may receive in the future.

[3] The Company’s Executive Vice President serves on an at-will basis at an annual base salary of $200,000. The Executive Vice President received a discretionary annual bonus of $40,000 and $25,000 for the year ended December 31, 2021 and 2020, respectively. On December 29, 2020, the Company’s Executive Vice President was granted 10,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022), subject to the Executive Vice President’s continued service to the Company. On January 18, 2022, the Company’s Executive Vice President was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024).
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Legal Proceedings
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Legal Proceedings

Note K – Legal Proceedings

[1] On July 26, 2021, the Company agreed to settle its patent litigation against Hewlett-Packard Company and Hewlett-Packard Enterprise Company (collectively, “Hewlett-Packard”) pending in the U.S. District Court for the Eastern District of Texas, Tyler Division, for infringement of the Company’s Remote Power Patent. Under the terms of the settlement agreement, Hewlett-Packard Enterprise Company paid the Company $17,000,000 in full settlement of the litigation and Hewlett-Packard received a fully paid license and release to the Remote Power Patent for its full term, which applies to sales of Power over Ethernet (“PoE”) products by Hewlett-Packard and its wholly-owned subsidiary Aruba Networks, LLC.

[2] On March 30, 2021, the Company entered into an amendment (the “Amendment”) to the Settlement and License Agreement, dated May 25, 2011, between the Company and Cisco (the “Agreement”). Pursuant to the Amendment, Cisco paid $18,692,000 to the Company to resolve a dispute relating to Cisco’s contractual obligation to pay royalties under the Agreement to the Company for the period beginning in the fourth quarter of 2017 through March 7, 2020 (when the Remote Power Patent expired) with respect to licensing the Remote Power Patent.

[3] On April 4, 2014 and December 3, 2014, the Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery has been substantially completed and a trial date has not yet been set.

[4] On May 9, 2017, Mirror Worlds Technologies, LLC, the Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“Facebook”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Facebook’s core technologies that enable Facebook’s Newsfeed and Timeline features. The lawsuit further alleged that Facebook’s unauthorized use of the stream-based solutions of the Company’s asserted patents has helped Facebook become the most popular social networking site in the world. On May 7, 2018, Facebook filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Facebook’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018, the Company filed a Notice of Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit reversed the summary judgment finding of the District Court and remanded the litigation to the Southern District of New York for further proceedings.

On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Facebook. In its ruling the Court (i) denied Facebook’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and intends to file an appeal to the U.S. Court of Appeals for the Federal Circuit.

[5] On December 15, 2020, the Company filed a lawsuit against Netgear in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company has objected to jurisdiction at the AAA and the dispute is pending.

[6] On January 7, 2021, the Company filed a lawsuit against Plantronics, Inc., the successor entity to Polycom, Inc., in the Supreme Court of the State of California, County of Santa Clara, for breach of a Settlement and License Agreement, dated September 29, 2016, with the Company for the failure of Plantronics and Polycom to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of PoE products. On October 26, 2021, the Company settled its litigation with Plantronics, Inc. in consideration for payment of $337,000.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Concentrations
 12 Months Ended
Dec. 31, 2021
Risks and Uncertainties [Abstract]  
Concentrations

Note L - Concentrations

Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2021 and 2020. Revenue from two licensees constituted an aggregate of 99% of the Company’s revenue for the year ended December 31, 2021. Revenue from one licensee constituted an aggregate of 94% of the Company’s revenue for the year ended December 31, 2020. At December 31, 2021 and December 31, 2020, there were no royalty receivables from licensees.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transaction
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
Related Party Transaction

Note M – Related Party Transaction

On May 27, 2021, the Company repurchased from a director of the Company 40,000 shares of its common stock at a purchase price of $3.27 per share or aggregate consideration of $130,800.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Repurchase Program
 12 Months Ended
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]  
Stock Repurchase Program

Note N – Stock Repurchase Program

On June 11, 2021, the Company’s Board of Directors authorized an extension and increase of the Share Repurchase Program to repurchase up to $5,000,000 of the Company’s common stock over the subsequent 24-month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in the Company’s discretion. The timing and amount of the shares repurchased are determined by management based on its evaluation of market conditions and other factors. The repurchase program may be increased, suspended or discontinued at any time.

During the year ended December 31, 2021, the Company repurchased an aggregate of 378,475 shares of its common stock pursuant to the Share Repurchase Program at a cost of approximately $1,077,000 or an average price per share of $2.85 per share.

Since inception of the Share Repurchase Program (August 2011) through December 31, 2021, the Company has repurchased an aggregate of 8,984,134 shares of its common stock at a cost of approximately $17,225,276 (exclusive of commissions) or an average per share price of $1.92 per share.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Dividend Policy
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Dividend Policy

Note O – Dividend Policy

On June 9, 2020, the Company’s Board of Directors approved the continuation of the Company’s dividend policy which consists of a semi-annual cash dividend of $0.05 per common share ($0.10 per common share annually) which are anticipated to be paid in March and September of each year. On February 23, 2021, the Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 31, 2021 to all common shareholders of record as of March 16, 2021. On September 10, 2021, the Board of Directors declared a semi-annual dividend of $0.05 per share with a payment date of September 30, 2021 to all common shareholders of record as of September 21, 2021. The Company’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
 12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events

Note P – Subsequent Events

[1] On February 23, 2022, the Company’s Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 24, 2022 to all common shareholders of record as of March 9, 2022.

[2] On February 23, 2022, the Company’s Board of Directors approved the grant of 15,000 RSUs to each of the Company’s three non-management directors. The RSUs vest over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15, 2022, June 15, 2022, September 15, 2022 and December 15, 2022.

[3] On March 11, 2022, 125,000 shares of the Company’s common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer were settled. With respect to the restricted stock unit settlement, the Chairman and Chief Executive Officer delivered 45,438 shares to satisfy withholding taxes and received 79,562 net shares of common stock. 

[4] On March 22, 2022, the Company entered into a new four year employment agreement with its Chairman and Chief Executive Officer. In connection with the agreement the Company granted to its Chairman and Chief Executive Officer 600,000 restricted stock units which vest in four tranches subject to certain conditions (see Note J[1] hereof). 

[5] On March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) consisting of six U.S. patents and two pending U.S. patents covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The Company paid the seller $500,000 at the closing and has an obligation to pay the seller an additional $500,000 and $375,000 of the Company's common stock upon achieving certain milestones with respect to the patent portfolio. The Company also has an obligation to pay the seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and 17.5% of net proceeds greater than $50 million.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Principles of Consolidation

 

[1]Principles of Consolidation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiary, Mirror Worlds Technologies, LLC. All intercompany transactions and balances are eliminated in consolidation.
Use of Estimates and Assumptions

 

[2]Use of Estimates and Assumptions

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements include revenue recognition, contingent legal fees and related costs, income taxes, valuation of patents and equity method investments, including evaluation of the Company’s basis difference. Actual results could be materially different from those estimates, upon which the carrying values were based.
Cash and Cash Equivalents

[3]Cash and Cash Equivalents

The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $250,000. At December 31, 2021 and 2020, the Company had $8,109,000 and $5,477,000, respectively, in excess of the FDIC insured limit.

 

The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.
Marketable Securities

 

[4]Marketable Securities

 

The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, fixed income mutual funds, and corporate bonds and notes (see Note G). At December 31, 2021 and December 31, 2020, included in marketable securities, the Company had aggregate certificates of deposit of $— and $3,500,000, respectively, at financial institutions that were within the FDIC limit. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.
Revenue Recognition

 

[5]Revenue Recognition

 

Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.

 

The Company determines revenue recognition through the follow steps:

 

•identification of the license agreement;
•identification of the performance obligations in the license agreement;
•determination of the consideration for the license;
•allocation of the transaction price to the performance obligations in the contract; and
•recognition of revenue when the Company satisfies its performance obligations.

 

Revenue disaggregated by source is as follows:

Schedule of disaggregation of revenue          
   Years Ended December 31, 
   2021   2020 
Fully-Paid Licenses  $17,000,000(1)  $— 
Royalty Bearing Licenses   19,029,000(2)   4,403,000(3)
Total Revenue  $36,029,000   $4,403,000 

__________________________

(1)Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
(2)Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).
(3)Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.

The Company relied on royalty reports received from third party licensees to record its revenue. From time to time, the Company may audit or otherwise dispute royalties reported from licensees. Any adjusted royalty revenue as a result of such audits or dispute is recorded by the Company in the period in which such adjustment is agreed to by the Company and the licensee or otherwise determined.

 

Revenue from the Company’s patent licensing business is generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license (a “Fully-Paid License”), or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent (a “Royalty Bearing License”).

 

The Company’s license agreements, both Fully-Paid Licenses and Royalty Bearing Licenses, typically include some combination of the following: (i) the grant of a non-exclusive license to manufacture and/or sell products covered by its patented technologies; (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted pursuant to these licenses typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company typically has no further performance obligations with respect to the grant of the non-exclusive licenses. Generally, the license agreements provide for the grant of the licenses, releases, and other obligations following execution of the agreement and the receipt of the up-front lump sum payment for a Fully-Paid License or a license initiation fee for a Royalty Bearing License.

 

The Company recognizes revenue from their Royalty Bearing Licenses in a manner consistent with the legal form of the arrangement, and in accordance with the royalty recognition constraint that applies to licenses of IP for which some or all of the consideration is in the form of sales or usage based royalty. Consequently, the Company recognizes revenue at the later of when (1) the subsequent sale occurs or (2) the performance obligation to which some or all of the sales based royalty has been satisfied.

 

Non-Refundable Up-Front Fees: Fully-Paid Licenses provide for a non-refundable up-front payment, for which the Company has no future obligations or performance requirements, revenue is generally recognized when the Company has obtained the signed license agreement, all performance obligations have been substantially performed, amounts are fixed and determinable, and collectability is reasonably assured. Revenue from Fully-Paid Licenses may consist of one or more installments. The timing and amount of revenue recognized from each licensee depends upon a number of factors including the specific terms of each agreement and the nature of the deliverables and obligations.

 
Equity Method Investments

 

[6]Equity Method Investments

 

Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized. Upon sale of equity method investments, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss.
Patents

 

[7]Patents

The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.

Income Taxes

 

[8]Costs of Revenue and Related Costs

The Company includes in costs of revenue for the year ended December 31, 2021 and 2020 contingent legal fees payable to patent litigation counsel, any other contractual payments related to net proceeds from settlements (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer.

During the year ended December 31, 2020, the Company had a change in estimate related to accrued contingency fees and related costs. The change was the result of the Company receiving new information reflecting additional legal costs in connection with certain contingent litigation. The effect of this change in estimate for the year ended December 31, 2020 was an increase in professional fees and related costs of $886,000 and a corresponding increase in our operating loss and net loss of $886,000, and a decrease in basic and diluted earnings per share of $0.04 per share.

 

[9]Income Taxes

The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.

ASC 740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2021 and 2020.

U.S. federal, state and local income tax returns prior to 2018 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.
Stock-Based Compensation

 

[10]Stock-Based Compensation

 

The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income based on their grant date fair values.

Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.
Earnings Per Share

 

[11]Earnings Per Share

The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.
Fair Value Measurements

 

[12]Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.

There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents, royalty receivable, other assets, accounts payable, and accrued expenses approximates fair value because of the short-term nature of these financial instruments.

The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.

The Company’s equity investment in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held development stage biotechnology company, is measured on a non-recurring basis and is classified within Level 3 as it is valued using significant unobservable inputs or data in an inactive market, and the valuation requires management judgment due to the absence of market price and inherent lack of liquidity.
Carrying Value, Recoverability and Impairment of Long-Lived Assets

 

[13]Carrying Value, Recoverability and Impairment of Long-Lived Assets

An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2021 and 2020, there was no impairment to the Company’s patents and equity investment.

The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.
Dividend Policy

 

[14]Dividend Policy

Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).
New Accounting Standards

 

[15]New Accounting Standards

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes. The ASU removes certain exceptions for performing intra-period allocation and calculating income taxes in interim periods. It also simplifies the accounting for income taxes by requiring recognition of franchise tax partially based on income as an income-based tax, requiring reflection of enacted changes in tax laws in the interim period and making improvements for income taxes related to employee stock ownership plans. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The adoption of this standard did not have a material effect on its consolidated financial statements.

 

Equity Securities

 

In January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The ASU amends and clarifies certain interactions between the guidance under Topic 321, Topic 323 and Topic 815, by reducing diversity in practice and increasing comparability of the accounting for these interactions. The amendments in the ASU should be applied on a prospective basis. The ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of this standard did not have a material effect on the Company’s consolidated financial statements.

 
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of disaggregation of revenue
Schedule of disaggregation of revenue          
   Years Ended December 31, 
   2021   2020 
Fully-Paid Licenses  $17,000,000(1)  $— 
Royalty Bearing Licenses   19,029,000(2)   4,403,000(3)
Total Revenue  $36,029,000   $4,403,000 

__________________________

(1)Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
(2)Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).
(3)Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Patents (Tables)
 12 Months Ended
Dec. 31, 2021
Patents  
Schedule of patent
        
 

2021

  

2020

 
Gross carrying amount  $7,949,000   $7,848,000 
Accumulated amortization   (6,565,000)   (6,270,000)
Patents, net  $1,384,000   $1,578,000 
Schedule of future amortization of current intangible
Schedule of future amortization of current intangible     
For the years ended December 31,     
2022   $301,000 
2023    236,000 
2024    90,000 
2025    90,000 
2026 and thereafter    667,000 
Total   $1,384,000 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Loss Per Share (Tables)
 12 Months Ended
Dec. 31, 2021
Net Income (Loss) Per Share:  
Schedule of Earnings per share
  2021   2020 
         
Weighted-average common shares
outstanding – basic		   24,136,821    24,011,354 
           

Dilutive effect of stock options and

restricted stock units

   393,747    

 

—

 
           
Weighted-average common shares
outstanding – diluted		   24,530,568    24,011,354 
           
Stock option and restricted stock units
excluded from the computation of diluted
income per share because the effect of
inclusion would have been anti-dilutive		   12,500    662,500 
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of components of the income taxes
   2021   2020 
Current          
   State and local  $144,000   $(34,000)
   Federal   2,808,000    (430,000)
Total Current Tax Expense (Benefit)  $2,952,000   $(464,000)
           
Deferred          
   State and local   83,000    (32,000)
   Federal   1,425,000    (458,000)
Total Deferred Tax Expense (Benefit)   1,508,000    (490,000)
           
Total Income Taxes  $4,460,000   $(954,000)
Schedule of components of deferred tax assets
Schedule of components of deferred tax assets   2021   2020 

Deferred tax assets (liability):
Net operating loss carry forwards

  $
—		   $1,665,000 
           
Deferred Tax Liability(1)   (554,000)   (711,000)
           
Total deferred tax assets (liability)  $(554,000)  $954,000 

_________________________

(1)   Deferred tax liability as a result of a temporary difference related to the Company’s equity method investment.
Schedule of reconciliation of income tax
  Years Ended 
  

December 31,

 
  

2021

  

2020

 
         
Income tax - statutory rate   21.00%   21.0%
Permanent difference   1.69%   (5.05)%
State and other   1.11%   1.48%
Valuation allowance on deferred tax assets   —%   18.4%
  Total   23.80%   35.83%
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Restricted Stock Units
  2021   2020 
  

Number

of Shares

   Weighted-Average Grant
Date Fair Value		  

Number

of Shares

   Weighted-Average Grant
Date Fair Value		 
Balance of restricted stock units outstanding at beginning of year   162,500   $2.25    340,000   $2.15 
Grants of restricted stock units   45,000    3.51    70,000    2.68 
Vested restricted stock units(1)   (195,000)   (2.47)   (247,500)   (2.23)
Balance of restricted stock units outstanding at end of year   12,500   $3.36    162,500   $2.25 

__________________________

(1)       Includes 125,000 shares of common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer which vested on July 14, 2021 and settled on March 11, 2022.
Schedule of stock option activity
 

2021

  

2020

 
       Weighted       Weighted 
       Average       Average 
   Options   Exercise   Options   Exercise 
  

Outstanding

  

Price

  

Outstanding

  

Price

 
Options outstanding
at beginning of year		   500,000   $1.19    605,000   $1.39 
Granted   —    —    —    — 
Expired   —    —    —    — 
Exercised   —    —    (105,000)  $2.34 
Options outstanding at end of year   500,000   $1.19    500,000   $1.19 
Options exercisable at end of year   500,000   $1.19    500,000   $1.19 
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Marketable Securities (Tables)
 12 Months Ended
Dec. 31, 2021
Marketable Securities  
Schedule of Marketable Securities
                
   December 31, 2021 
  

Cost
Basis

  

Gross Unrealized Gains

  

Gross Unrealized Losses

  

Fair Value

 
                 
Fixed income mutual funds  $14,462,000   $—   $(137,000)  $14,325,000 
Corporate bonds and notes   813,000    —    (12,000)   801,000 
Total marketable securities  $15,275,000   $—   $(149,000)  $15,126,000 

 

   December 31, 2020 
  

Cost
Basis

  

Gross Unrealized Gains

  

Gross Unrealized Losses

  

Fair Value

 
                 
Certificates of deposit  $3,534,000   $7,000   $—   $3,541,000 
Fixed income mutual funds   11,255,000    80,000    —    11,335,000 
Corporate bonds and notes   4,500,000    18,000    (28,000)   4,490,000 
Total marketable securities  $19,289,000   $105,000   $(28,000)  $19,366,000 
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Business (Details Narrative)
 12 Months Ended 26 Months Ended
Dec. 31, 2021
Number
Mar. 07, 2020
USD ($)
Defined Benefit Plan Disclosure [Line Items]    
Patents owned | Number 95  
Cisco [Member] | Settlement And License Agreement [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Contractual obligation to pay royalties | $   $ 18,691,890
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Product Information [Line Items]    
Total Revenue $ 36,029,000 $ 4,403,000
Fully Paid Licenses [Member]    
Product Information [Line Items]    
Total Revenue 17,000,000 [1]
Royalty Bearing Licenses [Member]    
Product Information [Line Items]    
Total Revenue $ 19,029,000 [2] $ 4,403,000 [3]
[1] Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).
[2] Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).
[3] Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Accounting Policies [Abstract]    
FDIC insured limit   $ 250,000
Cash in excess of FDIC insured limit $ 5,477,000 8,109,000
Certificates of deposit 3,500,000
Increase in professional fees and related costs 886,000  
Increase operating loss and net loss $ 886,000  
Decrease in basic and diluted earnings per share $ 0.04  
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Patents (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]    
Patents, net $ 1,384,000 $ 1,578,000
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount 7,949,000 7,848,000
Accumulated amortization (6,565,000) (6,270,000)
Patents, net $ 1,384,000 $ 1,578,000
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Patents (Details 1)
Dec. 31, 2021
USD ($)
Patents  
2022 $ 301,000
2023 236,000
2024 90,000
2025 90,000
2026 and thereafter 667,000
Total $ 1,384,000
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Patents (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Amortization expense $ 295,000 $ 292,000
Minimum [Member]    
Estimated remaining economic useful of patents 1 year 6 months  
Expiration dates of the patents within the Cox patent portfolio July 2023  
Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio September 2033  
Maximum [Member]    
Estimated remaining economic useful of patents 12 years 3 months 29 days  
Expiration dates of the patents within the Cox patent portfolio November 2023  
Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio May 2034  
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Loss Per Share (Details) - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Net Income (Loss) Per Share:    
Weighted-average common shares outstanding – basic 24,136,821 24,011,354
Dilutive effect of stock options and restricted stock units 393,747
Weighted-average common shares outstanding – diluted 24,530,568 24,011,354
Stock option and restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive 12,500 662,500
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Loss Per Share (Details Narrative) - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Net Income (Loss) Per Share:    
Potentially Dilutive Shares 12,500 662,500
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Current    
   State and local $ 144,000 $ (34,000)
   Federal 2,808,000 (430,000)
Total Current Tax Expense (Benefit) 2,952,000 (464,000)
Deferred    
   State and local 83,000 (32,000)
   Federal 1,425,000 (458,000)
Total Deferred Tax Expense (Benefit) 1,508,000 (490,000)
Total Income Taxes $ 4,460,000 $ (954,000)
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details 1) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets (liability): Net operating loss carry forwards    
Net operating loss carry forwards $ 1,665,000
Deferred Tax Liability [1] (554,000) (711,000)
Total deferred tax assets (liability) $ (554,000) $ 954,000
[1]   Deferred tax liability as a result of a temporary difference related to the Company’s equity method investment.
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details 2)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Income tax - statutory rate 21.00% 21.00%
Permanent difference 1.69% (5.05%)
State and other, net 1.11% 1.48%
Valuation allowance on deferred tax assets 18.40%
Total 23.80% 35.83%
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Valuation allowance $ 0 $ 490,000
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Equity [Abstract]    
Restricted stock, Outstanding Number of shares, Beginning Balance 162,500 340,000
Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance $ 2.25 $ 2.15
Grants of restricted stock units 45,000 70,000
Grants of restricted stock units, Weighted Average Grant Date Fair Value $ 3.51 $ 2.68
Vested restricted stock units (195,000) (247,500)
Vested restricted stock units, Weighted Average Grant Date Fair Value $ (2.47) $ (2.23)
Unvested Resricted stock, Outstanding Number of shares, Ending Balance 12,500 162,500
Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance $ 3.36 $ 2.25
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details 1) - Equity Option [Member] - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Option outstanding, beginning balance 500,000 605,000
Outstanding exercise price $ 1.19 $ 1.39
Granted
Granted
Expired
Expired
Exercised (105,000)
Exercised $ 2.34
Option outstanding, ending balance 500,000 500,000
Option outstanding exercise price, at end of year $ 1.19 $ 1.19
Option exercisable at end of year 500,000 500,000
Option exercise price at end of year $ 1.19 $ 1.19
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Aggregate intrinsic value of options exercisable $ 815,000 $ 1,250,000
Equity Option [Member] | Directors Three [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock options exercised to purchase shares on cashless basis   105,000
Exercise price   $ 2.34
Aggregate net shares issued   4,707
Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Restricted stock unit compensation expense 238,000 $ 302,000
Unrecognized restricted stock unit compensation expense $ 42,000  
Weighted average amortized period 11 months 26 days  
Accrued dividend rights on restricted stock unit $ 72,000 $ 53,000
2013 Stock Incentive Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Common stock available for issuance 1,837,500  
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Marketable Securities (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Fair Value [Member]    
Other Investment Not Readily Marketable [Line Items]    
Fixed income mutual funds $ 14,325,000 $ 11,335,000
Corporate bonds and notes 801,000 4,490,000
Total marketable securities 15,126,000 19,366,000
Certificates of deposit   3,541,000
Cost Basis [Member]    
Other Investment Not Readily Marketable [Line Items]    
Fixed income mutual funds 14,462,000 11,255,000
Corporate bonds and notes 813,000 4,500,000
Total marketable securities 15,275,000 19,289,000
Certificates of deposit   3,534,000
Gross Unrealized Gains [Member]    
Other Investment Not Readily Marketable [Line Items]    
Fixed income mutual funds 80,000
Corporate bonds and notes 18,000
Total marketable securities 105,000
Certificates of deposit   7,000
Gross Unrealized Losses [Member]    
Other Investment Not Readily Marketable [Line Items]    
Fixed income mutual funds (137,000)
Corporate bonds and notes (12,000) (28,000)
Total marketable securities $ (149,000) (28,000)
Certificates of deposit  
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Investment (Details Narrative) - USD ($)
 12 Months Ended
Mar. 12, 2021
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]      
Aggregrate investment   $ 6,000,000  
Equity investment   5,000,000  
Convertable note investment   1,000,000  
Iliad [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Aggregrate investment   6,000,000  
Equity investment   5,000,000  
Equity investment net loss   $ 999,000 $ 787,000
Iliad [Member] | Class C Units [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Ownership percentage not fully diluted   9.50%  
Ownership percentage fully diluted   7.20%  
I Liad Biotechnologies L L C [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Additional convertable note investment $ 1,000,000    
Maximum convertible debt offering $ 23,500,000    
Interest rate 6.00%    
Notes conversion, description The Notes are required to be converted into a Qualified Financing (minimum financing of $15 million) at the lesser of (i) 80% of the price paid per unit in such offering or (ii) a price based on an enterprise value of $176,000,000. In addition, the Notes shall convert in the event of a merger at the lower of an enterprise value of $176,000,000 or the stated valuation of ILiAD in the merger transaction. In the event of a change-in-control, noteholders will also have the option to have the Notes repaid except in a Qualified Financing or a stock-for-stock merger.    
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies (Details Narrative) - USD ($)
 12 Months Ended 104 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Loss Contingencies [Line Items]      
Obligated to pay Cox, net proceeds percentage 12.50%   12.50%
Obligated to pay Recognition      
First $125 Million 10.00%   10.00%
Next $125 Million 15.00%   15.00%
Over $250 Million 20.00%   20.00%
Recognition net proceeds payment related to Mirror Worlds patents     $ 3,127,000
Obligated to pay M2M      
First $100 Million 14.00%   14.00%
Next $100 Million 5.00%   5.00%
Additional consideration payable upon occurrence of certain future events $ 250,000   $ 250,000
Plan expense 102,000 $ 105,000  
Legal Service Agreement With Dovel And Luner For Litigation Filed In September 2011 [Member]      
Loss Contingencies [Line Items]      
Accrued expenses 4,586,000 $ 1,428,000 $ 4,586,000
Contingent legal fees 137,000    
Legal Service Agreement With Dovel And Luner For Litigation Settlement In July 2010 [Member]      
Loss Contingencies [Line Items]      
Contingent legal fees $ 5,760,000    
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Employment Arrangements and Other Agreements (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Mar. 22, 2022
Dec. 31, 2021
Dec. 31, 2020
Chief Executive Officer [Member] | New Employment Agreement [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Annual base salary $ 535,000    
Target annual bonus paid Chairman and CEO $ 175,000    
Annual discretionary bonus   $ 175,000 $ 125,000
Chairman And Chief Executive Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold   1,801,000 220,000
Chief Financial Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Annual base salary   175,000  
Annual discretionary bonus   22,500 15,000
Vice President [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Annual base salary   200,000  
Annual discretionary bonus   $ 40,000 $ 25,000
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Legal Proceedings (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended 27 Months Ended
Jul. 26, 2021
May 09, 2017
Oct. 26, 2021
Dec. 31, 2021
Mar. 30, 2021
Defined Benefit Plan Disclosure [Line Items]          
Plantronics Litigation     $ 337,000    
Google [Member] | On April 4, 2014 and December 3, 2014 [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Litigation pending, description       Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system.  
Facebook [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Litigation pending, description   Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“Facebook”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Facebook’s core technologies that enable Facebook’s Newsfeed and Timeline features.      
License Agreement [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Amount of royalties paid by Cisco         $ 18,692,000
Hewlett Packard Enterprise [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Plantronics Litigation $ 17,000,000        
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Concentrations (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Concentration Risk [Line Items]    
Royalty Receivables $ 0 $ 0
Remote Power Patent [Member]    
Concentration Risk [Line Items]    
Percentage revenue 100.00% 100.00%
Licensees Two [Member]    
Concentration Risk [Line Items]    
Percentage revenue 99.00%  
Licensees One [Member]    
Concentration Risk [Line Items]    
Percentage revenue   94.00%
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transaction (Details Narrative) - Board Of Directors [Member]
May 27, 2021
USD ($)
$ / shares
shares
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]  
Number of shares, common stock repurchased | shares 40,000
Price per share, common stock repurchased | $ / shares $ 3.27
Aggregate cost of common stock | $ $ 130,800
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Repurchase Program (Details Narrative) - USD ($)
 12 Months Ended 125 Months Ended
Dec. 31, 2021
Dec. 31, 2021
Jun. 11, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Number of shares, common stock repurchased since inception 378,475 8,984,134  
Aggregate cost of common stock repurchased since inception $ 1,077,000 $ 17,225,276  
Average price per share, common stock repurchased since inception $ 2.85 $ 1.92  
Board Of Directors [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Stock Repurchase Program, dollar amount     5,000,000
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Dividend Policy (Details Narrative) - $ / shares
 1 Months Ended 5 Months Ended 12 Months Ended
Sep. 10, 2021
Feb. 23, 2021
Jun. 09, 2020
Dec. 31, 2021
Dec. 31, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]          
Common Stock, Dividends, Per Share, Declared     $ 0.05 $ 0.10 $ 0.10
Board Of Directors [Member]          
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]          
Common Stock, Dividends, Per Share, Declared $ 0.05 $ 0.05      
Debt Instrument, Maturity Date Sep. 30, 2021 Mar. 31, 2021      
Semi-annual cash dividend record date Sep. 21, 2021 Mar. 16, 2021      
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Details Narrative) - USD ($)
 1 Months Ended 5 Months Ended 12 Months Ended
Mar. 11, 2022
Sep. 10, 2021
Mar. 25, 2022
Mar. 22, 2022
Feb. 23, 2022
Feb. 23, 2021
Jun. 09, 2020
Dec. 31, 2021
Dec. 31, 2020
Subsequent Event [Line Items]                  
Semi-annual cash dividend per common share             $ 0.05 $ 0.10 $ 0.10
Restricted Stock Units (RSUs) [Member]                  
Subsequent Event [Line Items]                  
Restricted stock units granted to directors           15,000   45,000 45,000
Board Of Directors [Member]                  
Subsequent Event [Line Items]                  
Semi-annual cash dividend per common share   $ 0.05       $ 0.05      
Dividend payment date   Sep. 30, 2021       Mar. 31, 2021      
Semi-annual cash dividend record date   Sep. 21, 2021       Mar. 16, 2021      
Subsequent Event [Member]                  
Subsequent Event [Line Items]                  
Amount paid to seller     $ 500,000            
Contigent Obligation to pay seller     500,000            
Common stock issued upon achieving certain milestones     $ 375,000            
First $50 million     15.00%            
Greater than $50 million     17.50%            
Subsequent Event [Member] | Board Of Directors [Member]                  
Subsequent Event [Line Items]                  
Semi-annual cash dividend per common share         $ 0.05        
Dividend payment date         Mar. 24, 2022        
Semi-annual cash dividend record date         Mar. 09, 2022        
Subsequent Event [Member] | Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]                  
Subsequent Event [Line Items]                  
RSU settled 125,000                
Shares delivered for withholding taxes 45,438                
Net shares received 79,562                
Restricted stock units granted       600,000          
XML 67 network1_10k-123121_htm.xml IDEA: XBRL DOCUMENT 0001065078 2021-01-01 2021-12-31 0001065078 2021-06-30 0001065078 2022-03-28 0001065078 2021-12-31 0001065078 2020-12-31 0001065078 2020-01-01 2020-12-31 0001065078 us-gaap:CommonStockMember 2019-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001065078 us-gaap:RetainedEarningsMember 2019-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001065078 2019-12-31 0001065078 us-gaap:CommonStockMember 2020-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001065078 us-gaap:RetainedEarningsMember 2020-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001065078 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001065078 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001065078 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001065078 us-gaap:CommonStockMember 2021-12-31 0001065078 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001065078 us-gaap:RetainedEarningsMember 2021-12-31 0001065078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001065078 nssi:SettlementAndLicenseAgreementMember nssi:CiscoMember 2018-01-01 2020-03-07 0001065078 nssi:FullyPaidLicensesMember 2021-01-01 2021-12-31 0001065078 nssi:FullyPaidLicensesMember 2020-01-01 2020-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2021-01-01 2021-12-31 0001065078 nssi:RoyaltyBearingLicensesMember 2020-01-01 2020-12-31 0001065078 srt:MinimumMember 2021-01-01 2021-12-31 0001065078 srt:MaximumMember 2021-01-01 2021-12-31 0001065078 us-gaap:PatentsMember 2021-12-31 0001065078 us-gaap:PatentsMember 2020-12-31 0001065078 nssi:StockIncentivePlanMember 2021-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001065078 nssi:DirectorsThreeMember us-gaap:StockOptionMember 2020-01-01 2020-12-31 0001065078 us-gaap:StockOptionMember 2020-12-31 0001065078 us-gaap:StockOptionMember 2019-12-31 0001065078 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001065078 us-gaap:StockOptionMember 2020-01-01 2020-12-31 0001065078 us-gaap:StockOptionMember 2021-12-31 0001065078 nssi:CostBasisMember 2021-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2021-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2021-12-31 0001065078 nssi:FairValueMember 2021-12-31 0001065078 nssi:CostBasisMember 2020-12-31 0001065078 nssi:GrossUnrealizedGainsMember 2020-12-31 0001065078 nssi:GrossUnrealizedLossesMember 2020-12-31 0001065078 nssi:FairValueMember 2020-12-31 0001065078 nssi:IliadMember 2021-12-31 0001065078 nssi:ClassCUnitsMember nssi:IliadMember 2021-12-31 0001065078 nssi:ClassCUnitsMember nssi:IliadMember 2021-01-01 2021-12-31 0001065078 nssi:ILiadBiotechnologiesLLCMember 2021-03-12 0001065078 nssi:ILiadBiotechnologiesLLCMember 2021-03-01 2021-03-12 0001065078 nssi:IliadMember 2021-01-01 2021-12-31 0001065078 nssi:IliadMember 2020-01-01 2020-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member 2021-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member 2020-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member 2021-01-01 2021-12-31 0001065078 nssi:LegalServiceAgreementWithDovelAndLunerForLitigationSettlementFiledInJuly2010Member 2021-01-01 2021-12-31 0001065078 2013-05-01 2021-12-31 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2022-03-01 2022-03-22 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2021-01-01 2021-12-31 0001065078 srt:ChiefExecutiveOfficerMember nssi:NewEmploymentAgreementMember 2020-01-01 2020-12-31 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001065078 nssi:ChairmanAndChiefExecutiveOfficerMember 2020-01-01 2020-12-31 0001065078 srt:ChiefFinancialOfficerMember 2021-01-01 2021-12-31 0001065078 srt:ChiefFinancialOfficerMember 2020-01-01 2020-12-31 0001065078 srt:VicePresidentMember 2021-01-01 2021-12-31 0001065078 srt:VicePresidentMember 2020-01-01 2020-12-31 0001065078 nssi:HewlettPackardEnterpriseMember 2021-07-25 2021-07-26 0001065078 nssi:LicenseAgreementMember 2019-01-01 2021-03-30 0001065078 nssi:GoogleMember nssi:OnAprilFourTwoThousandFourteenAndDecemberThreeTwoThousandFourteenMember 2021-01-01 2021-12-31 0001065078 nssi:FacebookMember 2017-05-08 2017-05-09 0001065078 2021-10-01 2021-10-26 0001065078 nssi:RemotePowerPatentMember 2020-01-01 2020-12-31 0001065078 nssi:RemotePowerPatentMember 2021-01-01 2021-12-31 0001065078 nssi:LicenseesTwoMember 2021-01-01 2021-12-31 0001065078 nssi:LicenseesOneMember 2020-01-01 2020-12-31 0001065078 nssi:BoardOfDirectorsMember 2021-05-26 2021-05-27 0001065078 nssi:BoardOfDirectorsMember 2021-06-11 0001065078 2011-08-01 2021-12-31 0001065078 2020-01-01 2020-06-09 0001065078 nssi:BoardOfDirectorsMember 2021-02-01 2021-02-23 0001065078 nssi:BoardOfDirectorsMember 2021-09-01 2021-09-10 0001065078 nssi:BoardOfDirectorsMember us-gaap:SubsequentEventMember 2022-02-01 2022-02-23 0001065078 us-gaap:RestrictedStockUnitsRSUMember 2021-02-01 2021-02-23 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2022-03-01 2022-03-11 0001065078 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2022-03-01 2022-03-22 0001065078 us-gaap:SubsequentEventMember 2022-03-01 2022-03-25 iso4217:USD shares iso4217:USD shares pure nssi:Number 0001065078 false 2021 FY 10-K true 2021-12-31 --12-31 false 1-15288 NETWORK-1 TECHNOLOGIES, INC. DE 11-3027591 65 Locust Avenue New Canaan CT 06840 (203) 920-1055 Common Stock $.01 par value NTIP NYSEAMER No No Yes Yes Non-accelerated Filer true false false false 47450000 23883024 Friedman LLP New York, New York 711 44497000 25505000 15126000 19366000 150000 120000 59773000 44991000 954000 1384000 1578000 2651000 3650000 1000000 13000 21000 5048000 6203000 64821000 51194000 2952000 459000 597000 137000 932000 380000 277000 180000 226000 4108000 2032000 554000 4662000 2032000 0.01 0.01 10000000 10000000 0 0 0 0 0.01 0.01 50000000 50000000 23792212 23792212 24105879 24105879 238000 241000 66361000 66124000 -6428000 -17193000 -12000 -10000 60159000 49162000 64821000 51194000 36029000 4403000 12147000 1653000 1500000 2407000 2263000 2162000 295000 292000 238000 302000 16443000 6816000 19586000 -2413000 327000 522000 -173000 15000 154000 537000 19740000 -1876000 2952000 -464000 1508000 -490000 4460000 -954000 15280000 -922000 -999000 -787000 14281000 -1709000 0.59 -0.07 0.58 -0.07 24136821 24011354 24530568 24011354 0.10 0.10 14281000 -1709000 -2000 -89000 14279000 -1798000 24036071 240000 65824000 -12636000 79000 53507000 -2435000 -2435000 302000 302000 247500 3000 -3000 -66510 -1000 1000 -161000 -161000 105000 1000 1000 -100293 -1000 -1000 -115889 -1000 -252000 -253000 -89000 -89000 -1709000 -1709000 24105879 241000 66124000 -17193000 -10000 49162000 -2429000 -2429000 238000 238000 70000 1000 -1000 -5192 -14000 -14000 -378475 -4000 -1073000 -1077000 -2000 -2000 14281000 14281000 23792212 238000 66361000 -6428000 -12000 60159000 14281000 -1709000 295000 292000 238000 302000 -999000 -787000 1508000 -954000 41000 -148000 88000 -343000 30000 22000 -142000 180000 2952000 8000 -41000 -758000 366000 19499000 -503000 -17154000 -24216000 13059000 17859000 101000 51000 1000000 2994000 6306000 2410000 2471000 14000 161000 1077000 253000 -3501000 -2885000 18992000 2918000 25505000 22587000 44497000 25505000 20000 31000 <p id="xdx_80B_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zrot6XqGjukc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b>Note A – <span id="xdx_829_zFJ6VoSOh7Y9">Business</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Network-1 Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns ninety-five (<span id="xdx_90D_eus-gaap--GainContingencyPatentsFoundInfringedUponNumber_uN_c20210101__20211231_zSAgjC7pJw7f" title="Patents owned">95</span>) patents including (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded sim cards in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds (see Note P[5]); (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Until March 7, 2020, when the Remote Power Patent expired, the Company had been actively engaged in licensing its Remote Power Patent (U.S. Patent No. 6,218,930). As of March 7, 2020, the Company had twenty-seven (27) license agreements with respect to its Remote Power Patent. As a result of the expiration of the Remote Power Patent, the Company no longer receives licensing revenue for its Remote Power Patent for any period subsequent to the expiration date (March 7, 2020). However, subsequent to the expiration date of the Remote Power Patent, the Company received licensing revenue from certain licensees for periods prior to March 7, 2020. On March 30, 2021, the Company entered into an amendment (the “Amendment”) to the Settlement and License Agreement, dated May 25, 2011, between the Company and Cisco (the “Agreement”). Pursuant to the Amendment, Cisco paid $<span id="xdx_903_eus-gaap--DefinedBenefitPlanSettlementsBenefitObligation_c20180101__20200307__us-gaap--RelatedPartyTransactionAxis__custom--CiscoMember__us-gaap--PlanNameAxis__custom--SettlementAndLicenseAgreementMember_pp0p0" title="Contractual obligation to pay royalties">18,691,890</span> to the Company to resolve a dispute relating to Cisco’s contractual obligation to pay royalties under the Agreement to the Company for the period beginning in the fourth quarter of 2017 through March 7, 2020 (when the Remote Power Patent expired) with respect to licensing the Remote Power Patent (see Note K[2] hereof). In addition, on July 26, 2021, the Company entered into a settlement agreement with Hewlett-Packard pursuant to which Hewlett-Packard paid the Company $17,000,000 in full settlement of a patent litigation involving the Remote Power Patent (see Note K[1] hereof). The Company believes that NETGEAR, Inc. (“Netgear”), another licensee of the Remote Power Patent, is obligated to pay the Company royalties that accrued but were not paid since the fourth quarter of 2017 through March 7, 2020. The Company has pending litigation against Netgear to recover such royalties (see Note K[5] hereof).</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition, the Company continually reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"/> 95 18691890 <p id="xdx_80C_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_z2Gdw5Dl1Uwe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><span style="font: small-caps 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b>Note </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">B – <span id="xdx_826_zSy2VVPFosvj" style="font-variant: small-caps">Summary of Significant Accounting Policies</span></span></b></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zb9CrLU5wbsf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><span style="font-variant: small-caps"><span> </span> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b>[1]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b><span id="xdx_864_zeTxaWHSzHzb">Principles of Consolidation</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiary, Mirror Worlds Technologies, LLC. All intercompany transactions and balances are eliminated in consolidation.</span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zaUdm6mBDfOa" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[2]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_867_ziEagPGpznwg">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements include revenue recognition, contingent legal fees and related costs, income taxes, valuation of patents and equity method investments, including evaluation of the Company’s basis difference. Actual results could be materially different from those estimates, upon which the carrying values were based.</span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zsDSjl5EqSBf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[3]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_867_zK0xmQ4k6DZd">Cash and Cash Equivalents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_c20211231_pp0p0" title="FDIC insured limit">250,000</span>. At December 31, 2021 and 2020, the Company had $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Cash in excess of FDIC insured limit">8,109,000</span> and $<span id="xdx_909_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20201231_zP8LQHpGYJdi" title="Cash in excess of FDIC insured limit">5,477,000</span>, respectively, in excess of the FDIC insured limit.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.</span></p> <p id="xdx_846_eus-gaap--MarketableSecuritiesPolicy_zCFJ7RIpBWma" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[4]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zvCN3RqYg5i">Marketable Securities</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, fixed income mutual funds, and corporate bonds and notes (see Note G). At December 31, 2021 and December 31, 2020, included in marketable securities, the Company had aggregate certificates of deposit of $<span id="xdx_90B_eus-gaap--CertificatesOfDepositAtCarryingValue_iI_c20211231_zE96KmxRHRic" title="Certificates of deposit"><span style="-sec-ix-hidden: xdx2ixbrl0553">—</span> </span>and $<span id="xdx_90A_eus-gaap--CertificatesOfDepositAtCarryingValue_iI_c20201231_zCVBiYB1yV5k">3,500,000</span>, respectively, at financial institutions that were within the FDIC limit. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.</span></p> <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zIx6Vn8Rv58f" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[5]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zeRkc9pALrF3">Revenue Recognition</span></b></span></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company determines revenue recognition through the follow steps:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identification of the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identification of the performance obligations in the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">determination of the consideration for the license;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">allocation of the transaction price to the performance obligations in the contract; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">recognition of revenue when the Company satisfies its performance obligations.</span></td></tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue disaggregated by source is as follows:</span></p> <table cellpadding="3" cellspacing="0" id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zVZIfDAB1apj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="display: none; text-align: left; padding-left: 25pt"><span id="xdx_8B1_zILMBtHEIQQd">Schedule of disaggregation of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: right"> </td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="vertical-align: top; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt; width: 54%">Fully-Paid Licenses</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_fKDEp_z7bVMCrEVLG5" style="vertical-align: bottom; width: 15%; text-align: right">17,000,000</td><td style="vertical-align: top; width: 1%; text-align: left"><sup>(1)</sup></td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_zD1xErCWpHEd" style="width: 15%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="letter-spacing: -0.2pt"><span style="-sec-ix-hidden: xdx2ixbrl0567">—</span></span></span></td><td style="vertical-align: top; width: 1%; text-align: left"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt">Royalty Bearing Licenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDIp_zrhk14rA2Rcd" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">19,029,000</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"><sup>(2)</sup></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDMp_z9xsUbGqpeQ5" style="border-bottom: Black 1pt solid; text-align: right">4,403,000</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"><sup>(3)</sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20210101__20211231_z8ManxuKvxda" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Revenue">36,029,000</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"><sup> </sup></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20200101__20201231_zh5UOOVKjTZi" style="border-bottom: Black 2.5pt double; text-align: right">4,403,000</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"><sup> </sup></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">__________________________</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F0A_zlX3ilVVUDsg" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span id="xdx_F1D_zryeKTScFh32" style="font: 10pt Times New Roman, Times, Serif">Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F09_zouSsTxUI4th" style="font: 10pt Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span id="xdx_F1B_zIH8rFKudE5l" style="font: 10pt Times New Roman, Times, Serif">Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F03_zYln0nOEmiEb" style="font: 10pt Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span id="xdx_F12_zRUCLPyyUJpj" style="font: 10pt Times New Roman, Times, Serif">Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.</span></td></tr></table> <p id="xdx_8A0_zPaGS8Xbkoua" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company relied on royalty reports received from third party licensees to record its revenue. From time to time, the Company may audit or otherwise dispute royalties reported from licensees. Any adjusted royalty revenue as a result of such audits or dispute is recorded by the Company in the period in which such adjustment is agreed to by the Company and the licensee or otherwise determined.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue from the Company’s patent licensing business is generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license (a “Fully-Paid License”), or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent (a “Royalty Bearing License”).</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s license agreements, both Fully-Paid Licenses and Royalty Bearing Licenses, typically include some combination of the following: (i) the grant of a non-exclusive license to manufacture and/or sell products covered by its patented technologies; (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted pursuant to these licenses typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company typically has no further performance obligations with respect to the grant of the non-exclusive licenses. Generally, the license agreements provide for the grant of the licenses, releases, and other obligations following execution of the agreement and the receipt of the up-front lump sum payment for a Fully-Paid License or a license initiation fee for a Royalty Bearing License.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes revenue from their Royalty Bearing Licenses in a manner consistent with the legal form of the arrangement, and in accordance with the royalty recognition constraint that applies to licenses of IP for which some or all of the consideration is in the form of sales or usage based royalty. Consequently, the Company recognizes revenue at the later of when (1) the subsequent sale occurs or (2) the performance obligation to which some or all of the sales based royalty has been satisfied.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Non-Refundable Up-Front Fees: Fully-Paid Licenses provide for a non-refundable up-front payment, for which the Company has no future obligations or performance requirements, revenue is generally recognized when the Company has obtained the signed license agreement, all performance obligations have been substantially performed, amounts are fixed and determinable, and collectability is reasonably assured. Revenue from Fully-Paid Licenses may consist of one or more installments. The timing and amount of revenue recognized from each licensee depends upon a number of factors including the specific terms of each agreement and the nature of the deliverables and obligations.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_eus-gaap--EquityMethodInvestmentsPolicy_zQU9eQChIIng" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[6]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86D_zm6QA6kZkEf6">Equity Method Investments</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, <i>Investments — Equity Method and Joint Ventures</i> (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized. Upon sale of equity method investments, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss.</span></p> <p id="xdx_843_ecustom--PatentsPolicyTextBlock_zpw6IE2DIA46" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[7]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_866_zZ1dm2JCNdfe">Patents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents. </span></p> <p id="xdx_84E_eus-gaap--CostOfSalesPolicyTextBlock_zh6f5rOV02jf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[8]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zLcFpmQIAlmj">Costs of Revenue and Related Costs</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company includes in costs of revenue for the year ended December 31, 2021 and 2020 contingent legal fees payable to patent litigation counsel, any other contractual payments related to net proceeds from settlements (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended December 31, 2020, the Company had a change in estimate related to accrued contingency fees and related costs. The change was the result of the Company receiving new information reflecting additional legal costs in connection with certain contingent litigation. The effect of this change in estimate for the year ended December 31, 2020 was an increase in professional fees and related costs of $<span id="xdx_909_ecustom--IncreaseInProfessionalFeesAndRelatedCosts_pp0p0_c20200101__20201231_zPFxjexL8KMa" title="Increase in professional fees and related costs">886,000</span> and a corresponding increase in our operating loss and net loss of $<span id="xdx_903_ecustom--IncreaseOperatingLossAndNetLoss_pp0p0_c20200101__20201231_zQ4elata2lf6" title="Increase operating loss and net loss">886,000</span>, and a decrease in basic and diluted earnings per share of $<span id="xdx_90D_ecustom--DecreaseInBasicAndDilutedEarningsPerShare_pp2d_c20200101__20201231_zUeNPd9fHMni" title="Decrease in basic and diluted earnings per share">0.04</span> per share.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[9]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86D_zcH2OHuseaN3">Income Taxes</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ASC 740-10, <i>Accounting for Uncertainty in Income Taxes</i>, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2021 and 2020.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">U.S. federal, state and local income tax returns prior to 2018 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.</span></p> <p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zbAD5gYPyqui" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[10]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_867_zpf266Pjgpph">Stock-Based Compensation</span></b></span></td></tr></table> <p style="font: 10pt/11.05pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, <i>Compensation </i><b>—</b> <i>Stock Compensation </i>(“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income based on their grant date fair values. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.</span></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_ztFwDrcYej6f" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[11]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_z5VYxxKgrEU6">Earnings Per Share</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.</span></p> <p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zO4fx5zzIQA3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[12]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86D_zS311fXFt668">Fair Value Measurements</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There are three levels of inputs that may be used to measure fair value:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The carrying value of the Company’s financial instruments, including cash and cash equivalents, royalty receivable, other assets, accounts payable, and accrued expenses approximates fair value because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s equity investment in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held development stage biotechnology company, is measured on a non-recurring basis and is classified within Level 3 as it is valued using significant unobservable inputs or data in an inactive market, and the valuation requires management judgment due to the absence of market price and inherent lack of liquidity.</span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zSkjFTSjNul7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[13]</b></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86C_zUgg6jVHDzj7">Carrying Value, Recoverability and Impairment of Long-Lived Assets</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 10pt 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2021 and 2020, there was no impairment to the Company’s patents and equity investment.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.</span></p> <p id="xdx_84C_eus-gaap--PolicyholdersDividendPolicy_zl90HNYCcMxl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>[14]</b></span></td><td><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zQRLlNQPTVPb">Dividend Policy</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).</span></p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKzNT7wwoGna" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[15]</b></span></td><td><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zJr3vzVspJRj">New Accounting Standards</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Income Taxes</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes</i>. The ASU removes certain exceptions for performing intra-period allocation and calculating income taxes in interim periods. It also simplifies the accounting for income taxes by requiring recognition of franchise tax partially based on income as an income-based tax, requiring reflection of enacted changes in tax laws in the interim period and making improvements for income taxes related to employee stock ownership plans. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The adoption of this standard did not have a material effect on its consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Equity Securities</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In January 2020, the FASB issued ASU 2020-01, <i>Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). </i>The ASU amends and clarifies certain interactions between the guidance under Topic 321, Topic 323 and Topic 815, by reducing diversity in practice and increasing comparability of the accounting for these interactions. The amendments in the ASU should be applied on a prospective basis. The ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of this standard did not have a material effect on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"/> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zb9CrLU5wbsf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><b><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><span style="font-variant: small-caps"><span> </span> </span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b>[1]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b><span id="xdx_864_zeTxaWHSzHzb">Principles of Consolidation</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiary, Mirror Worlds Technologies, LLC. All intercompany transactions and balances are eliminated in consolidation.</span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zaUdm6mBDfOa" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[2]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_867_ziEagPGpznwg">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements include revenue recognition, contingent legal fees and related costs, income taxes, valuation of patents and equity method investments, including evaluation of the Company’s basis difference. Actual results could be materially different from those estimates, upon which the carrying values were based.</span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zsDSjl5EqSBf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[3]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_867_zK0xmQ4k6DZd">Cash and Cash Equivalents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution are insured by the FDIC up to $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_c20211231_pp0p0" title="FDIC insured limit">250,000</span>. At December 31, 2021 and 2020, the Company had $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Cash in excess of FDIC insured limit">8,109,000</span> and $<span id="xdx_909_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20201231_zP8LQHpGYJdi" title="Cash in excess of FDIC insured limit">5,477,000</span>, respectively, in excess of the FDIC insured limit.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity of three months or less to be cash equivalents.</span></p> 250000 8109000 5477000 <p id="xdx_846_eus-gaap--MarketableSecuritiesPolicy_zCFJ7RIpBWma" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[4]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zvCN3RqYg5i">Marketable Securities</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from date of purchase, fixed income mutual funds, and corporate bonds and notes (see Note G). At December 31, 2021 and December 31, 2020, included in marketable securities, the Company had aggregate certificates of deposit of $<span id="xdx_90B_eus-gaap--CertificatesOfDepositAtCarryingValue_iI_c20211231_zE96KmxRHRic" title="Certificates of deposit"><span style="-sec-ix-hidden: xdx2ixbrl0553">—</span> </span>and $<span id="xdx_90A_eus-gaap--CertificatesOfDepositAtCarryingValue_iI_c20201231_zCVBiYB1yV5k">3,500,000</span>, respectively, at financial institutions that were within the FDIC limit. The Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit and fixed income mutual funds are recorded in net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.</span></p> 3500000 <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zIx6Vn8Rv58f" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[5]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zeRkc9pALrF3">Revenue Recognition</span></b></span></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company determines revenue recognition through the follow steps:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identification of the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identification of the performance obligations in the license agreement;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">determination of the consideration for the license;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">allocation of the transaction price to the performance obligations in the contract; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.6in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"/><span style="font: 10pt Times New Roman, Times, Serif"/>•</td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">recognition of revenue when the Company satisfies its performance obligations.</span></td></tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue disaggregated by source is as follows:</span></p> <table cellpadding="3" cellspacing="0" id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zVZIfDAB1apj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="display: none; text-align: left; padding-left: 25pt"><span id="xdx_8B1_zILMBtHEIQQd">Schedule of disaggregation of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: right"> </td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="vertical-align: top; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt; width: 54%">Fully-Paid Licenses</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_fKDEp_z7bVMCrEVLG5" style="vertical-align: bottom; width: 15%; text-align: right">17,000,000</td><td style="vertical-align: top; width: 1%; text-align: left"><sup>(1)</sup></td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_zD1xErCWpHEd" style="width: 15%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="letter-spacing: -0.2pt"><span style="-sec-ix-hidden: xdx2ixbrl0567">—</span></span></span></td><td style="vertical-align: top; width: 1%; text-align: left"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt">Royalty Bearing Licenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDIp_zrhk14rA2Rcd" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">19,029,000</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"><sup>(2)</sup></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDMp_z9xsUbGqpeQ5" style="border-bottom: Black 1pt solid; text-align: right">4,403,000</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"><sup>(3)</sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20210101__20211231_z8ManxuKvxda" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Revenue">36,029,000</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"><sup> </sup></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20200101__20201231_zh5UOOVKjTZi" style="border-bottom: Black 2.5pt double; text-align: right">4,403,000</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"><sup> </sup></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">__________________________</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F0A_zlX3ilVVUDsg" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span id="xdx_F1D_zryeKTScFh32" style="font: 10pt Times New Roman, Times, Serif">Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F09_zouSsTxUI4th" style="font: 10pt Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span id="xdx_F1B_zIH8rFKudE5l" style="font: 10pt Times New Roman, Times, Serif">Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F03_zYln0nOEmiEb" style="font: 10pt Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span id="xdx_F12_zRUCLPyyUJpj" style="font: 10pt Times New Roman, Times, Serif">Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.</span></td></tr></table> <p id="xdx_8A0_zPaGS8Xbkoua" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company relied on royalty reports received from third party licensees to record its revenue. From time to time, the Company may audit or otherwise dispute royalties reported from licensees. Any adjusted royalty revenue as a result of such audits or dispute is recorded by the Company in the period in which such adjustment is agreed to by the Company and the licensee or otherwise determined.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue from the Company’s patent licensing business is generated from negotiated license agreements. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a non-refundable lump sum payment for a non-exclusive fully-paid license (a “Fully-Paid License”), or (ii) a non-refundable lump sum payment (license initiation fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent (a “Royalty Bearing License”).</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s license agreements, both Fully-Paid Licenses and Royalty Bearing Licenses, typically include some combination of the following: (i) the grant of a non-exclusive license to manufacture and/or sell products covered by its patented technologies; (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted pursuant to these licenses typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company typically has no further performance obligations with respect to the grant of the non-exclusive licenses. Generally, the license agreements provide for the grant of the licenses, releases, and other obligations following execution of the agreement and the receipt of the up-front lump sum payment for a Fully-Paid License or a license initiation fee for a Royalty Bearing License.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes revenue from their Royalty Bearing Licenses in a manner consistent with the legal form of the arrangement, and in accordance with the royalty recognition constraint that applies to licenses of IP for which some or all of the consideration is in the form of sales or usage based royalty. Consequently, the Company recognizes revenue at the later of when (1) the subsequent sale occurs or (2) the performance obligation to which some or all of the sales based royalty has been satisfied.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Non-Refundable Up-Front Fees: Fully-Paid Licenses provide for a non-refundable up-front payment, for which the Company has no future obligations or performance requirements, revenue is generally recognized when the Company has obtained the signed license agreement, all performance obligations have been substantially performed, amounts are fixed and determinable, and collectability is reasonably assured. Revenue from Fully-Paid Licenses may consist of one or more installments. The timing and amount of revenue recognized from each licensee depends upon a number of factors including the specific terms of each agreement and the nature of the deliverables and obligations.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="3" cellspacing="0" id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zVZIfDAB1apj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="display: none; text-align: left; padding-left: 25pt"><span id="xdx_8B1_zILMBtHEIQQd">Schedule of disaggregation of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: right"> </td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="vertical-align: top; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: left; padding-bottom: 1pt; font-weight: bold; vertical-align: top"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt; width: 54%">Fully-Paid Licenses</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_fKDEp_z7bVMCrEVLG5" style="vertical-align: bottom; width: 15%; text-align: right">17,000,000</td><td style="vertical-align: top; width: 1%; text-align: left"><sup>(1)</sup></td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--FullyPaidLicensesMember_zD1xErCWpHEd" style="width: 15%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="letter-spacing: -0.2pt"><span style="-sec-ix-hidden: xdx2ixbrl0567">—</span></span></span></td><td style="vertical-align: top; width: 1%; text-align: left"><sup> </sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt">Royalty Bearing Licenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDIp_zrhk14rA2Rcd" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">19,029,000</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"><sup>(2)</sup></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--RoyaltyBearingLicensesMember_fKDMp_z9xsUbGqpeQ5" style="border-bottom: Black 1pt solid; text-align: right">4,403,000</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"><sup>(3)</sup></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 25pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20210101__20211231_z8ManxuKvxda" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Revenue">36,029,000</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"><sup> </sup></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20200101__20201231_zh5UOOVKjTZi" style="border-bottom: Black 2.5pt double; text-align: right">4,403,000</td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"><sup> </sup></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">__________________________</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F0A_zlX3ilVVUDsg" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span id="xdx_F1D_zryeKTScFh32" style="font: 10pt Times New Roman, Times, Serif">Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F09_zouSsTxUI4th" style="font: 10pt Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span id="xdx_F1B_zIH8rFKudE5l" style="font: 10pt Times New Roman, Times, Serif">Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof).</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0.35in"/><td style="width: 0.25in"><span id="xdx_F03_zYln0nOEmiEb" style="font: 10pt Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span id="xdx_F12_zRUCLPyyUJpj" style="font: 10pt Times New Roman, Times, Serif">Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.</span></td></tr></table> 17000000 19029000 4403000 36029000 4403000 <p id="xdx_841_eus-gaap--EquityMethodInvestmentsPolicy_zQU9eQChIIng" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[6]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86D_zm6QA6kZkEf6">Equity Method Investments</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equity method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, <i>Investments — Equity Method and Joint Ventures</i> (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized. Upon sale of equity method investments, the difference between sales proceeds and the carrying amount of the equity investment is recognized in profit or loss.</span></p> <p id="xdx_843_ecustom--PatentsPolicyTextBlock_zpw6IE2DIA46" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[7]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_866_zZ1dm2JCNdfe">Patents</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents. </span></p> <p id="xdx_84E_eus-gaap--CostOfSalesPolicyTextBlock_zh6f5rOV02jf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[8]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zLcFpmQIAlmj">Costs of Revenue and Related Costs</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company includes in costs of revenue for the year ended December 31, 2021 and 2020 contingent legal fees payable to patent litigation counsel, any other contractual payments related to net proceeds from settlements (see Note I[1] hereof) and incentive bonus compensation payable to its Chairman and Chief Executive Officer.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended December 31, 2020, the Company had a change in estimate related to accrued contingency fees and related costs. The change was the result of the Company receiving new information reflecting additional legal costs in connection with certain contingent litigation. The effect of this change in estimate for the year ended December 31, 2020 was an increase in professional fees and related costs of $<span id="xdx_909_ecustom--IncreaseInProfessionalFeesAndRelatedCosts_pp0p0_c20200101__20201231_zPFxjexL8KMa" title="Increase in professional fees and related costs">886,000</span> and a corresponding increase in our operating loss and net loss of $<span id="xdx_903_ecustom--IncreaseOperatingLossAndNetLoss_pp0p0_c20200101__20201231_zQ4elata2lf6" title="Increase operating loss and net loss">886,000</span>, and a decrease in basic and diluted earnings per share of $<span id="xdx_90D_ecustom--DecreaseInBasicAndDilutedEarningsPerShare_pp2d_c20200101__20201231_zUeNPd9fHMni" title="Decrease in basic and diluted earnings per share">0.04</span> per share.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[9]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86D_zcH2OHuseaN3">Income Taxes</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes (ASC 740), which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ASC 740-10, <i>Accounting for Uncertainty in Income Taxes</i>, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2021 and 2020.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">U.S. federal, state and local income tax returns prior to 2018 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.</span></p> 886000 886000 0.04 <p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zbAD5gYPyqui" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[10]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_867_zpf266Pjgpph">Stock-Based Compensation</span></b></span></td></tr></table> <p style="font: 10pt/11.05pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, <i>Compensation </i><b>—</b> <i>Stock Compensation </i>(“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income based on their grant date fair values. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.</span></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_ztFwDrcYej6f" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[11]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_z5VYxxKgrEU6">Earnings Per Share</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.</span></p> <p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zO4fx5zzIQA3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[12]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86D_zS311fXFt668">Fair Value Measurements</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There are three levels of inputs that may be used to measure fair value:</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The carrying value of the Company’s financial instruments, including cash and cash equivalents, royalty receivable, other assets, accounts payable, and accrued expenses approximates fair value because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s equity investment in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held development stage biotechnology company, is measured on a non-recurring basis and is classified within Level 3 as it is valued using significant unobservable inputs or data in an inactive market, and the valuation requires management judgment due to the absence of market price and inherent lack of liquidity.</span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zSkjFTSjNul7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[13]</b></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86C_zUgg6jVHDzj7">Carrying Value, Recoverability and Impairment of Long-Lived Assets</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 10pt 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December 31, 2021 and 2020, there was no impairment to the Company’s patents and equity investment.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.</span></p> <p id="xdx_84C_eus-gaap--PolicyholdersDividendPolicy_zl90HNYCcMxl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>[14]</b></span></td><td><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zQRLlNQPTVPb">Dividend Policy</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid (see Note O hereof).</span></p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKzNT7wwoGna" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[15]</b></span></td><td><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zJr3vzVspJRj">New Accounting Standards</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Income Taxes</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes</i>. The ASU removes certain exceptions for performing intra-period allocation and calculating income taxes in interim periods. It also simplifies the accounting for income taxes by requiring recognition of franchise tax partially based on income as an income-based tax, requiring reflection of enacted changes in tax laws in the interim period and making improvements for income taxes related to employee stock ownership plans. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The adoption of this standard did not have a material effect on its consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Equity Securities</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In January 2020, the FASB issued ASU 2020-01, <i>Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). </i>The ASU amends and clarifies certain interactions between the guidance under Topic 321, Topic 323 and Topic 815, by reducing diversity in practice and increasing comparability of the accounting for these interactions. The amendments in the ASU should be applied on a prospective basis. The ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of this standard did not have a material effect on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"/> <p id="xdx_80A_ecustom--PatentsTextBlock_zsVfQV13Z9Ki" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><span style="font: small-caps 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b>Note C – <span id="xdx_822_zTY0eahzRT9i">Patents</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s intangible assets at December 31, 2021 include patents with estimated remaining economic useful lives ranging from <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zHXmNaqcKJ2e" title="Estimated remaining economic useful of patents">1.50</span> to <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_zzCfBnHkIHTb" title="Estimated remaining economic useful of patents">12.33</span> years. For all periods presented, all the Company’s patents were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of December 31, 2021 and 2020 were as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_za12GUcT1gBb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Patents (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_z4Eii7qX5c3c" style="display: none">Schedule of patent</span></td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20211231_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--PatentsMember" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20201231_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--PatentsMember" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span/></td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2021</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 27pt">Gross carrying amount</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7,949,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7,848,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 27pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,565,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,270,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 27pt">Patents, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,384,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,578,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zlkMp6YyZ7Kk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amortization expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_903_eus-gaap--AmortizationOfFinancingCosts_pp0p0_c20210101__20211231_zSIKO2beEf1i" title="Amortization expense">295,000</span> and $<span id="xdx_909_eus-gaap--AmortizationOfFinancingCosts_c20200101__20201231_pp0p0" title="Amortization expense">292,000</span>, respectively. Future amortization of current intangible assets, net is as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zwrK5HzNcSM8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - Patents (Details 1)"> <tr style="vertical-align: bottom"> <td style="display: none; text-align: left; padding-bottom: 1pt"><span id="xdx_8BD_zmJV8WDZFqJ5">Schedule of future amortization of current intangible</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20211231" style="text-align: right"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span style="text-decoration: underline">For the years ended December 31,</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom"> <td style="width: 44%; text-align: left">2022</td><td style="width: 1%; text-align: left"> </td><td style="width: 28%"> </td> <td style="width: 2%; text-align: left">$</td><td style="width: 24%; text-align: right">301,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">2023</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">236,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2026 and thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">667,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,384,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_z9gKdVqx7Dvc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s Remote Power Patent expired on March 7, 2020. All patents within our Mirror Worlds Patent Portfolio and QoS Patents have also expired. All patents within the Cox Patent Portfolio expired in September 2021 except for two patents which expire in <span id="xdx_90A_ecustom--ExpirationDatesOfPatentsWithinCoxPatentPortfolio_c20210101__20211231__srt--RangeAxis__srt--MinimumMember" title="Expiration dates of the patents within the Cox patent portfolio">July 2023</span> and <span id="xdx_908_ecustom--ExpirationDatesOfPatentsWithinCoxPatentPortfolio_c20210101__20211231__srt--RangeAxis__srt--MaximumMember" title="Expiration dates of the patents within the Cox patent portfolio">November 2023</span>. The expiration dates of patents within the Company’s M2M/IoT Patent Portfolio range from <span id="xdx_902_ecustom--ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio_c20210101__20211231__srt--RangeAxis__srt--MinimumMember" title="Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio">September 2033</span> to <span id="xdx_900_ecustom--ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio_c20210101__20211231__srt--RangeAxis__srt--MaximumMember" title="Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio">May 2034</span><b>.</b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b> </b></span></p> P1Y6M P12Y3M29D <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_za12GUcT1gBb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Patents (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_z4Eii7qX5c3c" style="display: none">Schedule of patent</span></td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20211231_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--PatentsMember" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20201231_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--PatentsMember" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span/></td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2021</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 27pt">Gross carrying amount</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7,949,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7,848,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 27pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,565,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,270,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 27pt">Patents, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,384,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,578,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 7949000 7848000 -6565000 -6270000 1384000 1578000 295000 292000 <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zwrK5HzNcSM8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - Patents (Details 1)"> <tr style="vertical-align: bottom"> <td style="display: none; text-align: left; padding-bottom: 1pt"><span id="xdx_8BD_zmJV8WDZFqJ5">Schedule of future amortization of current intangible</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20211231" style="text-align: right"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span style="text-decoration: underline">For the years ended December 31,</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom"> <td style="width: 44%; text-align: left">2022</td><td style="width: 1%; text-align: left"> </td><td style="width: 28%"> </td> <td style="width: 2%; text-align: left">$</td><td style="width: 24%; text-align: right">301,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">2023</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">236,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2026 and thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">667,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,384,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 301000 236000 90000 90000 667000 1384000 July 2023 November 2023 September 2033 May 2034 <p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zn1VWsUkdAka" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note D – Income (<span id="xdx_820_z9AzjjOt73j4">Loss) Per Share</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during the period. Diluted per share data included the dilutive effects of stock options and restricted stock units. Potential shares of <span id="xdx_905_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zdJosnegn2wj" title="Potentially Dilutive Shares">12,500</span> and <span id="xdx_902_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_z5MS54uLeG89" title="Potentially Dilutive Shares">662,500</span> at December 31, 2021 and 2020, respectively, consist of options and restricted stock units. Computations of basic and diluted weighted average common shares outstanding are as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zqIOS37SPkg8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Loss Per Share (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zzctV0Y2GPrj" style="display: none">Schedule of Earnings per share</span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20210101_20211231" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20200101_20201231" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Weighted-average common shares <br/> outstanding – basic</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">24,136,821</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">24,011,354</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i_pdd" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Dilutive effect of stock options and </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">restricted stock units</span></p></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">393,747</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0674">—</span></span></p></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--WeightedaverageCommonSharesOutstandingDiluted_zGvuz5jH7vy5" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Weighted-average common shares <br/> outstanding – diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">24,530,568</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">24,011,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Stock option and restricted stock units <br/> excluded from the computation of diluted <br/> income per share because the effect of <br/> inclusion would have been anti-dilutive</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">662,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b> </b></span></p> <p id="xdx_8A0_zjf3mnOLnZKa" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b> </b></span></p> 12500 662500 <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zqIOS37SPkg8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Loss Per Share (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zzctV0Y2GPrj" style="display: none">Schedule of Earnings per share</span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20210101_20211231" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20200101_20201231" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Weighted-average common shares <br/> outstanding – basic</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">24,136,821</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">24,011,354</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i_pdd" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Dilutive effect of stock options and </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">restricted stock units</span></p></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">393,747</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0674">—</span></span></p></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--WeightedaverageCommonSharesOutstandingDiluted_zGvuz5jH7vy5" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Weighted-average common shares <br/> outstanding – diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">24,530,568</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">24,011,354</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive_i_pdd" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Stock option and restricted stock units <br/> excluded from the computation of diluted <br/> income per share because the effect of <br/> inclusion would have been anti-dilutive</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">662,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 24136821 24011354 393747 24530568 24011354 12500 662500 <p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zVQYUZsa8wG7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note E – <span id="xdx_825_zzs3uG39Gb91">Income Taxes</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Significant components of the income taxes were as follows for the years ended December 31, 2021 and 2020.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z6YvRMhKyWl9" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt"><b> <span id="xdx_8BD_z02Q51KK2bpj" style="display: none">Schedule of components of the income taxes</span></b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" id="xdx_494_20210101__20211231_zRebj1dyk1C4" style="border-bottom: Black 1pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" id="xdx_495_20200101__20201231_ziNmYgcx4sv4" style="border-bottom: Black 1pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1pt; text-align: left"><b> </b></td></tr> <tr id="xdx_403_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td style="text-align: left">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">   State and local</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">144,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(34,000</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">   Federal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,808,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(430,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">Total Current Tax Expense (Benefit)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,952,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(464,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td style="text-align: left">Deferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">   State and local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">   Federal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,425,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(458,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">Total Deferred Tax Expense (Benefit)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,508,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(490,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">Total Income Taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,460,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(954,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AD_zrLOnDyscGBh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Significant components of deferred tax assets as of December 31, 2021 and 2020 consisted of the following:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zUH7RQVM70qk" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zcvNOxHpLp7a"><b style="display: none">Schedule of components of deferred tax assets </b></span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom"> <td style="width: 56%; text-align: left"><p style="text-indent: -20pt; margin-left: 20pt; margin-top: 0; margin-bottom: 0">Deferred tax assets (liability):<br/> Net operating loss carry forwards</p></td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20211231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carry forwards"><span style="font: 10pt Times New Roman, Times, Serif"><br/><span style="-sec-ix-hidden: xdx2ixbrl0720">—</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20201231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carry forwards">1,665,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 20pt; text-align: left">Deferred Tax Liability<sup>(1)</sup></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--DeferredTaxLiability_iI_pp0p0_c20211231_fKDEp_zmj1S65ol6Ji" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability">(554,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--DeferredTaxLiability_iI_pp0p0_c20201231_fKDEp_zKt8fI44lRu2" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability">(711,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt">Total deferred tax assets (liability)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--DeferredTaxAssetsLiability_pp0p0_c20211231_zsuel8azO2N8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)">(554,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--DeferredTaxAssetsLiability_iI_pp0p0_c20201231_zVkMW95IGEbk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)">954,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">_________________________</span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; margin-bottom: 12pt"> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 3%"><span id="xdx_F04_zGTL1r1psmC" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 97%"><span id="xdx_F16_zkboP3H8drz5" style="font: 10pt Times New Roman, Times, Serif">  Deferred tax liability as a result of a temporary difference related to the Company’s equity method investment.</span></td></tr> </table> <p id="xdx_8AB_zV1rEdEwTFye" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt 27.35pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There was <span id="xdx_901_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_do_c20211231_zHyosDhfB8l2" title="Valuation allowance">no</span> valuation allowance as of December 31, 2021. As of December 31, 2020, the Company relieved a valuation allowance of $<span id="xdx_907_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_do_c20201231_zZoS0eQsN4i4">490,000</span>.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 12pt 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to the net income before income taxes is as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zT668dadXZ9j" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 2)"> <tr style="vertical-align: bottom"> <td><b><span id="xdx_8B1_zX155Nu08ty" style="display: none">Schedule of reconciliation of income tax</span></b></td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Years Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2021</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 9pt">Income tax - statutory rate</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zbWQ4ua5zEO2" title="Income tax - statutory rate">21.00</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20200101__20201231_zBZy8UsYgGoh" style="width: 12%; text-align: right" title="Income tax - statutory rate">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 9pt">Permanent difference</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20210101__20211231_zBmsA6AFl8b2" title="Permanent difference">1.69</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20200101__20201231_zZxm3XLQ4033" style="text-align: right" title="Permanent difference">(5.05</td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 9pt">State and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zWe1TVIKTWli" title="State and other, net">1.11</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20200101__20201231_zCX2fLUtr5O5" style="text-align: right" title="State and other, net">1.48</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 9pt">Valuation allowance on deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20210101__20211231_zMSvteiQDI53" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance on deferred tax assets"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0750">—</span></span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20200101__20201231_zEIweeIqZ3A9" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance on deferred tax assets">18.4</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 20pt">  Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20210101__20211231_zYDaZqPQjE28" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">23.80</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20200101__20201231_zSBSKL7LdRi6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">35.83</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A0_zH5HUQ5sLDG2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">While only the tax returns for the three years ended prior to December 31, 2021 are open for examination for taxes payable for those years, tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent that they generated loss carry-forwards that are available for those future years.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation to be classified as a PHC, it must satisfy two tests: (i) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership Test”) and (ii) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities<br/> <br/> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">and rents (the “Income Test”). During the second half of 2021, based on available information concerning the Company’s shareholder ownership, the Company did not satisfy the Ownership Test and thus the Company was not a PHC for 2021. If the Company were to become a PHC in any future year, we would be subject to an additional 20% tax on our UPHCI. In such event, the Company may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z6YvRMhKyWl9" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt"><b> <span id="xdx_8BD_z02Q51KK2bpj" style="display: none">Schedule of components of the income taxes</span></b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" id="xdx_494_20210101__20211231_zRebj1dyk1C4" style="border-bottom: Black 1pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" id="xdx_495_20200101__20201231_ziNmYgcx4sv4" style="border-bottom: Black 1pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1pt; text-align: left"><b> </b></td></tr> <tr id="xdx_403_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td style="text-align: left">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">   State and local</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">144,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(34,000</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">   Federal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,808,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(430,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">Total Current Tax Expense (Benefit)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,952,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(464,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td style="text-align: left">Deferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">   State and local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">   Federal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,425,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(458,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">Total Deferred Tax Expense (Benefit)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,508,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(490,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_i01_pp0p0" style="vertical-align: bottom"> <td style="text-align: left">Total Income Taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,460,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(954,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 144000 -34000 2808000 -430000 2952000 -464000 83000 -32000 1425000 -458000 1508000 -490000 4460000 -954000 <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zUH7RQVM70qk" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zcvNOxHpLp7a"><b style="display: none">Schedule of components of deferred tax assets </b></span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom"> <td style="width: 56%; text-align: left"><p style="text-indent: -20pt; margin-left: 20pt; margin-top: 0; margin-bottom: 0">Deferred tax assets (liability):<br/> Net operating loss carry forwards</p></td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20211231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carry forwards"><span style="font: 10pt Times New Roman, Times, Serif"><br/><span style="-sec-ix-hidden: xdx2ixbrl0720">—</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20201231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carry forwards">1,665,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 20pt; text-align: left">Deferred Tax Liability<sup>(1)</sup></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--DeferredTaxLiability_iI_pp0p0_c20211231_fKDEp_zmj1S65ol6Ji" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability">(554,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--DeferredTaxLiability_iI_pp0p0_c20201231_fKDEp_zKt8fI44lRu2" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred Tax Liability">(711,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt">Total deferred tax assets (liability)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--DeferredTaxAssetsLiability_pp0p0_c20211231_zsuel8azO2N8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)">(554,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--DeferredTaxAssetsLiability_iI_pp0p0_c20201231_zVkMW95IGEbk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total deferred tax assets (liability)">954,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0 27.35pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">_________________________</span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; margin-bottom: 12pt"> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 3%"><span id="xdx_F04_zGTL1r1psmC" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 97%"><span id="xdx_F16_zkboP3H8drz5" style="font: 10pt Times New Roman, Times, Serif">  Deferred tax liability as a result of a temporary difference related to the Company’s equity method investment.</span></td></tr> </table> 1665000 -554000 -711000 -554000 954000 0 490000 <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zT668dadXZ9j" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Income Taxes (Details 2)"> <tr style="vertical-align: bottom"> <td><b><span id="xdx_8B1_zX155Nu08ty" style="display: none">Schedule of reconciliation of income tax</span></b></td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Years Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2021</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 56%; text-align: left; padding-left: 9pt">Income tax - statutory rate</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zbWQ4ua5zEO2" title="Income tax - statutory rate">21.00</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20200101__20201231_zBZy8UsYgGoh" style="width: 12%; text-align: right" title="Income tax - statutory rate">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 9pt">Permanent difference</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20210101__20211231_zBmsA6AFl8b2" title="Permanent difference">1.69</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20200101__20201231_zZxm3XLQ4033" style="text-align: right" title="Permanent difference">(5.05</td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 9pt">State and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zWe1TVIKTWli" title="State and other, net">1.11</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20200101__20201231_zCX2fLUtr5O5" style="text-align: right" title="State and other, net">1.48</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 9pt">Valuation allowance on deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20210101__20211231_zMSvteiQDI53" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance on deferred tax assets"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0750">—</span></span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20200101__20201231_zEIweeIqZ3A9" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance on deferred tax assets">18.4</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 20pt">  Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20210101__20211231_zYDaZqPQjE28" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">23.80</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20200101__20201231_zSBSKL7LdRi6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">35.83</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 0.2100 0.210 0.0169 -0.0505 0.0111 0.0148 0.184 0.2380 0.3583 <p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zMLZKmYK4KJa" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>N<span style="font-variant: small-caps">ote </span>F – <span style="font-variant: small-caps"><span id="xdx_824_zJCgRP1tDSol">Stockholders’ Equity</span></span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The 2013 Stock Incentive Plan (“2013 Plan”) provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units. Awards under the 2013 Plan may be granted singly, in combination, or in tandem. Subject to standard anti-dilution adjustments as provided, the 2013 Plan provides for an aggregate of 2,600,000 shares of the Company’s common stock to be available for distribution. The Company’s Compensation Committee generally has the authority to administer the 2013 Plan, determine participants who will be granted awards, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2013 Plan may be granted to employees, directors and consultants of the Company and its subsidiaries. As of December 31, 2021, there were <span id="xdx_90C_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20211231__us-gaap--PlanNameAxis__custom--StockIncentivePlanMember_zTzGzD4Ep8Ne" title="Common stock available for issuance">1,837,500</span> shares of common stock available for issuance under the 2013 Plan.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[1]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Restricted Stock Units</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A summary of restricted stock units granted during the years ended December 31, 2021 and December 31, 2020 is as follows (each restricted stock unit represents the contingent right to receive one share of the Company’s common stock):</span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zZGh5XGTfQa3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><b><span id="xdx_8BC_zU0b04ZT8cci" style="display: none">Schedule of Restricted Stock Units</span></b></td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number</p> <p style="margin-top: 0; margin-bottom: 0">of Shares</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number</p> <p style="margin-top: 0; margin-bottom: 0">of Shares</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Balance of restricted stock units outstanding at beginning of year</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20211231_zh9LMqb7Uz94" style="width: 10%; text-align: right" title="Restricted stock, Outstanding Number of shares, Beginning Balance">162,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231_zuZCW5Vj4Yt8" style="width: 10%; text-align: right" title="Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance">2.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20200101__20201231_zw7JV4ECXe6k" style="width: 10%; text-align: right" title="Restricted stock, Outstanding Number of shares, Beginning Balance">340,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20200101__20201231_zeH8d1BYJ8Yf" style="width: 10%; text-align: right" title="Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance">2.15</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Grants of restricted stock units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20210101__20211231_zx3QL2RbDar" style="text-align: right" title="Grants of restricted stock units">45,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--IssuanceWeightedaverageGrantDateFairValue_pid_c20210101__20211231_zJCQ40eWTNUg" style="text-align: right" title="Grants of restricted stock units, Weighted Average Grant Date Fair Value">3.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20200101__20201231_zGLEGDrQqhu6" style="text-align: right" title="Grants of restricted stock units">70,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--IssuanceWeightedaverageGrantDateFairValue_c20200101__20201231_pdd" style="text-align: right" title="Grants of restricted stock units, Weighted Average Grant Date Fair Value">2.68</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif">Vested restricted stock units<sup>(1)</sup></span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20211231_z73MKiQ5BAtd" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units">(195,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_pid_di_c20210101__20211231_zn5gTQcP0cMh" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units, Weighted Average Grant Date Fair Value">(2.47</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231_zQeye3A2KO1c" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units">(247,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_pid_di_c20200101__20201231_zws59xNPO387" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units, Weighted Average Grant Date Fair Value">(2.23</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Balance of restricted stock units outstanding at end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20211231_z18CBgNwSwXf" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Resricted stock, Outstanding Number of shares, Ending Balance">12,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20211231_zJJivqzeOinb" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance">3.36</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20200101__20201231_zJUwYSt5OXi5" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Resricted stock, Outstanding Number of shares, Ending Balance">162,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20200101__20201231_zgultZqPNGR5" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance">2.25</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 27pt"/><td style="width: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">__________________________</span></td><td/></tr></table> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(1)       Includes 125,000 shares of common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer which vested on July 14, 2021 and settled on March 11, 2022.</span></p> <p id="xdx_8AA_zkhz86TSMDG6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Restricted stock unit compensation expense was $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zakqyAeEmesb" title="Restricted stock unit compensation expense">238,000</span> for the year ended December 31, 2021 and $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Restricted stock unit compensation expense">302,000</span> for the year ended December 31, 2020.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company has an aggregate of $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Unrecognized restricted stock unit compensation expense">42,000 </span>of unrecognized restricted stock unit compensation expense as of December 31, 2021 to be expensed over a weighted average period of <span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcWXOEL26ZRf" title="Weighted average amortized period">0.99</span> years.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based awards.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All of the Company’s issued restricted stock units have dividend equivalent rights. As of December 31, 2021 and 2020, there was $<span id="xdx_90B_ecustom--AccruedDividendRightsOnRestrictedStockUnit_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Accrued dividend rights on restricted stock unit">72,000</span> and $<span id="xdx_909_ecustom--AccruedDividendRightsOnRestrictedStockUnit_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Accrued dividend rights on restricted stock unit">53,000</span> accrued for dividend equivalent rights which were included in other accrued expenses.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b>[2]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.2pt"><b>Stock Options</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At December 31, 2021, one stock option to purchase 500,000 shares of common stock was outstanding representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan). The one stock option has a weighted average exercise price of $1.19 and a weighted average remaining life of 0.84 years. There were no grants of stock options during the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt/11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes stock option activity for the years ended December 31:</span></p> <p style="font: 10pt/9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="3" id="xdx_885_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJJRrJNKtD3l" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zKIIut5OzFng" style="display: none">Schedule of stock option activity</span></td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2021</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Options</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Options</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Options outstanding <br/> at beginning of year</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1jruzA6z78j" style="width: 10%; text-align: right" title="Option outstanding, beginning balance">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1wJ0PsGa4ul" style="width: 10%; text-align: right" title="Outstanding exercise price">1.19</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ze9Nzereubi5" style="width: 10%; text-align: right" title="Option outstanding, beginning balance">605,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zN1J1hcK3dXb" style="width: 10%; text-align: right" title="Outstanding exercise price">1.39</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0827">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0829">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0831">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0833">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl0835">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Expired"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0837">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl0839">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Expired"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0841">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBp2JGcYH8Td" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0843">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0845">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqKWPOKNfz2k" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised">(105,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised">2.34</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Options outstanding at end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzMoQP8UB3Mc" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding, ending balance">500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyxUu2u67OK3" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding exercise price, at end of year">1.19</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvzeDp3pTHNe" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding, ending balance">500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqTquTB1DN9d" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding exercise price, at end of year">1.19</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Options exercisable at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zM8Hnl0LFVu4" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercise price at end of year">1.19</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zIXwS5yomosc" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercise price at end of year">1.19</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zXZ8DYZyrFbj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended December 31, 2021 and 2020, the Company did not recognize any stock-based compensation related to the vesting of prior issued stock options to employees and directors. The Company at December 31, 2021 and 2020 had no remaining unrecognized expenses related to unvested stock options to employees and directors. The aggregate intrinsic value of all stock options exercisable at December 31, 2021 and 2020 was $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20211231_pp0p0" title="Aggregate intrinsic value of options exercisable">815,000</span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20201231_pp0p0" title="Aggregate intrinsic value of options exercisable">1,250,000</span>, respectively.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended December 31, 2020, stock options to purchase an aggregate of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20200101__20201231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember__srt--TitleOfIndividualAxis__custom--DirectorsThreeMember_zWK8rGLSf2xb" title="Stock options exercised to purchase shares on cashless basis">105,000</span> shares of the Company’s Common Stock at an exercise price of $<span id="xdx_904_ecustom--StockBasedCompensationExercisePrice_pp2d_c20200101__20201231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember__srt--TitleOfIndividualAxis__custom--DirectorsThreeMember_zmedfCnSlwAc" title="Exercise price">2.34</span> per share were exercised on net exercise (cashless basis) by each of the Company’s three outside directors. With respect to the net exercise (cashless) of these stock options, <span id="xdx_90B_ecustom--AggregateNetSharesIssued_pid_c20200101__20201231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember__srt--TitleOfIndividualAxis__custom--DirectorsThreeMember_z2IX8b8FEni6" title="Aggregate net shares issued">4,707</span> aggregate net shares were delivered to the outside directors.</span></p> 1837500 <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zZGh5XGTfQa3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><b><span id="xdx_8BC_zU0b04ZT8cci" style="display: none">Schedule of Restricted Stock Units</span></b></td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number</p> <p style="margin-top: 0; margin-bottom: 0">of Shares</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number</p> <p style="margin-top: 0; margin-bottom: 0">of Shares</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-Average Grant<br/> Date Fair Value</span></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Balance of restricted stock units outstanding at beginning of year</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20211231_zh9LMqb7Uz94" style="width: 10%; text-align: right" title="Restricted stock, Outstanding Number of shares, Beginning Balance">162,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231_zuZCW5Vj4Yt8" style="width: 10%; text-align: right" title="Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance">2.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20200101__20201231_zw7JV4ECXe6k" style="width: 10%; text-align: right" title="Restricted stock, Outstanding Number of shares, Beginning Balance">340,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20200101__20201231_zeH8d1BYJ8Yf" style="width: 10%; text-align: right" title="Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance">2.15</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Grants of restricted stock units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20210101__20211231_zx3QL2RbDar" style="text-align: right" title="Grants of restricted stock units">45,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--IssuanceWeightedaverageGrantDateFairValue_pid_c20210101__20211231_zJCQ40eWTNUg" style="text-align: right" title="Grants of restricted stock units, Weighted Average Grant Date Fair Value">3.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20200101__20201231_zGLEGDrQqhu6" style="text-align: right" title="Grants of restricted stock units">70,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--IssuanceWeightedaverageGrantDateFairValue_c20200101__20201231_pdd" style="text-align: right" title="Grants of restricted stock units, Weighted Average Grant Date Fair Value">2.68</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif">Vested restricted stock units<sup>(1)</sup></span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20211231_z73MKiQ5BAtd" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units">(195,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_pid_di_c20210101__20211231_zn5gTQcP0cMh" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units, Weighted Average Grant Date Fair Value">(2.47</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231_zQeye3A2KO1c" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units">(247,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_iN_pid_di_c20200101__20201231_zws59xNPO387" style="border-bottom: Black 1pt solid; text-align: right" title="Vested restricted stock units, Weighted Average Grant Date Fair Value">(2.23</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Balance of restricted stock units outstanding at end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20211231_z18CBgNwSwXf" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Resricted stock, Outstanding Number of shares, Ending Balance">12,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20211231_zJJivqzeOinb" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance">3.36</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20200101__20201231_zJUwYSt5OXi5" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Resricted stock, Outstanding Number of shares, Ending Balance">162,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20200101__20201231_zgultZqPNGR5" style="border-bottom: Black 1pt solid; text-align: right" title="Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance">2.25</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 27pt"/><td style="width: 18pt"><span style="font: 10pt Times New Roman, Times, Serif">__________________________</span></td><td/></tr></table> <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(1)       Includes 125,000 shares of common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer which vested on July 14, 2021 and settled on March 11, 2022.</span></p> 162500 2.25 340000 2.15 45000 3.51 70000 2.68 195000 2.47 247500 2.23 12500 3.36 162500 2.25 238000 302000 42000 P0Y11M26D 72000 53000 <table cellpadding="0" cellspacing="3" id="xdx_885_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJJRrJNKtD3l" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zKIIut5OzFng" style="display: none">Schedule of stock option activity</span></td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2021</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Options</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Options</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Options outstanding <br/> at beginning of year</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1jruzA6z78j" style="width: 10%; text-align: right" title="Option outstanding, beginning balance">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1wJ0PsGa4ul" style="width: 10%; text-align: right" title="Outstanding exercise price">1.19</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ze9Nzereubi5" style="width: 10%; text-align: right" title="Option outstanding, beginning balance">605,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zN1J1hcK3dXb" style="width: 10%; text-align: right" title="Outstanding exercise price">1.39</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0827">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0829">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0831">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Granted"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0833">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl0835">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Expired"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0837">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pn3d" style="text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl0839">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Expired"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0841">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBp2JGcYH8Td" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0843">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0845">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqKWPOKNfz2k" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised">(105,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised">2.34</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Options outstanding at end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzMoQP8UB3Mc" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding, ending balance">500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyxUu2u67OK3" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding exercise price, at end of year">1.19</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvzeDp3pTHNe" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding, ending balance">500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqTquTB1DN9d" style="border-bottom: Black 1pt solid; text-align: right" title="Option outstanding exercise price, at end of year">1.19</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Options exercisable at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zM8Hnl0LFVu4" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercise price at end of year">1.19</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercisable at end of year">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zIXwS5yomosc" style="border-bottom: Black 2.5pt double; text-align: right" title="Option exercise price at end of year">1.19</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 500000 1.19 605000 1.39 105000 2.34 500000 1.19 500000 1.19 500000 1.19 500000 1.19 815000 1250000 105000 2.34 4707 <p id="xdx_80B_ecustom--MarketableSecuritiesDisclosureTextBlock_zKo14tXnf6lj" style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note G – <span id="xdx_82D_zhJMvCQynwBe">Marketable Securities</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Marketable securities as of December 31, 2021 and 2020 were composed of: </span></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--MarketableSecuritiesTextBlock_zrFYc9BR6i03" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Securities (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B6_zPBBcejTFqNb" style="display: none">Schedule of Marketable Securities</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Gains</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Losses</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Fixed income mutual funds</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds">14,462,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="-sec-ix-hidden: xdx2ixbrl0886">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds">(137,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ShortTermBondFunds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds">14,325,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Corporate bonds and notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">813,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="-sec-ix-hidden: xdx2ixbrl0894">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">(12,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--CorporateBonds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">801,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_zbzaDJkFwiwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">15,275,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_zDtm0AlzFdUd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0902">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_zXcwnQb68WA4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">(149,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_zq7h6aSQ4F73" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">15,126,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt/11.05pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Gains</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Losses</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; padding-left: 5.4pt">Certificates of deposit</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit">3,534,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit">7,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit"><span style="-sec-ix-hidden: xdx2ixbrl0912">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit">3,541,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Fixed income mutual funds</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShortTermBondFunds_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_z8YI0zQDfoF4" style="text-align: right">11,255,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShortTermBondFunds_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_zJXXtTmrND55" style="text-align: right">80,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShortTermBondFunds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="-sec-ix-hidden: xdx2ixbrl0918">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShortTermBondFunds_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="text-align: right" title="Fixed income mutual funds">11,335,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Corporate bonds and notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--CorporateBonds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">4,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--CorporateBonds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">18,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CorporateBonds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">(28,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CorporateBonds_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">4,490,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_zS709JDDXEr" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">19,289,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_zheACVcsVQd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">105,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_zlrwW9P93uI5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">(28,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_zj3RD0zG2T53" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">19,366,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_z7lnr4Xu7Ibf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--MarketableSecuritiesTextBlock_zrFYc9BR6i03" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Securities (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B6_zPBBcejTFqNb" style="display: none">Schedule of Marketable Securities</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Gains</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Losses</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Fixed income mutual funds</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds">14,462,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds"><span style="-sec-ix-hidden: xdx2ixbrl0886">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShortTermBondFunds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds">(137,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ShortTermBondFunds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Fixed income mutual funds">14,325,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Corporate bonds and notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">813,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes"><span style="-sec-ix-hidden: xdx2ixbrl0894">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--CorporateBonds_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">(12,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--CorporateBonds_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">801,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_zbzaDJkFwiwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">15,275,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_zDtm0AlzFdUd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl0902">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_zXcwnQb68WA4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">(149,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--OtherInvestment_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_zq7h6aSQ4F73" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">15,126,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt/11.05pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cost<br/> Basis</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Gains</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gross Unrealized Losses</b></span></p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value</b></span></p></td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; padding-left: 5.4pt">Certificates of deposit</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit">3,534,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit">7,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit"><span style="-sec-ix-hidden: xdx2ixbrl0912">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="width: 10%; text-align: right" title="Certificates of deposit">3,541,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Fixed income mutual funds</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShortTermBondFunds_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_z8YI0zQDfoF4" style="text-align: right">11,255,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShortTermBondFunds_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_zJXXtTmrND55" style="text-align: right">80,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShortTermBondFunds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="text-align: right" title="Fixed income mutual funds"><span style="-sec-ix-hidden: xdx2ixbrl0918">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShortTermBondFunds_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="text-align: right" title="Fixed income mutual funds">11,335,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Corporate bonds and notes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--CorporateBonds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">4,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--CorporateBonds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">18,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CorporateBonds_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">(28,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CorporateBonds_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Corporate bonds and notes">4,490,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--CostBasisMember_zS709JDDXEr" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">19,289,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedGainsMember_zheACVcsVQd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">105,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--OtherInvestmentNotReadilyMarketableAxis__custom--GrossUnrealizedLossesMember_zlrwW9P93uI5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">(28,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--OtherInvestment_iI_pp0p0_c20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--FairValueMember_zj3RD0zG2T53" style="border-bottom: Black 2.5pt double; text-align: right" title="Total marketable securities">19,366,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 14462000 -137000 14325000 813000 -12000 801000 15275000 -149000 15126000 3534000 7000 3541000 11255000 80000 11335000 4500000 18000 -28000 4490000 19289000 105000 -28000 19366000 <p id="xdx_80E_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zrbLmk6rUDSl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note H – <span id="xdx_82A_zbfOFrRRqaMe">Equity Investment</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">During the period December 2018 – March 2021, the Company made an aggregate investment of $<span id="xdx_907_eus-gaap--Investments_c20211231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_pp0p0" title="Aggregrate investment">6,000,000</span> in ILiAD Biotechnologies, LLC (“ILiAD”), a privately held clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is developing key technologies and working with leading scientists to investigate the impact of Bordetella pertussis in a range of human disease and is currently focused on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). The aggregate investment of $<span id="xdx_90A_eus-gaap--Investments_c20211231_pp0p0" title="Aggregrate investment">6,000,000</span> by the Company includes a $<span id="xdx_908_eus-gaap--Goodwill_c20211231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_pp0p0" title="Equity investment">5,000,000</span> equity investment and a $<span id="xdx_900_eus-gaap--InvestmentsAndOtherNoncurrentAssets_c20211231_pp0p0" title="Convertable note investment">1,000,000</span> investment in a convertible note (see below). At December 31, 2021, the Company owned approximately <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20211231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ClassCUnitsMember_zdRvvYDiIdU9" title="Ownership percentage not fully diluted">9.5</span>% of the outstanding units of ILiAD on a non-fully diluted basis and <span id="xdx_902_ecustom--OwnershipPercentageFullyDiluted_dp_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ClassCUnitsMember_zi2G59hZHDck" title="Ownership percentage fully diluted">7.2</span>% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options, warrants and convertible notes). In connection with its investment, the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same compensation for service on the Board of Managers as other non-management Board members.</span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">On March 12, 2021, the Company invested $<span id="xdx_90E_ecustom--AdditionalConvertableNoteInvestment_iI_c20210312__us-gaap--RelatedPartyTransactionAxis__custom--ILiadBiotechnologiesLLCMember_zBVZrmgO3Sr7" title="Additional convertable note investment">1,000,000</span> in ILiAD as part of its private offering of up to $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20210301__20210312__us-gaap--RelatedPartyTransactionAxis__custom--ILiadBiotechnologiesLLCMember_pp0p0" title="Maximum convertible debt offering">23,500,000</span> of convertible notes (the “Notes”). The Notes have a maturity of three years with interest accruing at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210301__20210312__us-gaap--RelatedPartyTransactionAxis__custom--ILiadBiotechnologiesLLCMember_zctd1PvsVCUk" title="Interest rate">6</span>% per annum.<span id="xdx_904_eus-gaap--DebtConversionDescription_c20210301__20210312__us-gaap--RelatedPartyTransactionAxis__custom--ILiadBiotechnologiesLLCMember" title="Notes conversion, description"> The Notes are required to be converted into a Qualified Financing (minimum financing of $15 million) at the lesser of (i) 80% of the price paid per unit in such offering or (ii) a price based on an enterprise value of $176,000,000. In addition, the Notes shall convert in the event of a merger at the lower of an enterprise value of $176,000,000 or the stated valuation of ILiAD in the merger transaction. In the event of a change-in-control, noteholders will also have the option to have the Notes repaid except in a Qualified Financing or a stock-for-stock merger.</span></span></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the Company recorded a net loss from its equity method investment in ILiAD of $<span id="xdx_90D_ecustom--EquityInvestmentNetLoss_c20210101__20211231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_zakB2TxTjNvi" title="Equity investment net loss">999,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_ecustom--EquityInvestmentNetLoss_c20200101__20201231__us-gaap--RelatedPartyTransactionAxis__custom--IliadMember_zhp0o17dLXv" title="Equity investment net loss">787,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The difference between the Company’s share of equity in ILiAD’s net assets and the equity investment carrying value reported on the Company’s consolidated balance sheet at December 31, 2021 is due to an excess amount paid over the book value of the investment totaling approximately $<span id="xdx_90A_eus-gaap--Goodwill_c20211231_pp0p0" title="Equity investment">5,000,000</span> which are accounted for as equity method goodwill.</span></p> 6000000 6000000 5000000 1000000 0.095 0.072 1000000 23500000 0.06 The Notes are required to be converted into a Qualified Financing (minimum financing of $15 million) at the lesser of (i) 80% of the price paid per unit in such offering or (ii) a price based on an enterprise value of $176,000,000. In addition, the Notes shall convert in the event of a merger at the lower of an enterprise value of $176,000,000 or the stated valuation of ILiAD in the merger transaction. In the event of a change-in-control, noteholders will also have the option to have the Notes repaid except in a Qualified Financing or a stock-for-stock merger. 999000 787000 5000000 <p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zR0eF8RRG8ra" style="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note I – <span id="xdx_820_zX73FWhlb1Xg">Commitments and Contingencies</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[1]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Legal fees:</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Russ, August &amp; Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook, Inc. in the U.S. District Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds Patent Portfolio (see Note K[4] hereof). The terms of the Company’s agreement with Russ, August &amp; Kabat provide for cash payments on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Russ, August &amp; Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and December 2014 against Google Inc. and YouTube, LLC in the U.S. District Court for the Southern District of New York relating to certain patents within the Cox Patent Portfolio acquired by the Company from Dr. Cox (see Note K[3] hereof). The terms of the Company’s agreement with Russ, August &amp; Kabat provide for legal fees on a full contingency basis ranging from 15% to 30% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all expenses incurred with respect to this litigation.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Dovel &amp; Luner, LLP provided legal services to the Company with respect to the Company’s patent litigation filed in September 2011 against sixteen (16) data networking equipment manufacturers in the U.S. District Court for the Eastern District of Texas, (Tyler Division) (see Note K[1]). The terms of the Company’s agreement with Dovel &amp; Luner LLP essentially provided for legal fees on a full contingency basis ranging from 12.5% to 35% (with certain exceptions) of the net recovery (after deduction for expenses) depending on the stage of the preceding in which a result (settlement or judgment) is achieved. The Company was responsible for a portion of the expenses incurred with respect to this litigation. For the year ended December 31, 2021 and 2020, the Company incurred contingent legal fees and expenses to Dovel &amp; Luner of $<span id="xdx_909_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_c20211231__us-gaap--LitigationStatusAxis__custom--LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member_pp0p0" title="Accrued expenses">4,586,000</span> and $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pp0p0_c20201231__us-gaap--LitigationStatusAxis__custom--LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member_zfbN3xiqfKLk" title="Accrued expenses">1,428,000</span>, respectively, with respect to the litigation. As of December 31, 2021, the Company accrued contingency fees expenses of $<span id="xdx_908_eus-gaap--LegalFees_c20210101__20211231__us-gaap--LitigationStatusAxis__custom--LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member_pp0p0" title="Contingent legal fees">137,000</span> to Dovel &amp; Luner with respect to the litigation (see Note B[8] hereof).</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Dovel &amp; Luner, LLP also provided legal services to the Company with respect to the Company’s patent litigation settled in July 2010 against several major data networking equipment manufacturers including Cisco (see Note K[3]). The terms of the Company’s agreement with Dovel &amp; Luner, LLP provided for legal fees of a maximum aggregate cash payment of $1.5 million plus a contingency fee of up to 24% (based on the settlement being achieved at the trial stage) including legal fees of local counsel in Texas. With respect to any royalty payments payable by Cisco relating to royalties for the period prior to the expiration of the Remote Power Patent (March 7, 2020), the Company had an obligation to pay Dovel &amp; Luner contingency fees of 24% (see Note K[2] hereof). During the year ended December 31, 2021, the Company paid Dovel and Luner contingency fees and expenses of $<span id="xdx_90D_eus-gaap--LegalFees_c20210101__20211231__us-gaap--LitigationStatusAxis__custom--LegalServiceAgreementWithDovelAndLunerForLitigationSettlementFiledInJuly2010Member_pp0p0" title="Contingent legal fees">5,760,000</span>. There were no contingency fees paid to Dovel and Luner for the year ended December 31, 2020. In addition, as of December 31, 2021 and 2020, there were no outstanding contingency fees due Dovel &amp; Luner with respect to this litigation.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[2]</b></span></td><td><span style="font: 10pt Times New Roman, Times, Serif"><b>Patent Acquisitions:</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In connection with the Company’s acquisition of its Cox Patent Portfolio, the Company is obligated to pay Dr. Cox <span id="xdx_90A_ecustom--ObligatedToPaySellerNetProceedPercentage_iI_dp_c20211231_zVgBd7TzgZBb" title="Obligated to pay Cox, net proceeds percentage">12.5</span>% of the net proceeds (after deduction of expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the years ended December 31, 2021, and 2020, no expense was incurred with respect to the Cox Patent Portfolio. As of December 31, 2021 and 2020, no amounts were accrued with respect to the Cox Patent Portfolio.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition Interface, LLC (“Recognition”) pursuant to which Recognition received from the Company an interest in the net proceeds realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: <span id="xdx_90A_ecustom--ObligatedToPayRecognitionAbstract_iB_c20210101__20211231_z1BQK604LGG4" style="display: none" title="Obligated to pay Recognition">Obligated to pay Recognition</span> (i) <span id="xdx_90F_ecustom--First125Million_iI_dp_c20211231_z4OEiVqfTKf1" title="First $125 Million">10</span>% of the first $125 million of net proceeds; (ii) <span id="xdx_903_ecustom--Next125Million_iI_dp_c20211231_zk01YQticlh" title="Next $125 Million">15</span>% of the next $125 million of net proceeds; and (iii) <span id="xdx_901_ecustom--Over250Million_iI_dp_c20211231_zjd5XboVmcy8" title="Over $250 Million">20</span>% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, the Company has paid Recognition an aggregate of $<span id="xdx_903_ecustom--RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents_pp0p0_c20130501__20211231_zJpwZ2GzEEY9" title="Recognition net proceeds payment related to Mirror Worlds patents">3,127,000</span> with respect to such net proceeds interest related to the Mirror Worlds Patent Portfolio. No such payments were made by the Company to Recognition during the year ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is <span id="xdx_90A_ecustom--ObligatedToPayM2mAbstract_iB_c20210101__20211231_z8FNfOebXQjg" title="Obligated to pay M2M">obligated to pay M2M</span> <span id="xdx_90E_ecustom--First100_iI_dp_c20211231_zRCanPPaFaUd" title="First $100 Million">14</span>% of the first $100 million of net proceeds (after deduction of expenses) and <span id="xdx_90C_ecustom--Next100_iI_dp_c20211231_zqsF6kuMJvzi" title="Next $100 Million">5</span>% of net proceeds greater than $100 million from Monetization Activities (as defined) related to the patent portfolio. In addition, M2M will be entitled to receive from the Company $<span id="xdx_90C_ecustom--AadditionalConsideration_c20211231_pp0p0" title="Additional consideration payable upon occurrence of certain future events">250,000</span> of additional consideration upon the occurrence of certain future events related to the patent portfolio. As of the years ended December 31, 2021, and 2020, no expense was incurred with respect to the M2M/IoT Patent Portfolio. As of December 31, 2021 and 2020, no amounts were accrued with respect to the M2M/IoT Patent Portfolio.</span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><b>[3]</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Savings and investment plan:</b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts determined by the Board of Directors, subject to statutory limits. The 401(k) Plan expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_902_eus-gaap--StockOptionPlanExpense_c20210101__20211231_pp0p0" title="Plan expense">102,000</span> and $<span id="xdx_90C_eus-gaap--StockOptionPlanExpense_c20200101__20201231_pp0p0" title="Plan expense">105,000</span>, respectively, all of which was accrued as of December 31, 2021 and 2020 and is recorded within accrued expenses on the Company’s consolidated balance sheets.</span></p> 4586000 1428000 137000 5760000 0.125 0.10 0.15 0.20 3127000 0.14 0.05 250000 102000 105000 <p id="xdx_80B_ecustom--EmploymentArrangementsAndOtherAgreementsTextBlock_zfHuDjcRmNRk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note J - <span id="xdx_82D_zdgaVbG7jZg8">Employment Arrangements and Other Agreements</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[1] </b>On March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive Officer, pursuant to which he continues to serve as our Chairman and Chief Executive Officer for a four year term (“Term”), at an annual base salary of $<span id="xdx_903_eus-gaap--SalariesWagesAndOfficersCompensation_c20220301__20220322__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--NewEmploymentAgreementMember_pp0p0" title="Salary and Wage, Excluding Cost of Good and Service Sold">535,000</span> which shall be increased by 3% per annum during the term of the Agreement. The Agreement established an annual target bonus of $<span id="xdx_90D_ecustom--ProratedTargetBonus_c20220301__20220322__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--NewEmploymentAgreementMember_pp0p0" title="Target annual bonus paid Chairman and CEO">175,000</span> for the Chairman and Chief Executive Officer based upon performance. During the year ended December 31, 2021 and December 31, 2020, the Chairman and Chief Executive Officer received an annual discretionary bonus of $<span id="xdx_909_ecustom--AnnualDiscretionaryBonus_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--NewEmploymentAgreementMember_pp0p0" title="Annual discretionary bonus">175,000</span> and $<span id="xdx_90B_ecustom--AnnualDiscretionaryBonus_c20200101__20201231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--NewEmploymentAgreementMember_pp0p0" title="Annual discretionary bonus">125,000</span>, respectively.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, 600,000 restricted stock units (the “RSUs”, each RSU awarded by the Company to its officers, directors and consultants represents a contingent right to receive one share of the Company’s common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to the Chairman and Chief Executive Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the term of the Agreement that the Company’s common stock (the “Common Stock”) achieves a closing price for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the term of the Agreement that the Common Stock achieves a Closing Price (as defined above) of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the term of the Agreement, that the Common Stock achieves a Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by you for Good Reason (as defined) in each case prior to the last day of the term of the Agreement, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors or consultants have dividend equivalent rights.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Under the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company, whether pursuant to the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in an amount equal to 5% of the Company’s gross royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to our Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities with respect to patents other than the Remote</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Power Patent (including all of the Company’s patent portfolios and its investment in ILiAD Biotechnologies) (collectively, the “Incentive Compensation”). During the year ended December 31, 2021 and December 31, 2020, the Chairman and Chief Executive Officer earned Incentive Compensation of $<span id="xdx_905_eus-gaap--SalariesAndWages_c20210101__20211231__srt--TitleOfIndividualAxis__custom--ChairmanAndChiefExecutiveOfficerMember_zgmc4c3CYwBk">1,801,000</span> and $<span id="xdx_90A_eus-gaap--SalariesAndWages_c20200101__20201231__srt--TitleOfIndividualAxis__custom--ChairmanAndChiefExecutiveOfficerMember_zVZcQLrBZ8Nb">220,000</span>, respectively.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s patents with respect to licenses entered into with third parties during the term of his employment or at anytime thereafter, whether he is employed by us or not; provided, that, the employment of the Chairman and Chief Executive Officer has not been terminated by the Company “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In the event that the Chairman and Chief Executive Officer’s employment is terminated by us “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief Executive Officer shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i) during the term of the Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 month base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by us or “Without Good Reason” by the Chairman and Chief Executive Officer.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[2] </b>The Company’s Chief Financial Officer serves on an at-will basis at an annual base salary of $<span id="xdx_909_eus-gaap--SalariesWagesAndOfficersCompensation_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_pp0p0" title="Annual base salary">175,000</span>. The Company’s Chief Financial Officer received a discretionary annual bonus of $<span id="xdx_906_ecustom--AnnualDiscretionaryBonus_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_pp0p0" title="Annual discretionary bonus">22,500</span> for the year ended December 31, 2021 and $<span id="xdx_900_ecustom--AnnualDiscretionaryBonus_c20200101__20201231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_pp0p0" title="Annual discretionary bonus">15,000</span> for the year ended December 31, 2020. On December 29, 2020, the Chief Financial Officer was granted 7,500 RSUs under the 2013 Plan. 50% of such RSUs vested on the one year anniversary of the grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022), subject to the Chief Financial Officer’s continued service to the Company. In addition, in the event the Chief Financial Officer’s employment is terminated without “Good Cause” (as defined), he shall receive (i) (a) 6 months base salary or (b) 12 months base salary in the event of a termination without “Good Cause” within 6 months following a “Change of Control” of the Company (as defined) and (ii) accelerated vesting of all remaining unvested shares underlying his options, RSUs or any other awards he may receive in the future. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[3] </b>The Company’s Executive Vice President serves on an at-will basis at an annual base salary of $<span id="xdx_90A_eus-gaap--SalariesWagesAndOfficersCompensation_c20210101__20211231__srt--TitleOfIndividualAxis__srt--VicePresidentMember_pp0p0" title="Annual base salary">200,000</span>. The Executive Vice President received a discretionary annual bonus of $<span id="xdx_901_ecustom--AnnualDiscretionaryBonus_c20210101__20211231__srt--TitleOfIndividualAxis__srt--VicePresidentMember_pp0p0" title="Annual discretionary bonus">40,000</span> and $<span id="xdx_903_ecustom--AnnualDiscretionaryBonus_c20200101__20201231__srt--TitleOfIndividualAxis__srt--VicePresidentMember_pp0p0" title="Annual discretionary bonus">25,000</span> for the year ended December 31, 2021 and 2020, respectively. On December 29, 2020, the Company’s Executive Vice President was granted 10,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (December 29, 2021) and 50% of such RSUs vest on the two year anniversary of the grant (December 29, 2022), subject to the Executive Vice President’s continued service to the Company. On January 18, 2022, the Company’s Executive Vice President was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January 18, 2024).</span></p> 535000 175000 175000 125000 1801000 220000 175000 22500 15000 200000 40000 25000 <p id="xdx_80E_eus-gaap--LegalMattersAndContingenciesTextBlock_zZL5DWwdiEM6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note K –<span id="xdx_829_zQ5mp82OcR5g"> Legal Proceedings</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[1] </b>On July 26, 2021, the Company agreed to settle its patent litigation against Hewlett-Packard Company and Hewlett-Packard Enterprise Company (collectively, “Hewlett-Packard”) pending in the U.S. District Court for the Eastern District of Texas, Tyler Division, for infringement of the Company’s Remote Power Patent. Under the terms of the settlement agreement, Hewlett-Packard Enterprise Company paid the Company $<span id="xdx_902_eus-gaap--LitigationSettlementExpense_c20210725__20210726__us-gaap--RelatedPartyTransactionAxis__custom--HewlettPackardEnterpriseMember_pp0p0" title="Litigation">17,000,000</span> in full settlement of the litigation and Hewlett-Packard received a fully paid license and release to the Remote Power Patent for its full term, which applies to sales of Power over Ethernet (“PoE”) products by Hewlett-Packard and its wholly-owned subsidiary Aruba Networks, LLC.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[2] </b>On March 30, 2021, the Company entered into an amendment (the “Amendment”) to the Settlement and License Agreement, dated May 25, 2011, between the Company and Cisco (the “Agreement”). Pursuant to the Amendment, Cisco paid $<span id="xdx_905_ecustom--AmountOfRoyaltiesAgreedToBePaidByCisco_c20190101__20210330__srt--ConsolidatedEntitiesAxis__custom--LicenseAgreementMember_pp0p0" title="Amount of royalties paid by Cisco">18,692,000</span> to the Company to resolve a dispute relating to Cisco’s contractual obligation to pay royalties under the Agreement to the Company for the period beginning in the fourth quarter of 2017 through March 7, 2020 (when the Remote Power Patent expired) with respect to licensing the Remote Power Patent.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[3] </b>On April 4, 2014 and December 3, 2014, the <span id="xdx_904_ecustom--LitigationPendingDescription_c20210101__20211231__srt--TitleOfIndividualAxis__custom--GoogleMember__us-gaap--AwardDateAxis__custom--OnAprilFourTwoThousandFourteenAndDecemberThreeTwoThousandFourteenMember" title="Litigation pending, description">Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. </span>The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated. Discovery has been substantially completed and a trial date has not yet been set.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[4] </b>On May 9, 2017, Mirror Worlds Technologies, LLC, the <span id="xdx_906_ecustom--LitigationPendingDescription_c20170508__20170509__srt--TitleOfIndividualAxis__custom--FacebookMember" title="Litigation pending, description">Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“Facebook”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Facebook’s core technologies that enable Facebook’s Newsfeed and Timeline features. </span>The lawsuit further alleged that Facebook’s unauthorized use of the stream-based solutions of the Company’s asserted patents has helped Facebook become the most popular social networking site in the world. On May 7, 2018, Facebook filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Facebook’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018, the Company filed a Notice of Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit reversed the summary judgment finding of the District Court and remanded the litigation to the Southern District of New York for further proceedings.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Facebook. In its ruling the Court (i) denied Facebook’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and intends to file an appeal to the U.S. Court of Appeals for the Federal Circuit.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[5] </b>On December 15, 2020, the Company filed a lawsuit against Netgear in the Supreme Court of the State of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised in the litigation. The Company has objected to jurisdiction at the AAA and the dispute is pending.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[6] </b>On January 7, 2021, the Company filed a lawsuit against Plantronics, Inc., the successor entity to Polycom, Inc., in the Supreme Court of the State of California, County of Santa Clara, for breach of a Settlement and License Agreement, dated September 29, 2016, with the Company for the failure of Plantronics and Polycom to make royalty payments, and provide corresponding royalty reports, to the Company based on sales of PoE products. On October 26, 2021, the Company settled its litigation with Plantronics, Inc. in consideration for payment of $<span id="xdx_907_eus-gaap--LitigationSettlementExpense_pp0p0_c20211001__20211026_zXeGU26weMO2" title="Plantronics Litigation">337,000</span>.</span></p> 17000000 18692000 Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“Facebook”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Facebook’s core technologies that enable Facebook’s Newsfeed and Timeline features. 337000 <p id="xdx_804_eus-gaap--ConcentrationRiskDisclosureTextBlock_zQSO4KDk3Zn7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note L - <span id="xdx_82B_z0RlCLqwPUj5">Concentrations</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue from the Company’s Remote Power Patent constituted <span id="xdx_900_ecustom--PercentageRevenue_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--RemotePowerPatentMember_z2xb5XPuSaw9" title="Percentage revenue"><span id="xdx_906_ecustom--PercentageRevenue_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--RemotePowerPatentMember_ziD7nIcbPVFi" title="Percentage revenue">100</span></span>% of the Company’s revenue for the year ended December 31, 2021 and 2020. Revenue from two licensees constituted an aggregate of <span id="xdx_900_ecustom--PercentageRevenue_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--LicenseesTwoMember_zRg0i6so0EZ" title="Percentage revenue">99</span>% of the Company’s revenue for the year ended December 31, 2021. Revenue from one licensee constituted an aggregate of <span id="xdx_907_ecustom--PercentageRevenue_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--LicenseesOneMember_zbED32kckSz1" title="Percentage revenue">94</span>% of the Company’s revenue for the year ended December 31, 2020. At December 31, 2021 and December 31, 2020, there were <span id="xdx_90D_ecustom--RoyaltyReceivables_iI_do_c20211231_zQVowyHZgNTb" title="Royalty Receivables"><span id="xdx_90A_ecustom--RoyaltyReceivables_iI_do_c20201231_zuSd46KtI4x5" title="Royalty Receivables">no</span></span> royalty receivables from licensees.</span></p> 1 1 0.99 0.94 0 0 <p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zt5oSzqqcsW5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note M – <span id="xdx_821_zCRyvrtHEvt9">Related Party Transaction</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">On May 27, 2021, the Company repurchased from a director of the Company <span id="xdx_905_ecustom--NumberOfSharesCommonStockRepurchased_c20210526__20210527__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zSDmNkSYgfr3" title="Number of shares, common stock repurchased">40,000</span> shares of its common stock at a purchase price of $<span id="xdx_90E_ecustom--PricePerShareCommonStockRepurchased_c20210526__20210527__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zvPz7JIKGLgc" title="Price per share, common stock repurchased">3.27</span> per share or aggregate consideration of $<span id="xdx_901_ecustom--AggregateCostOfCommonStock_pp0p0_c20210526__20210527__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zFF4o2D91PS1" title="Aggregate cost of common stock">130,800</span>.</span></span></p> 40000 3.27 130800 <p id="xdx_80B_eus-gaap--AcceleratedShareRepurchasesTextBlock_zpMnzmOgqHqh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note N – <span id="xdx_82B_z2gXJeccGBv3">Stock Repurchase Program</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On June 11, 2021, the Company’s Board of Directors authorized an extension and increase of the Share Repurchase Program to repurchase up to $<span id="xdx_901_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_c20210611__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z9tEDfBgVcad" title="Stock Repurchase Program, dollar amount">5,000,000</span> of the Company’s common stock over the subsequent 24-month period. The common stock may be repurchased from time to time in open market transactions or privately negotiated transactions in the Company’s discretion. The timing and amount of the shares repurchased are determined by management based on its evaluation of market conditions and other factors. The repurchase program may be increased, suspended or discontinued at any time.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended December 31, 2021, the Company repurchased an aggregate of <span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210101__20211231_zlGC0ktHmbJi" title="Number of shares, common stock repurchased">378,475</span> shares of its common stock pursuant to the Share Repurchase Program at a cost of approximately $<span id="xdx_90D_eus-gaap--PaymentsForRepurchaseOfEquity_c20210101__20211231_pp0p0" title="Aggregate cost of common stock repurchased since inception">1,077,000</span> or an average price per share of $<span id="xdx_90C_ecustom--WeightedAveragePricePerShareCommonStockSubjectToRepurchase_c20210101__20211231_zXlEFgoe30nl" title="Average price per share, common stock repurchased">2.85</span> per share.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Since inception of the Share Repurchase Program (August 2011) through December 31, 2021, the Company has repurchased an aggregate of <span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20110801__20211231_pdd" title="Number of shares, common stock repurchased since inception">8,984,134</span> shares of its common stock at a cost of approximately $<span id="xdx_90B_eus-gaap--PaymentsForRepurchaseOfEquity_c20110801__20211231_pp0p0" title="Aggregate cost of common stock repurchased since inception">17,225,276</span> (exclusive of commissions) or an average per share price of $<span id="xdx_907_ecustom--WeightedAveragePricePerShareCommonStockSubjectToRepurchase_c20110801__20211231_pdd" title="Average price per share, common stock repurchased since inception">1.92</span> per share.</span></p> 5000000 378475 1077000 2.85 8984134 17225276 1.92 <p id="xdx_807_eus-gaap--ScheduleOfDividendPaymentRestrictionsTextBlock_zu6BcHdQz3aj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note O – <span id="xdx_827_zKKhTCzcGjJc">Dividend Policy</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On June 9, 2020, the Company’s Board of Directors approved the continuation of the Company’s dividend policy which consists of a semi-annual cash dividend of $<span id="xdx_900_eus-gaap--CommonStockDividendsPerShareDeclared_c20200101__20200609_zV6QVFSkxyZ1">0.05 </span></span><span style="font: 10pt Times New Roman, Times, Serif">per common share ($0.10 per common share annually) which are anticipated to be paid in March and September of each year. On February 23, 2021, the Board of Directors declared a semi-annual cash dividend of $<span id="xdx_90F_eus-gaap--CommonStockDividendsPerShareDeclared_c20210201__20210223__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pdd">0.05 </span></span><span style="font: 10pt Times New Roman, Times, Serif">per share with a payment date of <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20210201__20210223__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zcOpqBfzfuf3">March 31, 2021</span></span> <span style="font: 10pt Times New Roman, Times, Serif">to all common shareholders of record as of <span id="xdx_907_ecustom--SemiAnnualCashDividendRecordDate_dd_c20210201__20210223__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zLckSvshr8Wf">March 16, 2021</span></span><span style="font: 10pt Times New Roman, Times, Serif">. On September 10, 2021, the Board of Directors declared a semi-annual dividend of $<span id="xdx_901_eus-gaap--CommonStockDividendsPerShareDeclared_c20210901__20210910__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pdd">0.05 </span></span><span style="font: 10pt Times New Roman, Times, Serif">per share with a payment date of <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20210901__20210910__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zLd0dneWwbQh">September 30, 2021</span></span> <span style="font: 10pt Times New Roman, Times, Serif">to all common shareholders of record as of <span id="xdx_909_ecustom--SemiAnnualCashDividendRecordDate_dd_c20210901__20210910__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zqct7aXsfwf8">September 21, 2021</span></span><span style="font: 10pt Times New Roman, Times, Serif">. The Company’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.</span></p> 0.05 0.05 2021-03-31 2021-03-16 0.05 2021-09-30 2021-09-21 <p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zIcq2abJDTO5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Note P – <span id="xdx_82E_z9sARUKq0WQ9">Subsequent Events</span></b></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[1] </b>On February 23, 2022, the Company’s Board of Directors declared a semi-annual cash dividend of $<span id="xdx_909_eus-gaap--CommonStockDividendsPerShareDeclared_c20220201__20220223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zJzFIPffGcU5" title="Semi-annual cash dividend per common share">0.05</span> per share with a payment date of <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20220201__20220223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zOR65cSy1WFc" title="Dividend payment date">March 24, 2022</span> to all common shareholders of record as of <span id="xdx_909_ecustom--SemiAnnualCashDividendRecordDate_c20220201__20220223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z0O4mbN1vJxb" title="Semi-annual cash dividend record date">March 9, 2022</span>.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[2] </b>On February 23, 2022, the Company’s Board of Directors approved the grant of <span id="xdx_90A_ecustom--RestrictedStockUnitsGrantedToDirectors_c20210201__20210223__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQ9NASgbUQ96" title="Restricted stock units granted to directors">15,000 </span><span id="xdx_90C_ecustom--RestrictedStockUnitsGrantedToDirectors_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zeKAdIOEybz8" style="display: none"><span id="xdx_905_ecustom--RestrictedStockUnitsGrantedToDirectors_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4HiXecQGy78" style="display: none">45,000</span></span>RSUs to each of the Company’s three non-management directors. The RSUs vest over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15, 2022, June 15, 2022, September 15, 2022 and December 15, 2022.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[3] </b>On March 11, 2022, <span id="xdx_903_ecustom--RsuSettled_c20220301__20220311__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zPSWndibEDd7" title="RSU settled">125,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock subject to restricted stock units owned by the Company’s Chairman and Chief Executive Officer were settled. With respect to the restricted stock unit settlement, the Chairman and Chief Executive Officer delivered <span id="xdx_90E_eus-gaap--RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c20220301__20220311__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z0QFBu7EJxU7" title="Shares delivered for withholding taxes">45,438 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares to satisfy withholding taxes and received <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220301__20220311__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z7BAglfkXfrj" title="Net shares received">79,562 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net shares of common stock.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.35in; text-align: justify"><b>[4]</b> On March 22, 2022, the Company entered into a new four year employment agreement with its Chairman and Chief Executive Officer. In connection with the agreement the Company granted to its Chairman and Chief Executive Officer <span id="xdx_904_ecustom--RestrictedStockUnitsGranted_c20220301__20220322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zjWvcI0DCQBh" title="Restricted stock units granted">600,000</span> restricted stock units which vest in four tranches subject to certain conditions (see Note J[1] hereof). </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[5] </b>On March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) consisting of six U.S. patents and two pending U.S. patents covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The Company paid the seller $<span id="xdx_909_ecustom--AmountPaidToSeller_c20220301__20220325__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zC351jZVTZPl" title="Amount paid to seller">500,000</span> at the closing and has an obligation to pay the seller an additional $<span id="xdx_90D_ecustom--ObligationToPaySeller_c20220301__20220325__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlQxPoIUKDv3" title="Contigent Obligation to pay seller">500,000</span> and $<span id="xdx_90B_ecustom--ContingentCommonStockIssuedUponAchievingCertainMilestones_c20220301__20220325__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLe9EUYXqmya" title="Common stock issued upon achieving certain milestones">375,000</span> of the Company's common stock upon achieving certain milestones with respect to the patent portfolio. The Company also has an obligation to pay the seller <span id="xdx_901_ecustom--First50Million_dp_c20220301__20220325__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRmQL5cCCWM7" title="First $50 million">15</span>% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and <span id="xdx_90D_ecustom--GreaterThan50Million_dp_c20220301__20220325__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPfEpBjLWoQ6" title="Greater than $50 million">17.5</span>% of net proceeds greater than $50 million.</span></p> 0.05 2022-03-24 2022-03-09 15000 45000 45000 125000 45438 79562 600000 500000 500000 375000 0.15 0.175 Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof). Includes (1) $18,691,890 of royalty revenue from Cisco from resolution of a dispute under its license agreement with the Company (see Note K[2] hereof) and (2) $337,000 of royalty revenue received from Plantronics (see Note K[6] hereof). Includes revenue of $4,150,000 from a litigation settlement with Dell, Inc.   Deferred tax liability as a result of a temporary difference related to the Company’s equity method investment. EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 69 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 70 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 95 287 1 true 40 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://network-1.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://network-1.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Sheet http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://network-1.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - Business Sheet http://network-1.com/role/Business Business Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://network-1.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Patents Sheet http://network-1.com/role/Patents Patents Notes 9 false false R10.htm 00000010 - Disclosure - Loss Per Share Sheet http://network-1.com/role/LossPerShare Loss Per Share Notes 10 false false R11.htm 00000011 - Disclosure - Income Taxes Sheet http://network-1.com/role/IncomeTaxes Income Taxes Notes 11 false false R12.htm 00000012 - Disclosure - Stockholders??? Equity Sheet http://network-1.com/role/StockholdersEquity Stockholders??? Equity Notes 12 false false R13.htm 00000013 - Disclosure - Marketable Securities Sheet http://network-1.com/role/MarketableSecurities Marketable Securities Notes 13 false false R14.htm 00000014 - Disclosure - Equity Investment Sheet http://network-1.com/role/EquityInvestment Equity Investment Notes 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies Sheet http://network-1.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Employment Arrangements and Other Agreements Sheet http://network-1.com/role/EmploymentArrangementsAndOtherAgreements Employment Arrangements and Other Agreements Notes 16 false false R17.htm 00000017 - Disclosure - Legal Proceedings Sheet http://network-1.com/role/LegalProceedings Legal Proceedings Notes 17 false false R18.htm 00000018 - Disclosure - Concentrations Sheet http://network-1.com/role/Concentrations Concentrations Notes 18 false false R19.htm 00000019 - Disclosure - Related Party Transaction Sheet http://network-1.com/role/RelatedPartyTransaction Related Party Transaction Notes 19 false false R20.htm 00000020 - Disclosure - Stock Repurchase Program Sheet http://network-1.com/role/StockRepurchaseProgram Stock Repurchase Program Notes 20 false false R21.htm 00000021 - Disclosure - Dividend Policy Sheet http://network-1.com/role/DividendPolicy Dividend Policy Notes 21 false false R22.htm 00000022 - Disclosure - Subsequent Events Sheet http://network-1.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://network-1.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://network-1.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - Patents (Tables) Sheet http://network-1.com/role/PatentsTables Patents (Tables) Tables http://network-1.com/role/Patents 25 false false R26.htm 00000026 - Disclosure - Loss Per Share (Tables) Sheet http://network-1.com/role/LossPerShareTables Loss Per Share (Tables) Tables http://network-1.com/role/LossPerShare 26 false false R27.htm 00000027 - Disclosure - Income Taxes (Tables) Sheet http://network-1.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://network-1.com/role/IncomeTaxes 27 false false R28.htm 00000028 - Disclosure - Stockholders??? Equity (Tables) Sheet http://network-1.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://network-1.com/role/StockholdersEquity 28 false false R29.htm 00000029 - Disclosure - Marketable Securities (Tables) Sheet http://network-1.com/role/MarketableSecuritiesTables Marketable Securities (Tables) Tables http://network-1.com/role/MarketableSecurities 29 false false R30.htm 00000030 - Disclosure - Business (Details Narrative) Sheet http://network-1.com/role/BusinessDetailsNarrative Business (Details Narrative) Details http://network-1.com/role/Business 30 false false R31.htm 00000031 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 00000032 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables 32 false false R33.htm 00000033 - Disclosure - Patents (Details) Sheet http://network-1.com/role/PatentsDetails Patents (Details) Details http://network-1.com/role/PatentsTables 33 false false R34.htm 00000034 - Disclosure - Patents (Details 1) Sheet http://network-1.com/role/PatentsDetails1 Patents (Details 1) Details http://network-1.com/role/PatentsTables 34 false false R35.htm 00000035 - Disclosure - Patents (Details Narrative) Sheet http://network-1.com/role/PatentsDetailsNarrative Patents (Details Narrative) Details http://network-1.com/role/PatentsTables 35 false false R36.htm 00000036 - Disclosure - Loss Per Share (Details) Sheet http://network-1.com/role/LossPerShareDetails Loss Per Share (Details) Details http://network-1.com/role/LossPerShareTables 36 false false R37.htm 00000037 - Disclosure - Loss Per Share (Details Narrative) Sheet http://network-1.com/role/LossPerShareDetailsNarrative Loss Per Share (Details Narrative) Details http://network-1.com/role/LossPerShareTables 37 false false R38.htm 00000038 - Disclosure - Income Taxes (Details) Sheet http://network-1.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://network-1.com/role/IncomeTaxesTables 38 false false R39.htm 00000039 - Disclosure - Income Taxes (Details 1) Sheet http://network-1.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) Details http://network-1.com/role/IncomeTaxesTables 39 false false R40.htm 00000040 - Disclosure - Income Taxes (Details 2) Sheet http://network-1.com/role/IncomeTaxesDetails2 Income Taxes (Details 2) Details http://network-1.com/role/IncomeTaxesTables 40 false false R41.htm 00000041 - Disclosure - Income Taxes (Details Narrative) Sheet http://network-1.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://network-1.com/role/IncomeTaxesTables 41 false false R42.htm 00000042 - Disclosure - Stockholders' Equity (Details) Sheet http://network-1.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details 42 false false R43.htm 00000043 - Disclosure - Stockholders' Equity (Details 1) Sheet http://network-1.com/role/StockholdersEquityDetails1 Stockholders' Equity (Details 1) Details 43 false false R44.htm 00000044 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://network-1.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://network-1.com/role/StockholdersEquityTables 44 false false R45.htm 00000045 - Disclosure - Marketable Securities (Details) Sheet http://network-1.com/role/MarketableSecuritiesDetails Marketable Securities (Details) Details http://network-1.com/role/MarketableSecuritiesTables 45 false false R46.htm 00000046 - Disclosure - Equity Investment (Details Narrative) Sheet http://network-1.com/role/EquityInvestmentDetailsNarrative Equity Investment (Details Narrative) Details http://network-1.com/role/EquityInvestment 46 false false R47.htm 00000047 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://network-1.com/role/CommitmentsAndContingencies 47 false false R48.htm 00000048 - Disclosure - Employment Arrangements and Other Agreements (Details Narrative) Sheet http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative Employment Arrangements and Other Agreements (Details Narrative) Details http://network-1.com/role/EmploymentArrangementsAndOtherAgreements 48 false false R49.htm 00000049 - Disclosure - Legal Proceedings (Details Narrative) Sheet http://network-1.com/role/LegalProceedingsDetailsNarrative Legal Proceedings (Details Narrative) Details http://network-1.com/role/LegalProceedings 49 false false R50.htm 00000050 - Disclosure - Concentrations (Details Narrative) Sheet http://network-1.com/role/ConcentrationsDetailsNarrative Concentrations (Details Narrative) Details http://network-1.com/role/Concentrations 50 false false R51.htm 00000051 - Disclosure - Related Party Transaction (Details Narrative) Sheet http://network-1.com/role/RelatedPartyTransactionDetailsNarrative Related Party Transaction (Details Narrative) Details http://network-1.com/role/RelatedPartyTransaction 51 false false R52.htm 00000052 - Disclosure - Stock Repurchase Program (Details Narrative) Sheet http://network-1.com/role/StockRepurchaseProgramDetailsNarrative Stock Repurchase Program (Details Narrative) Details http://network-1.com/role/StockRepurchaseProgram 52 false false R53.htm 00000053 - Disclosure - Dividend Policy (Details Narrative) Sheet http://network-1.com/role/DividendPolicyDetailsNarrative Dividend Policy (Details Narrative) Details http://network-1.com/role/DividendPolicy 53 false false R54.htm 00000054 - Disclosure - Subsequent Events (Details Narrative) Sheet http://network-1.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://network-1.com/role/SubsequentEvents 54 false false All Reports Book All Reports network1_10k-123121.htm exh21-1_18604.htm exh23-1_18604.htm exh31-1_18604.htm exh31-2_18604.htm exh32-1_18604.htm exh32-2_18604.htm nssi-20211231.xsd nssi-20211231_cal.xml nssi-20211231_def.xml nssi-20211231_lab.xml nssi-20211231_pre.xml http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "network1_10k-123121.htm": { "axisCustom": 0, "axisStandard": 17, "contextCount": 95, "dts": { "calculationLink": { "local": [ "nssi-20211231_cal.xml" ] }, "definitionLink": { "local": [ "nssi-20211231_def.xml" ] }, "inline": { "local": [ "network1_10k-123121.htm" ] }, "labelLink": { "local": [ "nssi-20211231_lab.xml" ] }, "presentationLink": { "local": [ "nssi-20211231_pre.xml" ] }, "schema": { "local": [ "nssi-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 450, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 47, "http://network-1.com/20211231": 33, "http://xbrl.sec.gov/dei/2021q4": 4, "total": 84 }, "keyCustom": 65, "keyStandard": 222, "memberCustom": 26, "memberStandard": 13, "nsprefix": "nssi", "nsuri": "http://network-1.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "p", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://network-1.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Loss Per Share", "role": "http://network-1.com/role/LossPerShare", "shortName": "Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Income Taxes", "role": "http://network-1.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Stockholders\u2019 Equity", "role": "http://network-1.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:MarketableSecuritiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Marketable Securities", "role": "http://network-1.com/role/MarketableSecurities", "shortName": "Marketable Securities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:MarketableSecuritiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Equity Investment", "role": "http://network-1.com/role/EquityInvestment", "shortName": "Equity Investment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Commitments and Contingencies", "role": "http://network-1.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Employment Arrangements and Other Agreements", "role": "http://network-1.com/role/EmploymentArrangementsAndOtherAgreements", "shortName": "Employment Arrangements and Other Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Legal Proceedings", "role": "http://network-1.com/role/LegalProceedings", "shortName": "Legal Proceedings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Concentrations", "role": "http://network-1.com/role/Concentrations", "shortName": "Concentrations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Related Party Transaction", "role": "http://network-1.com/role/RelatedPartyTransaction", "shortName": "Related Party Transaction", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://network-1.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Stock Repurchase Program", "role": "http://network-1.com/role/StockRepurchaseProgram", "shortName": "Stock Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Dividend Policy", "role": "http://network-1.com/role/DividendPolicy", "shortName": "Dividend Policy", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Subsequent Events", "role": "http://network-1.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Patents (Tables)", "role": "http://network-1.com/role/PatentsTables", "shortName": "Patents (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Loss Per Share (Tables)", "role": "http://network-1.com/role/LossPerShareTables", "shortName": "Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Income Taxes (Tables)", "role": "http://network-1.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Stockholders\u2019 Equity (Tables)", "role": "http://network-1.com/role/StockholdersEquityTables", "shortName": "Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Marketable Securities (Tables)", "role": "http://network-1.com/role/MarketableSecuritiesTables", "shortName": "Marketable Securities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:GainContingencyPatentsFoundInfringedUponNumber", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Business (Details Narrative)", "role": "http://network-1.com/role/BusinessDetailsNarrative", "shortName": "Business (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:GainContingencyPatentsFoundInfringedUponNumber", "reportCount": 1, "unique": true, "unitRef": "N", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-012021-12-31_custom_FullyPaidLicensesMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedPatentsGross", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Patents (Details)", "role": "http://network-1.com/role/PatentsDetails", "shortName": "Patents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31_us-gaap_PatentsMember", "decimals": "0", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Patents (Details 1)", "role": "http://network-1.com/role/PatentsDetails1", "shortName": "Patents (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "p", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Patents (Details Narrative)", "role": "http://network-1.com/role/PatentsDetailsNarrative", "shortName": "Patents (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "nssi:PatentsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Loss Per Share (Details)", "role": "http://network-1.com/role/LossPerShareDetails", "shortName": "Loss Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Loss Per Share (Details Narrative)", "role": "http://network-1.com/role/LossPerShareDetailsNarrative", "shortName": "Loss Per Share (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Income Taxes (Details)", "role": "http://network-1.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Income Taxes (Details 1)", "role": "http://network-1.com/role/IncomeTaxesDetails1", "shortName": "Income Taxes (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "role": "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Income Taxes (Details 2)", "role": "http://network-1.com/role/IncomeTaxesDetails2", "shortName": "Income Taxes (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Income Taxes (Details Narrative)", "role": "http://network-1.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Stockholders' Equity (Details)", "role": "http://network-1.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2019-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2020-12-31_us-gaap_StockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Stockholders' Equity (Details 1)", "role": "http://network-1.com/role/StockholdersEquityDetails1", "shortName": "Stockholders' Equity (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2019-12-31_us-gaap_StockOptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "role": "http://network-1.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31_custom_FairValueMember", "decimals": "0", "first": true, "lang": null, "name": "nssi:ShortTermBondFunds", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Marketable Securities (Details)", "role": "http://network-1.com/role/MarketableSecuritiesDetails", "shortName": "Marketable Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "nssi:MarketableSecuritiesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31_custom_FairValueMember", "decimals": "0", "first": true, "lang": null, "name": "nssi:ShortTermBondFunds", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Equity Investment (Details Narrative)", "role": "http://network-1.com/role/EquityInvestmentDetailsNarrative", "shortName": "Equity Investment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "nssi:ObligatedToPaySellerNetProceedPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Commitments and Contingencies (Details Narrative)", "role": "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2013-05-012021-12-31", "decimals": "0", "lang": null, "name": "nssi:RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "p", "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2022-03-012022-03-22_srt_ChiefExecutiveOfficerMember_custom_NewEmploymentAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SalariesWagesAndOfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Employment Arrangements and Other Agreements (Details Narrative)", "role": "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "shortName": "Employment Arrangements and Other Agreements (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "nssi:EmploymentArrangementsAndOtherAgreementsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2022-03-012022-03-22_srt_ChiefExecutiveOfficerMember_custom_NewEmploymentAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SalariesWagesAndOfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-10-012021-10-26", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Legal Proceedings (Details Narrative)", "role": "http://network-1.com/role/LegalProceedingsDetailsNarrative", "shortName": "Legal Proceedings (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-10-012021-10-26", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "role": "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "nssi:RoyaltyReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Concentrations (Details Narrative)", "role": "http://network-1.com/role/ConcentrationsDetailsNarrative", "shortName": "Concentrations (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "nssi:RoyaltyReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-05-262021-05-27_custom_BoardOfDirectorsMember", "decimals": "INF", "first": true, "lang": null, "name": "nssi:NumberOfSharesCommonStockRepurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Related Party Transaction (Details Narrative)", "role": "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "shortName": "Related Party Transaction (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-05-262021-05-27_custom_BoardOfDirectorsMember", "decimals": "INF", "first": true, "lang": null, "name": "nssi:NumberOfSharesCommonStockRepurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AcceleratedShareRepurchasesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Stock Repurchase Program (Details Narrative)", "role": "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "shortName": "Stock Repurchase Program (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AcceleratedShareRepurchasesTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2020-01-012020-06-09", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Dividend Policy (Details Narrative)", "role": "http://network-1.com/role/DividendPolicyDetailsNarrative", "shortName": "Dividend Policy (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfDividendPaymentRestrictionsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2020-01-012020-06-09", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Subsequent Events (Details Narrative)", "role": "http://network-1.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-02-012021-02-23_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "lang": null, "name": "nssi:RestrictedStockUnitsGrantedToDirectors", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:GainLossOnInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Business", "role": "http://network-1.com/role/Business", "shortName": "Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://network-1.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:PatentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Patents", "role": "http://network-1.com/role/Patents", "shortName": "Patents", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "network1_10k-123121.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "nssi:PatentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 40, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r435", "r437", "r438" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r435", "r437", "r438" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r435", "r437", "r438" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r435", "r437", "r438" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r435", "r437", "r438" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://network-1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "nssi_AadditionalConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional consideration payable upon occurrence of certain future events", "label": "Additional consideration payable upon occurrence of certain future events" } } }, "localname": "AadditionalConsideration", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AccruedContingencyFeesAndRelatedCosts": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued contingency fees and related costs" } } }, "localname": "AccruedContingencyFeesAndRelatedCosts", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "nssi_AccruedDividendRightsOnRestrictedStockUnit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accrued dividend rights on restricted stock unit" } } }, "localname": "AccruedDividendRightsOnRestrictedStockUnit", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AccruedDividendRightsOnRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued dividend rights on restricted stock units" } } }, "localname": "AccruedDividendRightsOnRestrictedStockUnits", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_AdditionalConvertableNoteInvestment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional convertable note investment" } } }, "localname": "AdditionalConvertableNoteInvestment", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AggregateCostOfCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate cost of common stock" } } }, "localname": "AggregateCostOfCommonStock", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AggregateNetSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aggregate net shares issued" } } }, "localname": "AggregateNetSharesIssued", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_AmountOfRoyaltiesAgreedToBePaidByCisco": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of royalties agreed to be paid by Cisco.", "label": "Amount of royalties paid by Cisco" } } }, "localname": "AmountOfRoyaltiesAgreedToBePaidByCisco", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AmountPaidToSeller": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Amount paid to seller" } } }, "localname": "AmountPaidToSeller", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_AnnualDiscretionaryBonus": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Annual discretionary bonus" } } }, "localname": "AnnualDiscretionaryBonus", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent board of directors.", "label": "Board Of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_CashPaidDuringTheYearsForAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during the years for:" } } }, "localname": "CashPaidDuringTheYearsForAbstract", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "nssi_CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Certificates of deposit [Default Label]", "verboseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositGreaterThan3MonthsUp12MonthsMaturity", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_ChairmanAndChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chairman And Chief Executive Officer [Member]" } } }, "localname": "ChairmanAndChiefExecutiveOfficerMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_CiscoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cisco [Member]" } } }, "localname": "CiscoMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ClassCUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class C Units [Member]" } } }, "localname": "ClassCUnitsMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ContingentCommonStockIssuedUponAchievingCertainMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued upon achieving certain milestones" } } }, "localname": "ContingentCommonStockIssuedUponAchievingCertainMilestones", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_ConvertibleNoteInvestment": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ConvertibleNoteInvestment", "negatedLabel": "Convertible note investment" } } }, "localname": "ConvertibleNoteInvestment", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_ConvertibleNoteInvestments": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Convertible note investment" } } }, "localname": "ConvertibleNoteInvestments", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "nssi_CorporateBonds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Corporate bonds and notes" } } }, "localname": "CorporateBonds", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_CostBasisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost Basis [Member]" } } }, "localname": "CostBasisMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_DecreaseInBasicAndDilutedEarningsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Decrease in basic and diluted earnings per share" } } }, "localname": "DecreaseInBasicAndDilutedEarningsPerShare", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_DeferredTaxAssetsLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total deferred tax assets (liability)" } } }, "localname": "DeferredTaxAssetsLiability", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "nssi_DeferredTaxLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Liability" } } }, "localname": "DeferredTaxLiability", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "nssi_DirectorsThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Directors Three [Member]" } } }, "localname": "DirectorsThreeMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_DisclosureEmploymentArrangementsAndOtherAgreementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employment Arrangements And Other Agreements" } } }, "localname": "DisclosureEmploymentArrangementsAndOtherAgreementsAbstract", "nsuri": "http://network-1.com/20211231", "xbrltype": "stringItemType" }, "nssi_DisclosureMarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketable Securities" } } }, "localname": "DisclosureMarketableSecuritiesAbstract", "nsuri": "http://network-1.com/20211231", "xbrltype": "stringItemType" }, "nssi_DisclosurePatentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Patents" } } }, "localname": "DisclosurePatentsAbstract", "nsuri": "http://network-1.com/20211231", "xbrltype": "stringItemType" }, "nssi_DividendsAndDividendEquivalentsDeclared": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Dividends and dividend equivalents declared" } } }, "localname": "DividendsAndDividendEquivalentsDeclared", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_EmploymentArrangementsAndOtherAgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employment Arrangements and Other Agreements" } } }, "localname": "EmploymentArrangementsAndOtherAgreementsTextBlock", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreements" ], "xbrltype": "textBlockItemType" }, "nssi_EquityInvestmentNetLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Equity investment net loss" } } }, "localname": "EquityInvestmentNetLoss", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio" } } }, "localname": "ExpirationDatesOfPatentsWithinCompanysM2miotPatentPortfolio", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ExpirationDatesOfPatentsWithinCoxPatentPortfolio": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration dates of the patents within the Cox patent portfolio" } } }, "localname": "ExpirationDatesOfPatentsWithinCoxPatentPortfolio", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_FacebookMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent facebook.", "label": "Facebook [Member]" } } }, "localname": "FacebookMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_FairValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value [Member]" } } }, "localname": "FairValueMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_First100": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent percentage of first $100 million.", "label": "First $100 Million" } } }, "localname": "First100", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_First125Million": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent percentage of first $125 million.", "label": "First $125 Million" } } }, "localname": "First125Million", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_First50Million": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First $50 million" } } }, "localname": "First50Million", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_FullyPaidLicensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fully Paid Licenses [Member]" } } }, "localname": "FullyPaidLicensesMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "nssi_GoogleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent google.", "label": "Google [Member]" } } }, "localname": "GoogleMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_GreaterThan50Million": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Greater than $50 million" } } }, "localname": "GreaterThan50Million", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_GrossUnrealizedGainsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gross Unrealized Gains [Member]" } } }, "localname": "GrossUnrealizedGainsMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_GrossUnrealizedLossesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gross Unrealized Losses [Member]" } } }, "localname": "GrossUnrealizedLossesMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nssi_HewlettPackardEnterpriseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hewlett Packard Enterprise [Member]" } } }, "localname": "HewlettPackardEnterpriseMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ILiadBiotechnologiesLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "I Liad Biotechnologies L L C [Member]" } } }, "localname": "ILiadBiotechnologiesLLCMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_IliadMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Iliad [Member]" } } }, "localname": "IliadMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_IncreaseInProfessionalFeesAndRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase in professional fees and related costs" } } }, "localname": "IncreaseInProfessionalFeesAndRelatedCosts", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_IncreaseOperatingLossAndNetLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase operating loss and net loss" } } }, "localname": "IncreaseOperatingLossAndNetLoss", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_IssuanceWeightedaverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grants of restricted stock units, Weighted Average Grant Date Fair Value" } } }, "localname": "IssuanceWeightedaverageGrantDateFairValue", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "nssi_LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent legal service agreement with dovel and luner for litigation filed in september 2011.", "label": "Legal Service Agreement With Dovel And Luner For Litigation Filed In September 2011 [Member]" } } }, "localname": "LegalServiceAgreementWithDovelAndLunerForLitigationFiledInSeptember2011Member", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_LegalServiceAgreementWithDovelAndLunerForLitigationSettlementFiledInJuly2010Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent Legal Service Agreement With Dovel And Luner For Litigation Settlement In July 2010.", "label": "Legal Service Agreement With Dovel And Luner For Litigation Settlement In July 2010 [Member]" } } }, "localname": "LegalServiceAgreementWithDovelAndLunerForLitigationSettlementFiledInJuly2010Member", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_LicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent License Agreement.", "label": "License Agreement [Member]" } } }, "localname": "LicenseAgreementMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_LicenseesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Licensees One [Member]" } } }, "localname": "LicenseesOneMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_LicenseesTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Licensees Two [Member]" } } }, "localname": "LicenseesTwoMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_LitigationPendingDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Litigation pending, description.", "label": "Litigation pending, description" } } }, "localname": "LitigationPendingDescription", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_MarketableSecuritiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MarketableSecuritiesDisclosureTextBlock", "verboseLabel": "Marketable Securities" } } }, "localname": "MarketableSecuritiesDisclosureTextBlock", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecurities" ], "xbrltype": "textBlockItemType" }, "nssi_NetUnrealizedLossOnCorporateBondsAndNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net unrealized loss on corporate bonds and notes" } } }, "localname": "NetUnrealizedLossOnCorporateBondsAndNotes", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_NewEmploymentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent new employment agreement.", "label": "New Employment Agreement [Member]" } } }, "localname": "NewEmploymentAgreementMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_Next100": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent percentage of next $100 million.", "label": "Next $100 Million" } } }, "localname": "Next100", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_Next125Million": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent next $125 Million.", "label": "Next $125 Million" } } }, "localname": "Next125Million", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_NumberOfSharesCommonStockRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of shares, common stock repurchased" } } }, "localname": "NumberOfSharesCommonStockRepurchased", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_ObligatedToPayM2mAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Obligated to pay M2M" } } }, "localname": "ObligatedToPayM2mAbstract", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ObligatedToPayRecognitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Obligated to pay Recognition" } } }, "localname": "ObligatedToPayRecognitionAbstract", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "nssi_ObligatedToPaySellerNetProceedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Obligated to pay Cox, net proceeds percentage.", "label": "Obligated to pay Cox, net proceeds percentage" } } }, "localname": "ObligatedToPaySellerNetProceedPercentage", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_ObligationToPaySeller": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contigent Obligation to pay seller" } } }, "localname": "ObligationToPaySeller", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_OnAprilFourTwoThousandFourteenAndDecemberThreeTwoThousandFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represent On April 4, 2014 and December 3, 2014.", "label": "On April 4, 2014 and December 3, 2014 [Member]" } } }, "localname": "OnAprilFourTwoThousandFourteenAndDecemberThreeTwoThousandFourteenMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_OperatingLeaseObligations": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating lease obligations" } } }, "localname": "OperatingLeaseObligations", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock option and restricted stock units excluded from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive" } } }, "localname": "OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LossPerShareDetails" ], "xbrltype": "sharesItemType" }, "nssi_OtherInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total marketable securities" } } }, "localname": "OtherInvestment", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_Over250Million": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Over $250 Million", "label": "Over $250 Million" } } }, "localname": "Over250Million", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_OwnershipPercentageFullyDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership percentage fully diluted" } } }, "localname": "OwnershipPercentageFullyDiluted", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_PatentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PatentsPolicyTextBlock", "verboseLabel": "Patents" } } }, "localname": "PatentsPolicyTextBlock", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nssi_PatentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PatentsTextBlock", "verboseLabel": "Patents" } } }, "localname": "PatentsTextBlock", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/Patents" ], "xbrltype": "textBlockItemType" }, "nssi_PercentageRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage revenue" } } }, "localname": "PercentageRevenue", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "nssi_PricePerShareCommonStockRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Price per share, common stock repurchased" } } }, "localname": "PricePerShareCommonStockRepurchased", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_ProratedTargetBonus": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of Target annual bonus paid Chairman and CEO.", "label": "Target annual bonus paid Chairman and CEO" } } }, "localname": "ProratedTargetBonus", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Recognition net proceeds payment related to Mirror Worlds patents" } } }, "localname": "RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_RemotePowerPatentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Remote Power Patent [Member]" } } }, "localname": "RemotePowerPatentMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_RestrictedStockUnitsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units granted" } } }, "localname": "RestrictedStockUnitsGranted", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RestrictedStockUnitsGrantedToDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock units granted to directors" } } }, "localname": "RestrictedStockUnitsGrantedToDirectors", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_RoyaltyBearingLicensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty Bearing Licenses [Member]" } } }, "localname": "RoyaltyBearingLicensesMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "nssi_RoyaltyReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Royalty Receivables" } } }, "localname": "RoyaltyReceivables", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "nssi_RsuSettled": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RSU settled" } } }, "localname": "RsuSettled", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "nssi_SemiAnnualCashDividendRecordDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Semi-annual cash dividend record date", "label": "Semi-annual cash dividend record date" } } }, "localname": "SemiAnnualCashDividendRecordDate", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "nssi_SettlementAndLicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement And License Agreement [Member]" } } }, "localname": "SettlementAndLicenseAgreementMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ShortTermBondFunds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fixed income mutual funds" } } }, "localname": "ShortTermBondFunds", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "nssi_StockBasedCompensationExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price" } } }, "localname": "StockBasedCompensationExercisePrice", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_StockIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2013 Stock Incentive Plan [Member]" } } }, "localname": "StockIncentivePlanMember", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "nssi_ValueOfSharesDeliveredToFundWithholdingTaxes": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ValueOfSharesDeliveredToFundWithholdingTaxes", "negatedLabel": "Value of shares delivered to fund withholding taxes" } } }, "localname": "ValueOfSharesDeliveredToFundWithholdingTaxes", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nssi_ValueOfSharesDeliveredToPayWithholdingTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ValueOfSharesDeliveredToPayWithholdingTax", "verboseLabel": "Value of shares delivered to pay withholding taxes" } } }, "localname": "ValueOfSharesDeliveredToPayWithholdingTax", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_ValueOfSharesDeliveredToPayWithholdingTaxShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ValueOfSharesDeliveredToPayWithholdingTaxShares", "verboseLabel": "Value of shares delivered to pay withholding taxes, Shares" } } }, "localname": "ValueOfSharesDeliveredToPayWithholdingTaxShares", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "nssi_ValueOfSharesDeliveredToPayWithholdingTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Value of shares delivered to pay withholding taxes" } } }, "localname": "ValueOfSharesDeliveredToPayWithholdingTaxes", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_ValueOfSharesDeliveredToPayWithholdingTaxesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Value of shares delivered to pay withholding taxes, Shares" } } }, "localname": "ValueOfSharesDeliveredToPayWithholdingTaxesShares", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "nssi_VestingOfRestrictedStockUnits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Vesting of restricted stock units" } } }, "localname": "VestingOfRestrictedStockUnits", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nssi_VestingOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting of restricted stock units, Shares" } } }, "localname": "VestingOfRestrictedStockUnitsShares", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "nssi_WeightedAveragePricePerShareCommonStockSubjectToRepurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price per share common stock subject to repurchase.", "label": "Average price per share, common stock repurchased since inception" } } }, "localname": "WeightedAveragePricePerShareCommonStockSubjectToRepurchase", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "perShareItemType" }, "nssi_WeightedaverageCommonSharesOutstandingDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average common shares outstanding \u2013 diluted" } } }, "localname": "WeightedaverageCommonSharesOutstandingDiluted", "nsuri": "http://network-1.com/20211231", "presentation": [ "http://network-1.com/role/LossPerShareDetails" ], "xbrltype": "sharesItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r83", "r196", "r200", "r205", "r296", "r297", "r300", "r301", "r336", "r421" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r83", "r196", "r200", "r205", "r296", "r297", "r300", "r301", "r336", "r421" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r207", "r213", "r243", "r244", "r349", "r350", "r351", "r352", "r353", "r354", "r373", "r405", "r407", "r422", "r423" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r207", "r213", "r243", "r244", "r349", "r350", "r351", "r352", "r353", "r354", "r373", "r405", "r407", "r422", "r423" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r144", "r230", "r231", "r374", "r404", "r406" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r144", "r230", "r231", "r374", "r404", "r406" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r207", "r213", "r236", "r243", "r244", "r349", "r350", "r351", "r352", "r353", "r354", "r373", "r405", "r407", "r422", "r423" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r207", "r213", "r236", "r243", "r244", "r349", "r350", "r351", "r352", "r353", "r354", "r373", "r405", "r407", "r422", "r423" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r147", "r332" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_VicePresidentMember": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "label": "Vice President [Member]" } } }, "localname": "VicePresidentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AcceleratedShareRepurchasesTextBlock": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.", "label": "Stock Repurchase Program" } } }, "localname": "AcceleratedShareRepurchasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r22", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r16", "r38", "r39", "r40", "r394", "r412", "r413" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r37", "r40", "r46", "r47", "r48", "r85", "r86", "r87", "r299", "r408", "r409", "r451" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r14", "r265", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r85", "r86", "r87", "r262", "r263", "r264", "r307" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r70", "r178" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization of patents" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r246", "r259", "r266" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Restricted stock unit compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r57", "r70", "r209", "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r79", "r132", "r136", "r142", "r159", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r296", "r300", "r314", "r337", "r339", "r380", "r393" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r35", "r79", "r159", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r296", "r300", "r314", "r337", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r247", "r261" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r247", "r261" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r84", "r127" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/Business" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r20", "r72" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of year", "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of year" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets", "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r10", "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r67", "r315" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC insured limit" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash in excess of FDIC insured limit" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositAtCarryingValue": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate. A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit). Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties. Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r30", "r186", "r382", "r397" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r183", "r184", "r185", "r193", "r420" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common stock available for issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Cash dividends declared per share", "terseLabel": "Semi-annual cash dividend per common share", "verboseLabel": "Common Stock, Dividends, Per Share, Declared" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r85", "r86", "r307" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r13", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r13", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.01 par value; authorized 50,000,000 shares; 23,792,212 and 24,105,879 shares issued and outstanding at December 31, 2021 and December\u00a031, 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r42", "r44", "r45", "r53", "r385", "r401" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r121", "r122", "r146", "r311", "r312", "r419" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r121", "r122", "r146", "r311", "r312", "r416", "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r121", "r122", "r146", "r311", "r312", "r416", "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r120", "r121", "r122", "r123", "r311", "r313", "r419" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r121", "r122", "r146", "r311", "r312", "r419" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r75", "r298" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r58", "r79", "r159", "r196", "r197", "r198", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r314" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Costs of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Goods and Service [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Current" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r80", "r278", "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r80", "r278", "r286", "r288" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current", "verboseLabel": "Total Current Tax Expense (Benefit)" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r80", "r278", "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Notes conversion, description" } } }, "localname": "DebtConversionDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r28", "r208", "r323" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r29", "r207", "r310" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "verboseLabel": "Dividend payment date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r80", "r279", "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r70", "r80", "r279", "r286", "r287", "r288" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred taxes, net", "verboseLabel": "Total Deferred Tax Expense (Benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r267", "r268" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOtherTaxExpenseBenefit": { "auth_ref": [ "r80", "r280", "r285" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.", "label": "Deferred tax expense (benefit)" } } }, "localname": "DeferredOtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r80", "r279", "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets (liability): Net operating loss carry forwards" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r276", "r277" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carry forwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r276", "r277" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r273" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": { "auth_ref": [ "r235" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.", "label": "Contractual obligation to pay royalties" } } }, "localname": "DefinedBenefitPlanSettlementsBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r36", "r302", "r303", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Per Share:", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r54", "r90", "r91", "r92", "r93", "r94", "r98", "r101", "r106", "r107", "r108", "r112", "r113", "r308", "r309", "r386", "r402" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r54", "r90", "r91", "r92", "r93", "r94", "r101", "r106", "r107", "r108", "r112", "r113", "r308", "r309", "r386", "r402" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r109", "r110" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r109", "r110", "r111", "r114" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Loss Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r81", "r270", "r289" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Income tax - statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r270", "r289" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Valuation allowance on deferred tax assets" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r270", "r289" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Permanent difference" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent", "verboseLabel": "Total" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r270", "r289" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State and other, net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average amortized period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r260" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized restricted stock unit compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r46", "r47", "r48", "r85", "r86", "r87", "r89", "r95", "r97", "r115", "r161", "r226", "r227", "r262", "r263", "r264", "r282", "r283", "r307", "r316", "r317", "r318", "r319", "r320", "r321", "r408", "r409", "r410", "r451" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Ownership percentage not fully diluted" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r21", "r133", "r156" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Investment" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestment" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r21", "r66", "r158", "r314" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r325", "r326", "r327" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Amortization of right of use asset" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r151", "r152", "r153", "r154", "r155", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r210", "r224", "r306", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r440", "r441", "r442", "r443", "r444", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r177" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026 and thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r179" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r179" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r179" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r179" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r174", "r175", "r177", "r180", "r375", "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r177", "r376" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Gross carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r174", "r176" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r177", "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Estimated remaining economic useful of patents" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r177" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Patents, net of accumulated amortization", "verboseLabel": "Patents, net" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets", "http://network-1.com/role/PatentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainContingencyPatentsFoundInfringedUponNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of entity's patents that another entity was found to have infringed.", "label": "Patents owned" } } }, "localname": "GainContingencyPatentsFoundInfringedUponNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative" ], "xbrltype": "integerItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r61", "r70", "r150" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "negatedLabel": "Loss from equity investment" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r60" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r171", "r172", "r339", "r378" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "verboseLabel": "Equity investment" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r181", "r182" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Carrying Value, Recoverability and Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r132", "r135", "r138", "r141", "r143" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "INCOME (LOSS) BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r51", "r70", "r130", "r156", "r383", "r399" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "totalLabel": "INCOME (LOSS) BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE:" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r70" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r81", "r271", "r272", "r275", "r284", "r290", "r292", "r293", "r294" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r82", "r96", "r97", "r131", "r269", "r285", "r291", "r403" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Total Income Taxes", "totalLabel": "Total income taxes (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES PROVISION (BENEFIT):" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r69" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "verboseLabel": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r69" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Increase (Decrease) in Other Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r69" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r69" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Royalty receivables" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInSecurityDeposits": { "auth_ref": [ "r69" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in security deposits.", "label": "Security deposit" } } }, "localname": "IncreaseDecreaseInSecurityDeposits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "auth_ref": [ "r102", "r103", "r104", "r108" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.", "label": "Dilutive effect of stock options and restricted stock units" } } }, "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r387" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest and dividend income, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Investments": { "auth_ref": [ "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Aggregrate investment" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAndOtherNoncurrentAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments, and noncurrent assets classified as other.", "label": "Convertable note investment" } } }, "localname": "InvestmentsAndOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Contingent legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Proceedings" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LegalProceedings" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r24", "r79", "r137", "r159", "r196", "r197", "r198", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r297", "r300", "r301", "r314", "r337", "r338" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r19", "r79", "r159", "r314", "r339", "r381", "r396" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY:" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r27", "r79", "r159", "r196", "r197", "r198", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r297", "r300", "r301", "r314", "r337", "r338", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Plantronics Litigation" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation." } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG TERM LIABILITIES:" } } }, "localname": "LongTermNotesPayableAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r4", "r25" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable securities, at fair value" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesGainLoss": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Marketable Securities, Gain (Loss)", "negatedLabel": "Sales of marketable securities" } } }, "localname": "MarketableSecuritiesGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "verboseLabel": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLoss": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Net realized and unrealized gain (loss) on marketable securities" } } }, "localname": "MarketableSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "Schedule of Marketable Securities" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/MarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r56" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Marketable Securities, Unrealized Gain (Loss)", "negatedLabel": "Unrealized (gain) loss on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r67" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r67" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "NET CASH PROVIDED BY INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r67", "r68", "r71" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r41", "r43", "r48", "r52", "r71", "r79", "r88", "r90", "r91", "r92", "r93", "r96", "r97", "r105", "r132", "r135", "r138", "r141", "r143", "r159", "r196", "r197", "r198", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r309", "r314", "r384", "r400" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income", "totalLabel": "NET INCOME (LOSS)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CASH FINANCING ACTIVITY" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r62" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER INCOME" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r132", "r135", "r138", "r141", "r143" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "OPERATING INCOME (LOSS)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r9", "r26" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r11", "r379", "r392" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "totalLabel": "Total Other Assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER ASSETS:" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r33", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r40", "r46", "r47", "r49", "r316", "r318", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Net unrealized holding loss on corporate bonds and notes arising during the year, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER COMPREHENSIVE LOSS" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherInvestmentNotReadilyMarketableAxis": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Group of items that represent other investments not readily marketable, including description of investment, fair value, and value as measured by quoted value method.", "label": "Other Investment Not Readily Marketable [Axis]" } } }, "localname": "OtherInvestmentNotReadilyMarketableAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherInvestmentNotReadilyMarketableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Investment Not Readily Marketable [Line Items]" } } }, "localname": "OtherInvestmentNotReadilyMarketableLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherInvestmentNotReadilyMarketableNameDomain": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Name of the investment category or actual investment title." } } }, "localname": "OtherInvestmentNotReadilyMarketableNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestmentNotReadilyMarketableTable": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Description of the information about other investments not readily marketable, including, but not limited to, description of investment, fair value and value as measured by quoted price.", "label": "Other Investment Not Readily Marketable [Table]" } } }, "localname": "OtherInvestmentNotReadilyMarketableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/MarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r65" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchases of common stock, inclusive of commissions" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r65" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Aggregate cost of common stock repurchased since inception" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r65" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Cash dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r63" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Development of patents" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r149" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r247", "r261" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PolicyholdersDividendPolicy": { "auth_ref": [ "r390", "r391", "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for method of allocating earnings and dividends to policyholder. Includes, but is not limited to, policyholder in participating insurance contract.", "label": "Policyholders' Dividend [Policy Text Block]", "verboseLabel": "Dividend Policy" } } }, "localname": "PolicyholdersDividendPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r12", "r211" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r12", "r211" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r12", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.01 par value; authorized 10,000,000 shares; none issued and outstanding at December 31, 2021 and December 31, 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r64" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Maximum convertible debt offering" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EquityInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r417", "r418" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees and related costs" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r237", "r330", "r331", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r328", "r329", "r331", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/RelatedPartyTransaction" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Shares delivered for withholding taxes" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r15", "r227", "r265", "r339", "r395", "r411", "r413" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r85", "r86", "r87", "r89", "r95", "r97", "r161", "r262", "r263", "r264", "r282", "r283", "r307", "r408", "r410" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r50", "r79", "r128", "r129", "r134", "r139", "r140", "r144", "r145", "r146", "r159", "r196", "r197", "r198", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r314", "r388" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "REVENUE", "verboseLabel": "Total Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesWagesAndOfficersCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Annual base salary" } } }, "localname": "SalariesWagesAndOfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Net shares received" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of components of the income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/DividendPolicyDetailsNarrative", "http://network-1.com/role/EmploymentArrangementsAndOtherAgreementsDetailsNarrative", "http://network-1.com/role/RelatedPartyTransactionDetailsNarrative", "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of components of deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/BusinessDetailsNarrative", "http://network-1.com/role/EquityInvestmentDetailsNarrative", "http://network-1.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of statutory restrictions on the payment of dividends as prescribed by the National Association of Insurance Commissioners or state regulatory authorities.", "label": "Dividend Policy" } } }, "localname": "ScheduleOfDividendPaymentRestrictionsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/DividendPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of reconciliation of income tax" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r174", "r176", "r375" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of patent" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r247", "r261" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Restricted Stock Units" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r250", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of future amortization of current intangible" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/PatentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r34" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security deposits" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r69" ], "calculation": { "http://network-1.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows", "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Stock options exercised to purchase shares on cashless basis" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Option exercisable at end of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Option exercise price at end of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r252", "r261" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Option outstanding, ending balance", "periodStartLabel": "Option outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Option outstanding exercise price, at end of year", "periodStartLabel": "Outstanding exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r258" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Aggregate intrinsic value of options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r245", "r248" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative", "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "verboseLabel": "Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Unvested Resricted stock, Outstanding Number of shares, Ending Balance", "periodStartLabel": "Restricted stock, Outstanding Number of shares, Beginning Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance", "periodStartLabel": "Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested restricted stock units" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "negatedLabel": "Vested restricted stock units, Weighted Average Grant Date Fair Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at ending, Shares", "periodStartLabel": "Balance at beginning, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r32", "r46", "r47", "r48", "r85", "r86", "r87", "r89", "r95", "r97", "r115", "r161", "r226", "r227", "r262", "r263", "r264", "r282", "r283", "r307", "r316", "r317", "r318", "r319", "r320", "r321", "r408", "r409", "r410", "r451" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r85", "r86", "r87", "r115", "r374" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/PatentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Grants of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r12", "r13", "r226", "r227", "r254" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Cashless exercise of options, Shares", "negatedLabel": "Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://network-1.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r32", "r226", "r227" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Cashless exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetails1", "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Plan expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, dollar amount" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r12", "r13", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Treasury shares purchased and retired, Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r12", "r13", "r226", "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Treasury shares purchased and retired" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r13", "r17", "r18", "r79", "r148", "r159", "r314", "r339" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance \u2013 December 31, 2021", "periodStartLabel": "Balance \u2013 December 31, 2020", "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets", "http://network-1.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r78", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r225", "r227", "r229" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r322", "r341" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r322", "r341" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r322", "r341" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r322", "r341" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r340", "r342" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://network-1.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r151", "r152", "r153", "r154", "r155", "r210", "r224", "r306", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r440", "r441", "r442", "r443", "r444", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r116", "r117", "r118", "r119", "r124", "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates and Assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Potentially Dilutive Shares" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/LossPerShareDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r100", "r108" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).", "label": "Number of shares, common stock repurchased since inception" } } }, "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/StockRepurchaseProgramDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r98", "r108" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted-average common shares outstanding \u2013 basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://network-1.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://network-1.com/role/LossPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1828-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r127": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653" }, "r229": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r232": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "http://asc.fasb.org/topic&trid=2122478" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r294": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8,17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r342": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "820", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6480747&loc=d3e6772-158386" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(14)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6483535&loc=d3e16392-158451" }, "r415": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "505", "Topic": "944", "URI": "http://asc.fasb.org/subtopic&trid=4738323" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r424": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r425": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r426": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r427": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r428": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r429": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r430": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r431": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r432": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r433": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r434": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r435": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r436": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r437": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r438": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r439": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r440": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r441": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r442": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r443": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r444": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r445": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r446": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r447": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r448": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r449": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r450": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r84": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256" } }, "version": "2.1" } ZIP 74 0001072613-22-000370-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001072613-22-000370-xbrl.zip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

PG:J)W=NZY3%H03BL7V MEA0@H[Q;7>G7Z$ ?3H:[3C;]=@X2FTW)@=VF"H^(ZD"S>1DL[H%\='_GGI/!@^R6C$2<-N$IAT?1[O6,@EL9&7'0EZ]8ISC:9JK 7\J M\[SME+Q!QY 1]A<5H5\3].RNF=XU2'!2K6.14'CD^:'\% C-$@"%%,.>74H& M^*#J5N6E=2-P2$IJ9JO6ZB!M=P8NG'2"M]C3A NMT5;K[8:O(T0^"=F5"7?* M%?Z%14Z6L#E+KT.\PXMN9.K'>@=#F<0FE-EAY6,QW@%./BQX'2V5[NLRB4VT M#8T.@_;*,/3U$-]4VH(1*/'$'AGZ@$C 33E)V ML5=--"_@YZX1\5X7"H-&8BUFAGD1!& N^K"#11577S@I=G*,_J&<�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